UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
OR
x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2002
OR
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission file number 0-30394
Metalink Ltd.
(Exact name of Registrant as specified in its charter)
Israel
(Jurisdiction of
incorporation or organization)
Yakum Business Park, Yakum 60972, Israel
(Address of principal executive offices)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which registered
None None
Securities registered or to be registered pursuant to Section 12(g) of the Act:
Ordinary Shares, NIS 0.1 par value per share
(Title of Class)
Securities for which there is a reporting obligation pursuant to
Section 15(d) of the Act:
None
(Title of Class)
Indicate the number of outstanding shares of each of the issuer's classes
of capital or common stock as of the close of the period covered by the annual
report:
18,552,056 Ordinary Shares, NIS 0.1 par value per share
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. x Yes o No
Indicate by check mark which financial statement item the registrant has
elected to follow. o Item 17 x Item 18
Except for the historical information contained herein, the statements
contained in this annual report are forward-looking statements, within the
meaning of the Private Securities Litigation Reform Act of 1995 with respect to
our business, financial condition and results of operations. Actual results
could differ materially from those anticipated in these forward-looking
statements a result of various factors, including all the risks discussed in
"Item 3-Key Information-Risk Factors" and elsewhere in this annual report.
We urge you to consider that statements which use the terms "believe," "do
not believe," "expect," "plan," "intend," "estimate," "anticipate," and similar
expressions are intended to identify forward-looking statements. These
statements reflect our current views with respect to future events and are based
on assumptions and are subject to risks and uncertainties. Except as required by
applicable law, including the securities laws of the United States, we do not
intend to update or revise any forward-looking statements, whether as a result
of new information, future events or otherwise.
As used in this annual report, the terms "we," "us," "our," and "Metalink"
mean Metalink Ltd., and our consolidated subsidiary, unless otherwise indicated.
"Multi-Mode DSL(TM)", "NML(TM)", "Olympus-DSL(TM)", "Turbo SDSL(TM)"and
"VDSLPlus(TM)" are our trademarks. All other trademarks and trade names
appearing in this annual report are owned by their respective holders.
TABLE OF CONTENTS
Page
PART I
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS 1
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 1
ITEM 3. KEY INFORMATION 2
ITEM 4. INFORMATION ON THE COMPANY 20
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 31
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 43
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 56
ITEM 8. FINANCIAL INFORMATION 58
ITEM 9. THE OFFER AND LISTING 60
ITEM 10. ADDITIONAL INFORMATION 64
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 81
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 82
PART II
ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES 83
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS
AND USE OF PROCEEDS 83
ITEM 15. [RESERVED] 83
ITEM 16. [RESERVED] 83
PART III
ITEM 17. FINANCIAL STATEMENTS 84
ITEM 18. FINANCIAL STATEMENTS 84
ITEM 19. EXHIBITS 85
PART I
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS
Not applicable.
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE
Not applicable.
ITEM 3. KEY INFORMATION
A. Selected Financial Data
We have derived the following selected consolidated financial data presented
below for each of the years ended December 31, 2002, 2001 and 2000 from our
consolidated financial statements and notes included in this annual report. The
selected consolidated financial data for the years ended as of December 31, 1999
and 1998 have been derived from audited financial statements not included in
this annual report. Our consolidated financial statements have been prepared in
accordance with U.S. GAAP. You should read the selected consolidated financial
data together with the section of this annual report entitled "Operating and
Financial Review and Prospects" and our consolidated financial statements
incorporated by reference to this annual report. Please see note 2 of our
consolidated financial statements for an explanation of the number of shares
used in computing per share data.
Year Ended December 31,
1998 1999 2000 2001 2002
(In thousands, except share and per share data)
Statement of Operations Data:
Revenues $ 9,159 $ 11,708 $ 23,302 $ 14,049 $ 6,636
Cost of revenues:
Costs and expenses 5,040 5,878 9,794 6,086 4,589
Royalties to the Government
of Israel 143 209 469 364 144
Total cost of revenues 5,183 6,087 10,263 6,450 4,733
Gross profit 3,976 5,621 13,039 7,599 1,903
Operating expenses:
Gross research and
development 3,839 6,065 12,592 17,060 15,240
Royalty bearing grant 1,301 1,965 3,381 3,457 3,213
Research and development, net 2,538 4,100 9,211 13,603 12,027
Sales and marketing, net 1,510 2,026 3,665 5,465 4,814
General and administrative 798 1,138 3,042 3,526 2,884
Non-cash compensation 182 382 791 745 799
Total operating expenses 5,028 7,646 16,709 23,339 20,524
Operating loss (1,052) (2,025) (3,670) (15,740) (18,621)
Financial income (expenses), net:
Interest income (expenses), net (63) 145 5,986 4,629 2,283
Non-cash charge for warrants - (1,400) - - -
Total financial income
(expenses), net (63) (1,255) 5,986 4,629 2,283
Net (loss) profit $(1,115) $(3,280) $ 2,316 $(11,111) $(16,338)
Earnings (loss) per share:
Basic $ (0.09) $ (0.27) $ 0.13 $ (0.61) $ (0.89)
Diluted $ (0.09) $ (0.27) $ 0.11 $ (0.61) $ (0.89)
Shares used in computing
earnings (loss) per
ordinary share:
Basic 12,010,745 12,309,339 18,269,556 18,260,798 18,407,190
Diluted 12,010,745 12,309,339 20,773,382 18,260,798 18,407,190
As of December 31,
1998 1999 2000 2001 2002
(In thousands)
Consolidated Balance Sheet Data:
Cash and cash equivalents $ 1,013 $ 4,281 $ 8,851 $ 15,946 $ 9,158
Short-term investments - 42,816 86,268 64,967 20,691
Long-term investments - 2,952 15,344 9,172 46,197
Working capital 1,396 46,971 97,324 82,430 32,719
Total assets 5,455 55,850 125,266 104,733 89,706
Short-term bank
credits and loans 500 - - - -
Shareholders equity 2,351 50,991 117,632 98,497 83,558
B. Capitalization and Indebtedness
Not Applicable.
C. Reasons for the Offer and Use of Proceeds
Not Applicable.
D. Risk Factors
Our business, operating results and financial condition could be seriously
harmed due to any of the following risks. If we do not successfully address any
of the risks described below, we could experience a material adverse effect on
our business, results of operations and financial condition, and our share price
may decline. We cannot assure you that we will successfully address any of these
risks.
Slowdown in the telecommunication industry might continue to adversely affect
our business and results of operations.
Telecommunications service providers and their customers are the principal
end-users of substantially all of our products. During 2001 and 2002, the
telecommunications industry in much of the world, including in our principal
markets, has been experiencing an apparent slowdown, resulting in decreases and
delays in the procurement and deployment of new telecommunications equipment. As
a result, we experienced a significant decline in demand for our products in
2001 and 2002. It is likely that any prolonged and substantial curtailment of
growth in the telecommunications industry will have an adverse effect, which may
be material, upon us. Any such curtailment may result from circumstances
unrelated to us or our product offerings and over which we have no control. In
addition, a market perception that these conditions could have an impact on our
company may harm the trading prices of our shares, whether or not our business
and results of operations are actually affected.
In the past six months we achieved significant design wins across Asia-Pacific
including Korea, Japan, China and Taiwan. Should the SARS disease continue to
spread in the Asia Pacific region, it might have a material adverse effect on
our ability to gain substantial revenues from these design wins.
Our future financial performance will depend significantly on the successful
marketing, market acceptance , and our ability to increase the revenues from our
VDSL chip sets worldwide, and in the Asia pacific region, in particular. If for
any reason our revenues from these chip sets decrease, or do not increase, our
results of operations will be harmed. Thus, the spread of the SARS disease in
the Asia Pacific region, and in particular in Korea, Japan, China and Taiwan,
may have a materially adverse effect on our revenues.
We have a history of operating losses.
We have incurred significant operating losses since our inception, and we may
not achieve operating profitability for the foreseeable future. We reported
operating losses of approximately $3.7 million for the year ended December 31,
2000, $15.7 million for the year ended December 31, 2001, and $18.6 million for
the year ended December 31, 2002. As of December 31, 2002, our accumulated
deficit was approximately $33.9 million. We reported revenues of approximately
$6.6 million for the year ended December 31, 2002. Despite the fact that we are
making expenditures in anticipation of generating higher revenues, our revenues
may not grow and may even continue to decline. Moreover, even if we are
successful in increasing our revenues, we may be delayed in doing so. If our
revenues do not increase as necessary or if our expenses increase at a greater
pace than our revenues, we will not likely be able to achieve, sustain or
increase profitability on a quarterly or annual basis. Our quarterly operating
results are volatile. This may cause our share price to decline.
Our quarterly operating results have varied significantly in the past and are
likely to vary significantly in the future.
These variations result from a number of factors, many of which are
substantially outside of our control, including:
o Our revenues depend upon the size, timing and shipment of orders for our chip
sets, especially large orders from some of our customers. We do not receive
orders in the same amounts each quarter.
o Our customers may not be able to forecast their needs or accurately or
efficiently manage their inventory positions.
o Year-end customer ordering patterns have caused our revenues to be strongest
in the first and second quarters of 2001 and 2002 and to be weaker in other
quarters of the year. We can not assure you that these quarters will be the
strongest ones in the future, as these facts may be also a result of other
factors such as the apparent slowdown in the telecommunication industry during
these years.
o Our limited order backlog makes revenues in any quarter substantially
dependent on orders received and delivered in that quarter.
o Customers may cancel or postpone orders in our backlog.
o The timing and level of market acceptance for existing chip sets, chip sets
under development and new applications or chip sets introduced by us or by our
competitors is uncertain.
o The effectiveness of our customers in marketing and selling their DSL
equipment.
o Changes in pricing by us or our competitors.
o Unfavorable changes in the prices of the components we purchase or license.
o Because only a small portion of our expenses varies with our revenues, if
revenue levels for a quarter fall below our expectations, our earnings will
decrease.
o A delay in the receipt of revenue arising from postponement of orders by
customers or, shipping delays of existing orders, even from one customer, may
have a significant negative impact on our results of operations for a given
period. We have experienced such delays in the past, and our results of
operations for those periods were, as a result, negatively impacted.
o The mix of chip sets sold and the mix of sales channels through which they are
sold.
o Changes in resource allocation by our customers due to their operating budget
cycles.
o Deferrals of customer orders in anticipation of new applications or new chip
sets introduced by us or by our competitors.
o Delays in delivery by the subcontractors who manufacture our chips.
o General economic conditions.
Because of the variations which we have experienced in our quarterly operating
results, we do not believe that period-to-period comparisons of our results of
operations are necessarily meaningful or should necessarily be relied upon as
indicators of future performance.
Accordingly, our operating results may be below public expectations in future
fiscal periods. Our failure to meet these expectations may cause our share price
to decline.
The loss of one or more of our key customers would result in a loss of a
significant amount of our revenues.
Relatively few customers account for a large percentage of our net revenues. Our
business will be seriously harmed if we do not generate as much revenue as we
expect from these customers, or if we experience a loss of any of our
significant customers, or suffer a substantial reduction in orders from those
customers. In 2002, we had only one customer which accounted for more than 10%
of our revenues, namely ECI, which accounted for 45% of our revenues. We cannot
be certain that this customer will maintain these levels of purchases. We do not
have contracts with any of our customers that obligate them to continue to
purchase our chip sets, and these customers could cease purchasing our chip sets
at any time. We expect that sales of our chip sets to relatively few customers
will continue to account for a significant portion of our net revenues for the
foreseeable future.
If the market for DSL solutions does not continue to develop, we will not be
able to sell enough of our chip sets to achieve, sustain or increase
profitability.
DSL solutions compete with a variety of different high-speed data
transmission technologies, including cable modem, satellite and wireless
technologies. If any technology that competes with DSL technology is more
reliable, faster or less expensive, reaches more customers or has other
advantages over DSL technology, the demand for our chip sets will decrease, and
we may not sell enough of our chip sets to achieve, sustain or increase
profitability.
Substantial sales of our chip sets will not occur unless end-customer
telecommunication service providers increasingly deploy DSL systems.
The success of our products is dependent upon the decision by end-customer
telecommunication service providers to deploy DSL systems that include our
chipsets and the timing of the deployment. Factors that will impact the
deployment include:
o a prolonged approval process, including laboratory tests, technical trials,
marketing trials, initial commercial deployment and full commercial deployment.
This process usually takes approximately a year in Europe and United States and
around six months in the Asia Pacific region. During this process we are subject
to numerous tests and trials, under which we may not continue to the final stage
of commercial deployment;
o the development of a viable telecommunication service provider business model
for DSL systems and services, including the capability to market, sell, install
and maintain DSL systems and services; o cost constraints, such as installation
costs and space and power requirements at the telecommunication service
provider's central office, affect purchases of DSL systems that contain our
chipsets;
o varying and uncertain conditions of the local loop, including the size and
length of the copper wire, electrical interference and interference with
existing voice and data telecommunication services;
o challenges of interoperability among DSL equipment manufacturers' products,
which may affect sales of the systems in which our chipsets are contained;
o evolving and current industry standards for DSL technologies that could affect
the end-market for our products; and
o government regulations, including regulation of telecommunication service
providers' rates and ability to recapture capital expenditures on DSL systems,
by governments in the United States and around the world.
If telecommunication service providers do not expand their deployment of DSL
systems or if additional telecommunication service providers do not offer DSL
services on a timely basis, our business will be harmed. Recently a standards
working group in the United States reached consensus position to develop a draft
proposed American National Standard for VDSL using Multi Carrier Modulation
(DMT) and a draft proposed Committee T1 Technical Requirement (TRQ) document for
VDSL using Single Carrier Modulation (QAM). As Metalink's VDSL chip sets are
based on QAM, if DMT is ultimately adopted as a standard our business would be
adversely affected.
If the DSL equipment manufacturers which utilize our chip sets are not
successful in selling their systems, sales of our chip sets will decline
significantly.
We rely upon DSL equipment manufacturers to integrate our chip sets into their
DSL systems. If their systems are not successful, we will not be able to sell
our chip sets to them in substantial quantities. Their systems may be
unsuccessful for a large number of reasons, substantially all of which are
beyond our control.
Our chip sets may not adequately serve the needs of end users.
Our chip sets are sold primarily through OEMs. Thus, the feedback that we
receive with respect to the field performance of our chip sets from
telecommunication service providers and their users may be limited. This may
impair our ability to design chip sets that are responsive to the needs of the
end users of our chip sets. This may harm the market acceptance of our chip
sets.
We currently depend on sales of our European standard, E1 HDSL and SDSL, chip
sets.
For the year ended December 31, 2002, we derived approximately 58% of our
revenues from our E1 HDSL and SDSL chip sets. Our future financial performance
will depend significantly on the successful marketing and market acceptance of
this line of chip sets. If for any reason our revenues from this chip set
decrease, our results of operations will be harmed.
If we do not achieve "design wins" with equipment manufacturers during the
design stage of a new product, we may be unable to secure production orders from
these customers in the future.
Once a DSL equipment manufacturer has designed its system to include a
particular supplier's chip set, the DSL equipment manufacturer may be reluctant
to change its source of chip sets. Accordingly, the failure to achieve design
wins with key DSL equipment manufacturers could create barriers to future sales
opportunities.
We must develop new chip sets and new applications for our existing chip sets to
remain competitive. If we fail to do so on a timely basis, we may lose market
share.
The markets for DSL solutions such as ours are characterized by:
o rapid technological changes;
o frequent new product introductions;
o changes in customer requirements; and
o evolving industry standards.
Accordingly, our future success will depend to a substantial extent on our
ability to:
o invest significantly in research and development;
o develop, introduce and support new chip sets and new applications for existing
chip sets on a timely basis;
o gain market acceptance of our chip sets;
o anticipate customer requirements; and
o comply with industry standards. We may not be able to complete the development
and market introduction of new chip sets or new applications successfully. If we
fail to develop and deploy new chip sets and new applications on a timely basis,
we may lose market share to our competitors and our revenues will decline.
Because competition in the market for our solutions is intense, we may lose
market share, and we may be unable to achieve or maintain profitability.
Our market is highly competitive, and we expect competition to intensify in the
future. We may not be able to compete effectively in our market, and we may lose
market share to our competitors. Our principal competitors include Conexant
Systems, Inc., GlobeSpanVirata, Infineon Technologies AG, Ikanos Communications
Inc and ST Microelectronics Inc. We expect to continue to face competition from
these and other competitors. Larger companies with substantial resources, brand
recognition and sales channels may form alliances or merge with, or acquire
competing DSL chip set providers and emerge as significant competitors. In
addition, competitors may bundle their products or incorporate a DSL chip set
component into existing products in a manner that renders our chip sets
obsolete.
Competition may result in lower prices and a corresponding reduction in our
ability to recover our costs. This may impair our ability to achieve or maintain
profitability.
We expect that price competition among DSL chip set suppliers will reduce our
gross margins in the future. We anticipate that average selling prices of DSL
chip sets will continue to decline as product technologies mature. Since we do
not manufacture our own chip sets, we may be unable to reduce our manufacturing
costs in response to declining average per unit selling prices. Many of our
competitors are larger and have greater resources than we do. These competitors
may be able to achieve greater economies of scale and may be less vulnerable to
price competition than we are. Declines in average selling prices will generally
lead to declines in gross margins for chip sets. If we are unable to recover
costs, we will likely be unable to achieve profitability.
In order to attain and maintain profitability, we must manage our resources
effectively in a volatile market.
The volatility of our industry has placed, and will continue to place, a
significant strain on our managerial, operational and financial resources. We
must also implement sophisticated inventory and control systems. We cannot
assure you that our management team will be able to work together effectively to
manage our organization.
To manage resources effectively, particularly in slower economic times, we must:
o improve and expand our Management Information Systems ("MIS") . Specifically,
in January 2001, we implemented a new Enterprise Resources Planning ("ERP")
system - "Oracle Application System" - in order to manage our information
systems. The new system supports the control of our operations. In order to
better manage our organization to deal with potential growth in the future, we
are considering implementation of additional modules and enhanced existing ones
in the ERP system;
o hire, train, manage and retain qualified employees when the business is
growing, and, when industry conditions decline, reduce the workforce; and
o effectively manage relationships with our customers, subcontractors, suppliers
and other third parties.
We cannot assure you that we have made adequate allowances for the costs and
risks associated with this volatility, that our systems, procedures or controls
will be adequate to support our operations, or that our management will be able
to offer and expand our product categories successfully to meet changing market
conditions. Any delay in implementing, or transitioning to, new or enhanced
systems, procedures or controls may seriously harm our ability to record and
report financial and management information on a timely and accurate basis or
otherwise manage our expanding operations. If we are unable to do so
effectively, our revenues may not increase, our costs of operations may increase
and our business may be harmed.
Because we operate in international markets, we are subject to additional risks.
We currently offer our chip sets in a number of countries, through independent
sales representatives and distributors, and we intend to enter additional
geographic markets. Our business is subject to risks which often characterize
international markets, including:
o potentially weak protection of intellectual property rights;
o economic and political instability;
o import or export licensing requirements;
o trade restrictions;
o difficulties in collecting accounts receivable;
o longer payment cycles;
o unexpected changes in regulatory requirements and tariffs;
o seasonal reductions in business activities in some parts of the world, such as
during the summer months in Europe;
o the impact of SARS or other regional epidemics;
o fluctuations in exchange rates; and
o potentially adverse tax consequences.
These risks may impair our ability to generate revenues from our increased
global sales efforts.
Because of our long product development process and sales cycle, we may incur
substantial expenses before we earn associated revenues.
We incur substantial product development and marketing expenditures prior to
generating associated revenues. We do not receive substantial orders for our
chip sets during the period that potential customers test and evaluate our chip
sets. This period typically lasts from six to twelve months or longer, and
volume production of products that incorporate our chip sets typically does not
begin until this test and evaluation period has been completed. As a result, a
significant period of time may elapse between our product development and sales
efforts and any realization by us of revenues from volume ordering of our chip
sets by our customers, or we may never realize revenues from our efforts.
Because we do not have long-term contracts with our customers, our customers can
discontinue purchases of our chip sets at any time.
We sell our chip sets based on individual purchase orders. Our customers are not
obligated by long-term contracts to purchase our chip sets. Our customers can
generally cancel or reschedule orders upon short notice. Furthermore, achieving
a design win with a customer does not necessarily mean that this customer will
order large volumes of our products. A design win is not a binding commitment by
a customer to purchase our chip sets. Rather, it is a decision by a customer to
use our chip sets in the design process of that customer's products. A customer
can discontinue using our chip sets at any time.
We currently rely on a limited number of subcontractors to manufacture and
assemble our chips.
We currently rely on a single subcontractor for the manufacture of each chip
included in our chip sets and on a limited number of subcontractors for the
assembly of finished chips and other related services. Our subcontractors
manufacture, assemble and test our chips in Singapore, South Korea, the Republic
of China (Taiwan) and the United States. These subcontractors currently have
limited manufacturing capacity, which may be inadequate to meet our demand. If
the operations of our subcontractors were halted, even temporarily, or if they
were unable to operate at full capacity for an extended period of time, we could
experience business interruption, increased costs, loss of goodwill and loss of
customers. Delays in the manufacture of chip sets are typical in our industry,
and we have experienced these delays in the past. Regional epidemics, such as
SARS, could also have a negative impact on our suppliers.
We are dependent upon a limited number of suppliers of key components.
We currently obtain key components from a single supplier or from a limited
number of suppliers. We generally do not have long-term supply contracts with
our suppliers. These factors subject us to the following risks:
o delays in delivery or shortages in components could interrupt and delay the
manufacturing and delivery of our chip sets and may result in cancellation of
orders by our customers;
o suppliers could increase component prices significantly and with immediate
effect;
o we may not be able to develop alternative sources for chip set components, if
and as required in the future; o suppliers could discontinue the manufacture or
supply of components used in our chip sets. In such event, we might need to
modify our chip sets, which may cause delays in shipments, increased
manufacturing costs and increased chip sets prices; and
o we may hold more inventory than is immediately required to compensate for
potential component shortages or discontinuance.
We may experience delays in the delivery of components from our suppliers.
Delays and shortages in the supply of components are typical in our industry. We
have experienced delays and shortages on more than one occasion in the past. In
addition, failure of worldwide semiconductor manufacturing capacity to rise
along with a rise in demand could result in our subcontract manufacturers
allocating available capacity to other customers, including customers that are
larger or have long-term supply contracts in place. Our inability to obtain
adequate foundry capacity at acceptable prices, or any delay or interruption in
supply, could reduce our revenues or increase our cost of revenue and could harm
our business and results of operations.
Undetected hardware and software errors may increase our costs and impair the
market acceptance of our chip sets.
Our chip sets may contain undetected errors. This may result either from errors
we have failed to detect or from errors in components supplied by third parties.
These errors are likely to be found from time to time in new or enhanced chip
sets after commencement of commercial shipments. Because our customers integrate
our chip sets into their systems with components from other vendors, when
problems occur in a system it may be difficult to identify the component which
has caused the problem. Regardless of the source of these errors, we will need
to divert the attention of our engineering personnel from our product
development efforts to address the detection of the errors. We may incur
significant warranty and repair costs related to errors, and we may also be
subject to liability claims for damages related to these errors. The occurrence
of errors, whether caused by our chip sets or the components of another vendor,
may result in significant customer relations problems and injury to our
reputation and may impair the market acceptance of our chip sets.
Our success depends on our ability to attract, train and retain qualified
engineers and sales and technical support personnel.
Upon growth in our business, we will need to hire additional engineers and
highly trained technical support personnel in Israel, North America, Europe and
in the Asia Pacific region. We currently have a small technical support staff.
To support any growth, we will need to increase our technical staff to support
new customers and the expanding needs of existing customers as well as our
continued research and development operations.
Hiring highly qualified engineers and technical support personnel is competitive
in our industry, due to the limited number of people available with the
necessary skills and understanding of our products. Our success depends upon our
ability to attract, train and retain highly qualified engineers and technical
support personnel.
Our chip sets require a sophisticated marketing and sales effort targeted at
several levels within a prospective customer's organization. As competition for
qualified sales personnel continues, we may not be able to hire sufficient sales
personnel to support our marketing efforts.
We are dependent on our key personnel, in particular Tzvi Shukhman, our chief
executive officer, the loss of whom would negatively affect our business.
Our future success depends in large part on the continued services of our senior
management and key personnel. In particular, we are highly dependent on the
services of Tzvi Shukhman, our chairman and chief executive officer. All of our
employees have entered into employment contracts with us except for Mr.
Shukhman. We do not carry key person life insurance on our senior management or
key personnel. Any loss of the services of Tzvi Shukhman, other members of
senior management or other key personnel could negatively affect our business.
A majority of the Company's outstanding shares are held by two individuals, who
exert significant control over the Company's direction.
At June 16, 2003, 10,717,451 ordinary shares (57.7%) are held by Messrs. Tzvi
Shukhman and Uzi Rozenberg, who are directors of the Company. Mr. Shukhman is
also ceo and chairman of the board of Metalink. Currently, Messrs. Shukhman and
Rozenberg control the outcome of various actions that require shareholder
approval. For example, these shareholders could elect all of our directors,
delay or prevent a transaction in which shareholders might receive a premium
over the prevailing market price for their shares and prevent changes in control
or management. In addition, Messrs. Shukhman and Rozenberg are parties to a
voting agreement, pursuant to which they act in concert with respect to the
nomination and election of directors.
Messrs. Shukhman and Rozenberg have filed a registration statement with the
Securities and Exchange Commission relating to 10,565,651 shares. Were they to
sell all of those shares, they would no longer have the ability to direct the
voting of those shares, and new management could be elected.
In addition, because these shares are held by affiliates of the Company, they
are not generally considered to be included in the "public float" of the
Company's tradable shares. The market price for all shares could drop
significantly as these shares are sold, or as the market perceives such a sale
as imminent.
Our profitability could suffer if third parties infringe upon our proprietary
technology.
Our profitability could suffer if third parties infringe upon our intellectual
property rights or misappropriate our technologies and trademarks for their own
businesses. To protect our rights to our intellectual property, we rely on a
combination of patent, trademark and copyright law, trade secret protection,
confidentiality agreements and other contractual arrangements with our
employees, affiliates, strategic partners and others. We currently own five
unregistered trademarks, two patents in Israel and three patents in the United
States. We have also filed one additional provisional patent application in the
United States. The protective steps we have taken may be inadequate to deter
misappropriation of our proprietary information. We may be unable to detect the
unauthorized use of, or take appropriate steps to enforce, our intellectual
property rights. Moreover, pursuant to current U.S. and Israeli laws, we may not
be able to enforce existing non-competition agreements. Effective patent,
trademark, copyright and trade secret protection may not be available in every
country in which we offer, or intend to offer, our products. Any failure to
adequately protect our intellectual property could devalue our proprietary
content and impair our ability to compete effectively. Further, defending our
intellectual property rights could result in the expenditure of significant
financial and managerial resources.
Our products may infringe on the intellectual property rights of others.
Third parties may assert against us infringement claims or claims that we have
violated a patent or infringed a copyright, trademark or other proprietary right
belonging to them. For example, the ownership by an unaffiliated third party of
a valid trademark with respect to the name Metalink, or the use of that name by
any unaffiliated third party (whether or not a valid trademark exists), could
cause confusion and otherwise have a material adverse effect upon our business
and financial condition. In addition, any infringement claim, even if not
meritorious, could result in the expenditure of significant financial and
managerial resources.
We may need to raise additional funds, which may not be available.
We expect that the net proceeds from our initial public offering and secondary
public offering and cash from operations will be sufficient to meet our working
capital and capital expenditure needs for at least the next twelve months. After
that, we may need to raise additional funds in the future for a number of uses,
including:
o expanding research and development programs;
o hiring additional qualified personnel;
o implementing further marketing and sales activities; and
o acquiring complementary businesses.
We may not be able to obtain additional funds on acceptable terms or at all. If
we cannot raise needed funds on acceptable terms, we may not be able to:
o develop new products;
o enhance our existing products;
o remain current with evolving industry standards;
o take advantage of future opportunities; or
o respond to competitive pressures or unanticipated requirements.
We may encounter difficulties with acquisitions, which could harm our business.
We may make investments in complementary companies, products or technologies. If
we acquire a company, we may have difficulty integrating that company's
personnel, operations, products and technologies. These difficulties may disrupt
our ongoing business, distract our management and employees and increase our
expenses.
Volatility of our share price could adversely affect our shareholders.
The market price of our ordinary shares is likely to be highly volatile and
could be subject to wide fluctuations in response to numerous factors, including
the following:
o actual or anticipated variations in our quarterly operating results or those
of our competitors;
o announcements by us or our competitors of technological innovations;
o introduction and adoption of new industry standards;
o introductions of new products by us or our competitors;
o announcements by us or by securities analysts of changes in financial
estimates;
o conditions or trends in our industry;
o changes in the market valuations of our competitors;
o announcements by us or our competitors of significant acquisitions;
o entry into strategic partnerships or joint ventures by us or our competitors;
o additions or departures of key personnel;
o sales of ordinary shares.
Many of these factors are beyond our control and may materially adversely affect
the market price of our ordinary shares, regardless of our performance.
Our ordinary shares have been listed for trading on the Nasdaq National Market
since December 2, 1999. As of December 3, 2000, our ordinary shares have also
been listed for trading on the Tel Aviv Stock Exchange. Volatility of the price
of our ordinary shares on either market is likely to be reflected on the price
of our ordinary shares on the other market. In addition, fluctuations in
exchange rate between the New Israeli Shekel or NIS and the dollar may affect
the price of our ordinary shares on the Tel Aviv Stock Exchange and, as a
result, may affect the market price of our ordinary shares on the Nasdaq
National Market.
Investors may not be able to resell their ordinary shares following periods of
volatility because of the market's adverse reaction to that volatility. In
addition, the stock market in general, and the market for Israeli and technology
companies in particular, has been highly volatile. We cannot assure you that our
ordinary shares will trade at the same levels of shares of other technology
companies or that shares of technology companies in general will sustain their
current market prices.
If we continue to be characterized as a passive foreign investment company, our
U.S. shareholders may suffer adverse tax consequences.
If, for any taxable year, our passive income, or our assets which produce
passive income, exceed specified levels, we may be characterized as a passive
foreign investment company, or PFIC, for U.S. federal income tax purposes. This
characterization could result in adverse U.S. tax consequences to our
shareholders. As previously announced, we believe that we were characterized as
a PFIC for 2001 and 2002. Although we will endeavor to avoid such
characterization in the future, we may not be able to do so. Any U.S. person who
held our shares at any time during 2001 or 2002 was eligible to mitigate the
consequences of our PFIC characterization by electing to treat us as a
"qualified electing fund" or QEF under the Internal Revenue code. The QEF
election would result in the U.S. taxpayer annually including in income a pro
rata share of the Company's earnings and net capital gains, regardless of
whether the Company distributes any gains. During 2001 and 2002, the Company did
not have earnings, so no income was includable in U.S. taxpayers' income.
Alternatively, U.S. taxpayers were also able to make a "mark-to-market" election
under the Internal Revenue Code, under which the taxpayer treats the shares as
if they were sold and immediately repurchased at the close of each taxable year.
In a mark-to-market election, the U.S. taxpayer must include as ordinary income
the amount of any increase in the market value of the shares since the close of
the preceding taxable year, or the beginning of the taxpayer's holding period,
if less than one year. We recommend that shareholders consult their own tax
advisers about the PFIC rules generally and about the advisability, procedure
and timing of their making QEF or mark-to-market elections.
Risks Relating to Our Location in Israel
Conditions in Israel affect our operations and may limit our ability to produce
and sell our products.
Our principal offices and research and development facilities are located in
Israel. Political, economic and military conditions in Israel directly affect
our operations. We could be adversely affected by any major hostilities
involving Israel, the interruption or curtailment of trade between Israel and
its trading partners, a significant increase in inflation, or a significant
downturn in the economic or financial condition of Israel. The future of the
"peace process" between Israel and the Palestinians is uncertain and has
deteriorated due to on-going violence between Israelis and Palestinians. Such
ongoing hostilities may hinder Israel's international trade relations and may
limit the geographic markets where we can sell our products. Furthermore,
certain parties with whom we do business have declined to travel to Israel
during this period, forcing us to make alternative arrangements where necessary,
and the United States Department of State has issued advisories regarding travel
to Israel, impeding the ability of travelers to attain travel insurance.
Moreover, several countries still restrict business with Israel and with Israeli
companies. We could be adversely affected by adverse developments in the "peace
process" or by restrictive laws or policies directed towards Israel or Israeli
businesses.
Some of our directors, officers and employees are currently obligated to perform
annual reserve duty and are subject to being called to active duty at any time
under emergency circumstances. We cannot assess the full impact of these
requirements on our workforce or business if conditions should change and we
cannot predict the effect on us of any expansion or reduction of these
obligations.
Provisions of Israeli law may delay, prevent or make difficult a merger or
acquisition of us, which could prevent a change of control and depress the
market price of our shares.
The Israeli Companies Law generally requires that a statutory merger be approved
by a company's board of directors and by a majority of the shares voting on the
proposed merger. With respect to the shareholder vote of each potential merger
partner, unless a court rules otherwise, the merger will not be deemed approved
if a majority of the ordinary shares held by shareholders which are not the
other potential merger partner (nor a person who holds 25% or more of the shares
of capital stock or has the right to appoint 25% or more of the directors, of
the other potential merger partner) vote against the merger. Upon the request of
any creditor of a party to the proposed merger, a court may delay or prevent the
merger if it concludes that there is a reasonable concern that, as a result of
the merger, the surviving company will be unable to satisfy its obligations. In
addition, a merger may not be completed unless at least 70 days have passed
since the filing of the merger proposal with the Israeli Registrar of Companies.
Finally, Israeli tax law treats some acquisitions, such as stock-for-stock
exchanges between an Israeli company and a foreign company less favorably than
U.S. tax laws. For example, Israeli tax law may, under certain circumstances,
subject a shareholder who exchanges his ordinary shares for shares in another
corporation to taxation prior to the sale of the shares received in such
stock-for stock swap.
These provisions of Israeli corporate and tax law and the uncertainties
surrounding such law may have the effect of delaying, preventing or making more
difficult a merger or acquisition of us. This could prevent a change of control
of us and depress the market price of our ordinary shares which otherwise might
rise as a result of such a change of control.
Because substantially all of our revenues are generated in U.S. dollars while a
portion of our expenses are incurred in New Israeli Shekels, our results of
operations may be seriously harmed if the rate of inflation in Israel exceeds
the rate of devaluation of the NIS against the U.S. dollar or if the NIS is
appreciated against the U.S. dollar.
We generate substantially all of our revenues in dollars, but we incur a portion
of our expenses, principally salaries, related personnel expenses and occupancy
expenses in NIS. As a result, we are exposed to the risk that the rate of
inflation in Israel will exceed the rate of devaluation of the NIS in relation
to the dollar or that the timing of this devaluation lags behind inflation in
Israel or that the NIS is appreciated against the dollar. In 2002 the NIS was
depreciated against the dollar in the rate of 7.27% while the rate of inflation
was 6.5%. We can not be certain that the trends which have affected us in 2002
will continue. If the dollar costs of our operations in Israel increase, our
dollar-measured results of operations will be adversely affected.
To date, we have not engaged in hedging transactions. In the future, we might
enter into currency hedging transactions to decrease the risk of financial
exposure from fluctuations in the exchange rate of the dollar against the New
Israeli Shekel. These measures may not adequately protect us from material
adverse effects due to the impact of inflation in Israel.
The tax benefits we currently receive require us to meet several conditions,
which we may fail to satisfy.
Our investment programs were granted the status of an approved enterprise under
Israel's Law for Encouragement of Capital Investments, 1959, pursuant to which
we have elected the alternative package of tax benefits. To be eligible for tax
benefits as a result of the approved enterprise status granted to us under
Israeli law, we must continue to meet certain conditions, including making
certain investments in fixed assets, financing a percentage of investments with
share capital and maintaining a minimum level of revenues. If we fail to meet
such conditions in the future, the tax benefits would be canceled and we could
be required to refund the tax benefits already received. This could harm our
business and our profitability.
The tax benefits we currently receive may be reduced in the future.
The tax benefits we receive may not be continued in the future at their current
levels or at all. Israeli governmental authorities have indicated that the
government may reduce or eliminate these benefits in the future. The termination
or reduction of these tax benefits could harm our business and our
profitability.
The government programs we currently participate in require us to meet several
conditions, which we may fail to satisfy.
We have received grants from the Office of the Chief Scientist of the Ministry
of Industry and Trade of the Government of Israel for the financing of a
significant portion of our research and development expenditures in Israel, and
we intend to apply for additional grants in the future. If, for any reason, the
Office of the Chief Scientist determined that we have not complied with the
terms of our grants or the R&D Law, or it is determined that an approval for a
grant was knowingly obtained due to false or misleading statements, we could be
exposed to penalties, suspension or cancellation of the grant approvals, the
refund of benefits previously granted (plus linkage to the consumer price index
and interest) and denial of any future applications for grants or these
consents, and the savings that have been previously realized in our research and
development programs as a result of these grants would no longer be available to
us, potentially increasing the Company's operating expenses.
The government programs in which we currently participate may be terminated or
reduced in the future.
The Israeli authorities have indicated that the government may reduce or abolish
grants from the Office of the Chief Scientist of the Ministry of Industry and
Trade in the future. Termination or substantial reduction of Chief Scientist
grants would require us to divert other funds to research and development and
increase our other operational costs.
It may be difficult to enforce a U.S. judgment against us, our officers and
directors.
We are incorporated in Israel. The majority of our executive officers and
directors are nonresidents of the United States, and a substantial portion of
our assets and the assets of these persons are located outside the United
States. Therefore, it may be difficult to enforce a judgment obtained in the
United States against us or any of these persons.
ITEM 4. INFORMATION ON THE COMPANY
A. History and Development of the Company
Metalink was incorporated in September 1992 as a corporation under the laws of
the State of Israel. In September 2000, we moved our principal executive offices
from Tel-Aviv to a new location at Yakum Business Park, Yakum 60972, Israel. Our
telephone number is 972-9-960- 5555. In 1997, we established a wholly-owned
subsidiary in the United States, Metalink Inc., which is incorporated in
Delaware. Metalink Inc. is involved in research and development activities,
provides technical support to our customers and conducts the distribution of our
products in North America. Metalink Inc. is located at 105C Lake Forest Way,
Folsom, California 95630, and its telephone number is 916-355-1580.
In December 1999, we completed our initial public offering of 4,600,000 ordinary
shares and our ordinary shares commenced trading on the Nasdaq National Market
under the symbol "MTLK". In March 2000, we completed our secondary public
offering of 1,500,000 ordinary shares. As of December 3, 2000, our ordinary
shares are traded also on the Tel-Aviv Stock Exchange.
During the period between December 2000 and April 2001 we have purchased at
market price at broker transactions 898,500 of our ordinary shares for
approximately $9.88 million, pursuant to a repurchase program authorized by our
board and approved by the Tel-Aviv District Court.
In January 2001, we implemented a new enterprise resources planning system. The
new system supports the control of our operations.
Capital expenditures were $0.8 million for year 2002. The expenditures were
principally for capital equipment and software used in our research and
development activities.
B. Business Overview General
We design, develop and market digital subscriber line (DSL) chip sets used by
manufacturers of telecommunication equipment. Our chip sets enable the digital
transmission of voice, video and data over copper wire communications lines at
speeds that are up to 1,000 times faster than transmission rates provided by
conventional analog modems. Our chip sets typically include two individual
integrated circuits, or chips, and include an analog front-end (AFE) for line
interfacing with analog signals and a digital signal processor (DSP) / framer
for signal and data processing of the messages being transmitted. We are a
leader in DSL semiconductor technology because of our expertise in the
development of advanced modem algorithms, in the design of very large scale
integrated circuits and in digital signal processing. We have sold over seven
million of our chips to original equipment manufacturers (OEMs) that incorporate
our chip sets into their own products. These OEMs, which include ECI Telecom
Ltd., Alcatel Networks Corporation, Schmid Telecommunication Ltd., Marconi
Communications GmbH, Siemens AG, ADC Telecommunications Inc, and others, have
sold products containing our chip sets to telecommunication service providers
throughout the world, including Bell Canada, Qwest, Verizon, British Telecom,
Deutsche Telecom, Telecom Italia and France Telecom. In addition, we engage in
the research and development of high-throughput wireless local area networks
(HT-WLAN) chipsets. Solutions under this category enable digital broadband
communications of voice, video and data at significantly higher rates than
conventional wireless local area networking (WLAN) solutions. We are an Israeli
company and our principal executive offices
are located at Yakum Business Park, Yakum 60972, Israel. Our telephone number is
972-9-960-5555.
Products and Technology
We offer a broad suite of DSL chip set solutions. A typical chip set consists of
an analog front-end (AFE) device and a digital device. The AFE serves as an
interface between the analog signals transmitted along the copper wire and the
digital device. The AFE performs various analog signal-processing functions,
such as converting the analog signals into digital format and vice-versa. The
digital device include multiple functions including the transceiver (DSP)
section implementing the modulation and demodulation of the digital signal, the
framer section which serves as an interface between the DSP functional block and
the digital network system. In some cases the digital device may contain
additional functionality such as a network processor, higher layers processing
etc.
Our chip sets support the transmission of digital transmissions over copper wire
using different line codes, including two bit per quadrant (2BlQ), pulse
amplitude modulation (PAM) and quadrature amplitude modulation (QAM). Each of
our chip sets is software programmable to meet the specific needs of each
customer. This enables the implementation of multiple DSL configurations, such
as high bit-rate DSL ( HDSL) and Symmetric DSL (SDSL), a broad range of
transmission rates, performance enhancement and feature upgrades in compliance
with various industry standards.
HDSL. HDSL is a cost-effective alternative to traditional repeatered T1 (in
North America) and El (in the rest of the world) transmission services, which
generally offer transmission speeds of 1.5 or 2.0 megabits per second, (Mbps).
The HDSL system creates a link between the central office and a customer network
premise over unconditioned copper wire. T1 HDSL has been standardized by the
American National Standards Institute, or ANSI, and allows the transmission of
1.544 Mbps over two copper wire pairs using 2BlQ line code. El HDSL has been
standardized by the European Telecom Standards Institute (ETSI) and allows the
transmission of 2.320 Mbps over either one, two or three copper wire pairs,
depending on the operator's deployment strategy and generally uses the 2BlQ line
code. ETSI's specifications for 1-Pair HDSL were also adopted by the
International Telecommunication Union (ITU). We currently offer El HDSL for
1-Pair, 2- Pair and 3-Pair copper wire configurations and a T1 HDSL which is a
2-Pair configuration, each of which uses 2BlQ line coding. We were the driving
force in setting the ETSI standard for 1- Pair El HDSL solutions.
SDSL. Similar to HDSL, SDSL uses 2BlQ encoding to offer a symmetric link over a
single copper wire at maximum symmetric rates of 2.320 Mbps. SDSL is used by
competitive local exchange carriers, or CLECs, to allow their business customers
cost effective access to the network, including high-speed access to the
Internet and remote local area networks (LANs), integrated with multiple
transmissions of voice channels and video conferencing. To date, the SDSL
technology has been recognized as an accepted specification and is not likely to
be adopted as a formal standard by any of the standardizing bodies. We currently
offer chip sets for SDSL-based systems in various configurations.
HDSL2 and HDSL4. HDSL2 improves on the T1 HDSL 2-Pair solution by offering
similar performance achieved using only a single copper wire pair. This is
achieved by using the PAM-16 line code in combination with Trellis coding. This
standard was further enhanced to support an extended reach 4 wire mode, using
the same PAM-16 line code referred to as HDSL4. During 2002 we completed the
development and integration of our second generation HDSL2/HDSL4/SHDSL DSP
product, and the new device combined with our HDSL2/HDSL4/SHDSL AFE is now being
shipped in commercial volumes.
G.SHDSL. G.SHDSL improves on the SDSL and HDSL technologies by providing rate
adaptive solutions at rates of up to 2.320 Mbps, while increasing the maximum
range of transmissions by 20%, compared to that allowed by the legacy
technologies. G.SHDSL supports various encoding technologies, including the
technologically-advanced Trellis coded PAM-16. We are a contributor to the
standardization of G.SHDSL, and we have developed proprietary algorithms for the
efficient implementation of this technology. During the year 2001, we completed
the development and integration of our first generation SHDSL solution that
includes an eight-port G.SHDSL digital device, a single port G.SHDSL digital
device and an single port G.SHDSL analog front end. During 2001 we also
completed the development of a second generation digital device optimized for
T1/E1 transport applications. This device, incorporated the entire digital
functionality of a T1/E1 transport application combining the DSL transceiver and
framer, T1/E1 framer, host processor and RAM. To the best of our knowledge, this
is the only device available in the market with such high levels of optimization
and integration for T1/E1 transport applications. We offer a variety of SHDSL
products for CO, CPE and repeater applications which are being installed in
major operator networks including Deutche Telekom, France Telecom, Telecom
Italia and British Telecom.
VDSL. VDSL technology defines very high transmission rates over a single copper
wire pair. This includes symmetric transmission at a rate of up to 30 Mbps and
asymmetric transmission of 100 Mbps downstream and 6 Mbps upstream. VDSL is
typically deployed in combination with an optical network unit. This unit is
connected by copper wire to multiple subscribers located in large complexes,
such as large residential complexes, hotels and campuses. The unit multiplexes
the bandwidth of hundreds of subscribers onto a single fiber that carries the
information to the central office. VDSL applications include high bandwidth
data, multiple video and voice channels, broadband access and broadband wide
area networks (WANs). VDSL has been standardized by ANSI and ETSI and is
currently at its standardization stage in ITU-T and IEEE. We are an active
participant in all these standardization processes. Recently a standards working
group in the United States reached consensus position to develop a draft
proposed American National Standard for VDSL using Multi Carrier Modulation
(DMT) and a draft proposed Committee T1 Technical Requirement (TRQ) document for
VDSL using Single Carrier Modulation (QAM). We have developed powerful
algorithms for VDSL, including NML, that optimize the performance in the
operating environment. During 2001, we finished the development and started
integration of two generations of VDSL solutions, including a single port 2-band
digital device, a single port 4-band digital device, a dual port 3-band device
and a single port 4-band analog front end. To the best of our knowledge these
devices were the first available standard compliant solutions according to the
quadrature amplitude modulation (QAM)-based ETSI and ANSI standards. During 2002
we completed the development of our 3rd generation VDSL product family including
a Quad and Single port full 4-band VDSL devices. These devices address the
Ethernet over VDSL (EoVDSL) market requirements which are rapidly evolving in
the Asia-Pacific region. To the best of our knowledge, the Quad device was the
first to integrate four full 4-band standard VDSL ports in a single package.
The following is a table of our proprietary chips which form the chip sets
offered by us to our customers:
The following is a table of our proprietary chips which form the chip sets
offered by us to our customers:
Chips Function Sampling Date Maximum Transmission Rates(Mbps)
MtH 1242 2BlQ AFE 2Q97 1.168
MtH 2441 2BlQ AFE 3Q99 2.320
MtH 2443 Low-power, small size 2BIQ AFE 3Q99 2.320
MtH 2445 2B1Q AFE 2.320
MtH 1210BL 2BlQ encoding/decoding DSP 2Q97 1.168
MtH 2410BL Low-power 2BlQ encoding/decoding DSP 1Q99 2.320
MtH 2411 Advanced, low-power 2BlQ encoding/decoding DSP 3Q99 2.320
MtH 2430CL Universal T1 /El standards compliant framer 3Q98 2.320
MtH 2431 Single Pair Framer 2.320
MtH 2470 Dual Advanced, low-power integrated dual 3Q99 2.320
DSP and dual framer
MtS 870 Octal SHDSL transceiver/framer 4Q00 4.640
MtS 170 Single SHDSL transceiver frame 1Q01 4.640
MtS 140 Single SHDSL AFE 4Q00 4.640
MtS 142 Single SHDSL/HDSL2/HDSL4 AFE with integrated 2Q01 4.640
line-driver
MtS180 SHDSL/HDSL2/HDSL4 system on a chip for T1/E1 1Q02 4.640
/TDM transport applications
MtS172 SHDSL/HDSL2/HDSL4 transciever with integrated T1/E1 2Q02 4.640
framer
MtV 9170 VDSL transceiver/framer for 2-band applications 1Q01 26
MtV 9370 Dual VDSL transceiver/framer for 3-band applications 3Q01 52
MtV 9171 VDSL transceiver/framer for 4-band applications 4Q01 52
MtV 9141 VDSL AFE for 2,3 and 4-band applications 4Q01 52
The following table enumerates our product applications:
Chip Set Applications Products Configuration
Octal G.shdsl SHDSL CO application MtS870 Each chip set consists of one octal DSP / framer and eight AFE chips.
MtS140 OR
MtS142 DSP / framer and eight AFE chips.
G.shdsl CPE application MtS170 Each chip-set consist of a single DSP / framer chip and a single AFE chip.
MtS140 OR
MtS142 / framer and a single AFE chip.
Single pair T1 HDSL2 and E1 G.SHDSL MtS170 Each chip-set consist of a single DSP / framer chip and a single AFE chip.
MtS140 OR
MtS142 / framer and a single AFE chip.
Two pair T1 HDSL4 and E1 G.SHDSL MtS170 Each chip-set consist of a two DSP / framer chip and two AFE chips.
MtS140
MtS142
Single pair T1 HDSL2 MtS180 Each chip-set consist of a single DSP / framer chip and a single AFE chip.
MtS142
Two pair T1 HDSL4 MtS180 Each chip-set consist of a single system on a chip, single DSM /Framer,
MtS172 and two AFE devices
MtS142
CO dual three band VDSL application MtV9370 Each chip-set consist of a DSP/ framer chip and two AFE chips.
MtV9141
CO and CPE four band VDSL application MtV9171 Each chip-set consist of a single DSP / framer chip and a single AFE chip.
MtV9141
CPE two-band VDSL application MtV9170 Each chip-set consist of a single DSP / framer chip and four AFE chips.
EoVDSL four-band CO application MtV9141
MtV9470
MtV9141
EoVDSL CPE four band VDSL application MtV9172 Each chip-set consist of a DSP / framer chip and fsingle AFE chip.
MtV9141
Customers
Our customers, telecommunication equipment manufacturers, incorporate our chip
sets into the products that they sell to telecommunication service providers.
Since we commenced operations in 1993, we have shipped over seven million of our
chips to our customers, or OEM partners, including ECI, Marconi Communications,
Alcatel, Schmid, Siemens, ADC Telecommunications Inc, and others. These chips
are used in telecommunication equipment deployed worldwide by telecommunications
service providers including Bell Canada, Qwest, Verizon, British Telecom,
Deutshe Telekom, Telecom Italia and France Telecom. Our largest customer is ECI
which accounted for more than 10% of our total sales in 2002. We do not have
purchase contracts with any of our customers that obligate them to continue to
purchase our chip sets and these customers could cease purchasing our chip sets,
at any time.
Our chip sets are being incorporated into the following systems:
o T1/El transmission equipment, which is used by telecommunications service
provider to enable transmission speeds of 1.544 Mbps, for T1 lines, and 2.048
Mbps, for El lines;
o Digital subscriber line access multiplexers (DSLAMs), which are used to
terminate up to hundreds of lines in a central office and aggregate them onto
high-speed lines for transmission to the communications backbone;
o DSL enabled Digital loop carriers (DLC), which are used to terminate up to
hundreds of DSL and telephony lines, typically in a remote terminal (RT) or an
optical network unit (ONU);
o Ethernet based Digital subscriber line access multiplexers (DSLAMs) and
Ethernet Switches, which are used to terminate tens of lines in a building
basement or street cabinet and aggregate them onto high-speed Optical Ethernet
link for transmission to the communications backbone;
o DSL network interface units, which are customer premises equipment
that enable high-speed data transmission over the local loop;
o DSL-compatible routers, which are used to connect one or more personal
computers to the local loop;
o DSL-integrated access device (IAD) that combine voice and data transport
over single twisted pair; and
o DSL residential gateways and set-top boxes (STB) that combined Video, Voice
and Data transport over single twisted pair.
Our customers market their products to public and private telecommunications
service providers. These service providers include incumbent local exchange
carriers or ILECs, CLECs and Internet service providers.
The following is a summary of revenues by geographic area. Revenue is attributed
to geographic region based on the location of the customers.
Year ended December 31,
2002 2001 2000
(in thousands)
Revenues:
Israel $ 3,170 $ 3,070 $ 8,227
United States 1,285 680 569
Italy 913 326 156
Switzerland 144 5,329 6,356
Canada 93 2,989 6,053
Other foreign countries
(mainly European) 1,031 1,655 1,941
$ 6,636 $14,049 $23,302
Sales and Marketing
We have established a worldwide network of independent sales representatives and
distributors. These independent entities are selected for their ability to
provide effective field sales, marketing communications and technical support to
our customers.
We have sales representative in the following countries:
Europe: Austria, France, Germany, Italy, Poland, Portugal and Spain.
Asia: Republic of China (Taiwan), People Republic of China (Mainland China),
Japan, Singapore and South Korea.
North America: Canada and the United States
South America: Brazil.
The listed sales representatives, also, offer our customers technical support
and customer services.
We also sell our products directly to select customers in
Israel and Europe. Direct sale customers include ECI and Schmid. Our sales
force, technical support personnel and key engineers work together in teams to
support key customers. We have located technical support capabilities in key
geographic locations.
Our marketing strategy focuses on key customer sponsorships to promote early
adoption of our chip sets in the products of DSL equipment manufacturers who are
market innovators and market leaders. Through our ongoing relationships,
customers provide us with feedback on product specifications and applications
while participating in product testing simultaneously with our certification
process. This approach accelerates customers' time to market, enables us to
achieve early design wins and volume commitments for our chip sets.
We intend to continue to invest resources in marketing communications efforts,
including participation in trade shows and trade events and direct marketing
campaigns. These efforts are directed at enhancing our brand recognition and
building our reputation as a leading developer of DSL chip sets, as well as our
customer service and responsiveness.
Research and Development
We believe that our future success will depend upon our ability to maintain our
technological leadership, to enhance our existing products and to introduce on a
timely basis new commercially viable products addressing the needs of our
customers. Accordingly, we intend to continue to devote a significant portion of
our personnel and financial resources to research and development. As part of
the product development process, we seek to develop close relationships with
industry innovators in our target segments and engage in product development
partnerships to meet their needs.
As of May 31, 2003 our research and development staff consisted of 99 employees.
Research and development activities take place at our facilities in Yakum,
Israel and at the design centers of our subsidiary in Folsom, California, and
Georgia, Atlanta. We intend to continue adding research and development
personnel in the near future. We deploy standard procedures for the design,
development and quality assurance of our new product developments.
The Government of Israel, through the Office of the Chief Scientist of the
Israeli Ministry of Industry and Trade, encourages research and development
projects which result in products for export. Since 1995, we received grants
from the Office of the Chief Scientist for the development of our products. See
"Item 5-Operating and Financial Review and Prospects-Operating
Results-Government Grants." We expect our research and development expenses to
grow as we hire additional personnel to develop new, and upgrade existing
products.
Manufacturing
We do not own or operate a semiconductor fabrication facility. As
a fabless provider of chip sets, we subcontract our entire semiconductor
manufacturing to third party contractors. Our chip sets are delivered to us
fully assembled and tested based on our proprietary designs. The use of the
fabless model allows us to focus substantially most of our resources on
determining customer requirements and on the design, development and support of
chip sets and to have significantly reduced capital requirements.
We currently subcontract our semiconductor wafer manufacturing to Chartered
Semiconductor Manufacturing Corporation in Singapore and Taiwan Semiconductor
Manufacturing Company (TSMC) and the packaging and testing of our chip sets to
Singapore Technologies Assembly and Test Services (STATS), Advanced
Semiconductor Engineering Inc. (ASE Inc.) & ASE Test Ltd and Amkor Technology
Inc in Korea. The selection of these manufacturers was based on the breadth of
available technology, quality, manufacturing capacity and support for design
tools used by us. All of the fabrication, assembly and test facilities are ISO
9002 / QS9000 / SAC certified.
None of our chip sets is currently manufactured by more than one contractor. In
the event one of our contractors notifies us that it intends to cease
manufacturing a chip or that it is temporarily unable to manufacture a chip, we
may not have an adequate opportunity to order sufficient quantities of the
effected chip to prevent shipments to customers from being adversely affected
while we qualify a new manufacturer.
We intend to continue for the foreseeable future to rely on third parties for
substantially all of our wafer manufacturing, assembly and test requirements.
All of our subcontract manufacturers produce products for other companies. We do
not have long-term manufacturing agreements with any of our foundries. Our
foundries are not obligated to supply us with products for any specific period,
in any specific quantity or at any specific price, except as may be provided in
a particular purchase order that has been accepted by one of our foundries.
We must place orders at least 14 to 16 weeks in advance of expected delivery. As
a result, we have only a limited ability to react to fluctuations in demand for
our chip sets, which could cause us to have excess or a shortage of inventory of
a particular chip.
Proprietary Rights
We rely on patent, copyright, trademark and trade secret laws, confidentiality
agreements and other contractual arrangements with our employees, strategic
partners and others to protect our technology. We own unregistered trademarks
for the names NML, Multi-Mode DSL, Turbo SDSL, Olympus-DSL and VDSLPlus. We do
not currently own any registered copyrights.
In addition, our NML technology is protected by two patents in Israel and three
patents in the United States. One of the two Israeli patents was issued in favor
of us following a settlement agreement we entered into with an opposing company.
Most of our chip-sets design is based on the NML technology. We have filed two
additional patent applications in the United States and Israel. These
applications may not result in any patent or patents being issued and, if
issued, the patents may not provide adequate protection against competitive
technology and may not be held valid and enforceable if challenged. In addition,
other parties may assert rights as inventors of the underlying technologies,
which could limit our ability to fully exploit the rights conferred by any
patent that we receive. Our competitors may be able to design around any patent
that we receive and other parties may obtain patents that we would need to
license or circumvent in order to exploit our patents.
Competition
The DSL and the Wireless chip set market is intensely competitive. We expect
competition to intensify as current competitors expand their product offerings
and new competitors enter the market. We believe that we must compete on the
basis of a variety of factors, including time to market, functionality,
conformity to industry standards, performance, price, breadth of product lines,
product migration plans, and technical support.
We believe our principal competitors in the DSL market for HDSL, SDSL, HDSL2 and
G.SHDSL products include, GlobespanVirata, Infineon and Conexant. Our principal
competition for VDSL QAM based products include Infineon. Other competitors
offering VDSL DMT based products include ST Microelectronics and Ikanos. In
addition to these competitors, there have been announcements by other integrated
circuit companies that they intend to enter the DSL chip set market,
specifically ADSL IC companies targting introduction of VDSL DMT products.
We expect to continue to face competition from these and other competitors.
Larger companies with substantial resources, brand recognition and sales
channels may form alliances or merge with, or acquire competing DSL chip set
providers and emerge as significant competitors. For example, in December 2001,
two of our principal competitors, GlobeSpan and Virata, announced the closing of
their merger. Said merger may adversely effect our market share and as a result
might adversely effect our result of operations. In addition, competitors may
bundle their products or incorporate a DSL chip set component into existing
products in a manner that renders our chip sets obsolete.
Further, some of our customers face competition from companies, which design
their own chip sets. Because these companies do not purchase all of their chip
sets from suppliers such as us, if these competitors displace our customers in
the DSL equipment market, our customers would no longer need our chip sets, and
our business would be seriously harmed.
Many of our competitors have greater name recognition, their own manufacturing
capabilities, significantly greater financial and technical resources, and the
sales, marketing and distribution strengths that are normally associated with
large multinational companies. These competitors may also have preexisting
relationships with our customers or potential customers. These competitors may
compete effectively with us because in addition to the above-listed factors,
they more quickly introduce new technologies, more rapidly or effectively
address customer requirements or devote greater resources to the promotion and
sale of their products than we do. Further, in the event of a manufacturing
capacity shortage, these competitors may be able to manufacture products when we
are unable to do so.
As the DSL market matures, the industry may become subject to increasing price
competition driven by the lowest cost providers of chip sets. We anticipate that
average per unit selling prices of DSL chip sets will continue to decline as
product technologies mature. If we are unable to reduce our costs sufficiently
to offset declines in the average per unit selling prices or are unable to
introduce new higher performance products with higher average per unit selling
prices, our operating results will be seriously harmed. Since we do not
manufacture our own products, we may be unable to negotiate volume discounts
with our foundries in order to reduce the costs of manufacturing our chip sets
in response to declining average per unit selling prices. Many competitors are
larger with greater resources and therefore may be able to achieve economies of
scale and would be less vulnerable to price competition. Our inability to
achieve manufacturing efficiencies would have an adverse impact on our operating
results.
C. Organizational Structure
See "Item 5-Operating and Financial Review and Prospects-Over View"
D. Property, Plants and Equipment
Our headquarters and principal administrative, finance, sales and marketing
operations are located in approximately 45,000 square feet of leased office
space in Yakum, Israel. The lease expires in September 2010. In the United
States, we lease approximately 10,000 square feet of office space in Folsom,
California (the Folsom Lease") and we intend to lease 1,300 square feet of
office in Atlanta Georgia. The Folsom Lease will expire in March 2005, and we
will have the option to extend the lease for two additional five-year periods.
In addition we currently lease sales and support office in San Jose, California
(864 square feet). Currently, our offices in San Jose are not occupied and we
intend to try and sublease these premises for the remainder of the lease period,
which concludes March 2004. Aggregate rental payments, at rates in effect at
December 31, 2002 are approximately $936,000 and the projected payments for 2003
are approximately $1,008,000. We may need to increase the size of our current
facilities, seek new facilities, close certain facilities or sublease portions
of our existing facilities in order to address our needs in the future.
Total rent expenses for the years ended December 31, 2002, 2001 and 2000 were
$936,000, $957,000 and $543,000, respectively.
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS
Overview
We design, develop and market digital subscriber line (DSL) chip sets used by
manufacturers of telecommunication equipment. Our chip sets enable the digital
transmission of voice, video and data over copper wire communications lines at
speeds that are up to 1,000 times faster than transmission rates provided by
conventional analog modems. In addition, we engage in the research and
development of high-throughput wireless local area networks (HT-WLAN) chipsets.
Solutions under this category enable digital broadband communications of voice,
video and data at significantly higher rates than conventional wireless local
area networking (WLAN) solutions.
We were incorporated in September 1992 under the laws of the State of Israel.
From our inception through the third quarter of 1994, our operating activities
related primarily to establishing a research and development organization,
developing prototype chip designs which meet industry standards and developing
strategic OEM partnerships with leading telecommunication equipment
manufacturers. We shipped our first chip set in the fourth quarter of 1994.
Since that time, we have continued to focus on developing additional products
and applications, shaping new industry standards and building our worldwide
indirect sales and distribution channels. In addition, in 1997, we established a
wholly owned subsidiary in the United States, Metalink Inc., which is
incorporated in Delaware and is headquartered in Northern California. Metalink
Inc. is involved in research and development activities, provides technical
support to our customers and conducts the distribution of our products in North
America. In 1999, we established our Northern California research and
development design center, and in 2003 we established our Atlanta research and
development design center for our wireless activities. In December 1999, we
completed our initial public offering of 4,600,000 ordinary shares, from which
we received net proceeds of approximately $49.8 million. In March 2000, we
completed our secondary public offering of 1,500,000 ordinary shares, from which
we received net proceeds of approximately $62.7 million.
Critical Accounting Policies
Management's discussion and analysis of our financial condition and
results of operations is based upon our consolidated financial statements, which
have been prepared in accordance with accounting principles generally accepted
in the United States. The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting periods presented. These estimates include assessing the
collectability of accounts receivable, and the use and recoverability of
inventory. Actual results could differ from those estimates. The markets for our
products are characterized by intense competition, rapid technological
development and frequent new product introductions, all of which could impact
the future realizability of our assets.
We believe the following critical accounting policies affect our more
significant judgments and estimates used in the preparation of our consolidated
financial statements.
Revenue recognition
Revenue from product sales is recognized upon shipment to the customer, when the
risk of loss has been transferred to the customer, price and terms are fixed,
and when no significant vendor obligations exist and collection of the resulting
receivable is reasonably assured. Our revenue recognition policy is significant
because our revenue is a key component of our operations. In addition, our
revenue recognition determines the timing of certain expenses, such as sales
commissions. We follow very specific and detailed guidelines in measuring
revenue; however, certain judgments affect the application of our revenue
policy. Revenue results are difficult to predict, and any shortfall in revenue
or delay in recognizing revenue could cause our operating results to vary
significantly from quarter to quarter and could result in future operating
losses.
Inventories
Inventories are stated at the lower of cost or market. Cost is determined on a
moving average basis. We regularly review inventory values and quantities on
hand and write down our inventory for estimated obsolescence or unmarketable
inventory equal to the difference between the cost of inventory and the
estimated market value based upon assumptions about future demand and market
conditions. Our estimates of future product demand may prove to be inaccurate,
in which case we may have understated or overstated the provision required for
excess and obsolete inventory. If actual market conditions are less favorable
than those expected by management, additional inventory write-downs may be
required. If our inventory is determined to be undervalued, we may have
over-reported our costs of goods sold in previous periods and would be required
to recognize such additional operating income at the time of sale. Therefore,
although we make every effort to ensure the accuracy of our estimates of future
product demand, any significant unanticipated changes in demand or technological
developments could have a significant impact on the value of our inventory and
our reported operating results.
A. Operating Results
General
Revenues. Our revenues are derived from sales of our chip sets to our customers
with which we have OEM partnerships for the design of DSL systems based on our
solutions. Our revenues are generated in U.S. dollars, and the majority of our
expenses are incurred in dollars. Consequently, we use the dollar as our
functional currency. Our consolidated financial statements are prepared in
dollars in accordance with generally accepted accounting principles in the
United States. For the year ended December 31, 2002, one customer accounted for
approximately 45% of our revenues.
We sell our chip sets in Europe, Israel, North America and Asia through
independent sales representatives and distributors. We also sell our chip sets
directly to select customers in Israel and Europe. For the year ended December
31, 2002, approximately 76% of our sales were in Europe and Israel, 21% in North
America and 3% in Asia.
Cost of Revenues. Our cost of revenues consists primarily of materials and
components used in the manufacture and assembly of our chips, salaries and other
personnel related expenses for those engaged in operations, fees for
subcontractors who manufacture, assemble and test our chip sets, other overhead
expenses and royalties paid to the Government of Israel and to certain parties.
Gross Research and Development. Research and development expenses consist
primarily of salaries and other personnel related expenses related to the
design, development and enhancement of our products and other overhead expenses.
In addition, we subcontract the layout and mask development production of our
chips to unaffiliated third parties. All research and development costs are
expensed as incurred. We believe that continued investment in research and
development is critical to attaining our strategic product objectives. We expect
these expenses to increase in the future as we continue to develop new products
and product applications.
Research and Development, Net. The Government of Israel, through the Office of
the Chief Scientist, encourages research and development projects which result
in products for export. In 2000, 2001 and 2002, we received grants from the
Office of the Chief Scientist for the development of our products. Research and
development expenses are net of grants received or accrued from the Government
of Israel.
Sales and Marketing. Sales and marketing expenses consist primarily of salaries
and other personnel related expenses for those engaged in the sales, marketing
and support of our products, as well as commissions, trade show, promotional and
public relations expenses. Our success in increasing revenues depends on our
ability to increase our customer base, achieve design wins, drive industry
standards and introduce new products and product applications. Accordingly, we
intend to pursue sales and marketing campaigns, and we therefore expect these
expenses to increase in the future.
General and Administrative. General and administrative expenses consist
primarily of salaries and other personnel related expenses for executive,
accounting and administrative personnel, professional fees, and other general
corporate expenses. As we incur additional costs related to the growth of our
business and our becoming a public company, we expect that general and
administrative expenses will also increase.
Amortization of Deferred Stock Compensation. Amortization of deferred stock
compensation expenses consist of the charge incurred by us arising from the
grant of options to purchase our ordinary shares at exercise prices below the
fair market value of our ordinary shares at the date of the grant. This discount
is recorded and charged to our earnings over the vesting period of the options.
We have recorded a total of $4,667,000 of deferred stock compensation as of
December 31,2002. We have incurred amortization of deferred stock compensation
expenses of $791,000 in 2000, $745,000 in 2001 and $799,000 in 2002.
We expect to recognize stock compensation expenses of $626,000 in 2003, $206,000
in 2004, $15,000 in 2005 and $5,000 in 2006. We cannot guarantee, however, that
we will not accrue additional stock compensation expenses in the future or that
our current estimate of these costs will prove accurate, either of which events
could seriously harm our business and results of operations.
Financial Income , Net. Financial income, net consists primarily of interest
earned on marketable debt securities and certificates of deposits in which we
invested, gains and losses from the exchange differences of monetary balance
sheet items denominated in non-dollar currencies and bank commissions.
Taxes. Israeli companies are generally subject to income tax at the corporate
rate of 36%. However, we are eligible for tax benefits which should result in
our income being taxed at a lower rate for some time after we begin to report
taxable income and exhaust our net loss carry forwards.
The table below sets forth, for the periods indicated, financial data, expressed
as a percentage of total revenues which we believe to be significant in
analyzing our results of operations. The data is as follows:
Year Ended December 31,
2000 2001 2002
Revenues 100% 100% 100%
Cost of revenues:
Costs and expenses 42 43 69
Royalties to the Government of Israel 2 3 2
Total Cost of revenues 44 46 71
Gross profit 56 54 29
Operating expenses:
Gross research and development 54 121 230
Royalty bearing grant 14 24 48
Research and development, net 40 97 182
Sales and marketing, net 16 39 73
General and administrative 13 25 43
Non-cash compensation 3 5 12
Total operating expenses 72 166 310
Operating loss (16) (112) (281)
Financial income, net 26 33 34
Net loss 10% (79)% (247)%
Year Ended December 31, 2002 Compared with Year Ended December 31, 2001
Revenues. Revenues in 2002 were $6.6 million, a decrease of $7.4 million
compared with revenues of $14 million in 2001. The decrease in revenues reflects
general economic conditions and increased weakness in the telecommunication
market in North America and Europe, and the fact that customers have reduced
orders while diminishing inventories previously purchased.
Cost of Revenues. Cost of revenues was $4.7 million in 2002, a decrease of $1.7
million compared with cost of revenues of $6.4 million in 2001. This decrease is
primarily attributable to the decrease in revenues. Cost of revenues as a
percentage of revenues increased to 71% in 2002 from 46% in 2001, primarily
attributable to the decrease in revenues volume and the fixed cost elements in
the cost of good sold.
Gross Research and Development Expenses. Gross research and development expenses
were $15.2 million in 2002, a decrease of $1.8 million compared with gross
research and development expenses of $17 million in 2001. This decrease is
primarily attributable to decrease in subcontractors and salaries expenses.
Inclusive of stock based compensation charges, Gross research and development
expenses were $15.4 million in 2002, a decrease of $1.8 million compared with
gross research and development expenses of $17.2 million in 2001. Gross research
and development as a percentage of revenues increased to 230% in 2002 from 121%
in 2001 primarily attributable to the decrease in revenues volume, offset by
decrease in gross research and development expenses mentioned above. Inclusive
stock based compensation charges, Gross research and development as a percentage
of revenues increased to 232% in 2002 from 123% in 2001.We expect to continue
investing significant resources in research and development programs for new
products and enhancements of existing products.
Research and Development, Net. Grants from the Office of the Chief
Scientist, totaling $3.2 million in 2002 compared with $3.5 million in 2001, are
applied as reductions to gross research and development expenses. Research and
development expenses (net) were $12 million in 2002, or 181% of revenues,
compared with $13.6 million in 2001, or 97% of revenues. As grants were
approximately the same in both 2001 and 2002, the increase in research and
development, net, as a percentage of revenue is primarily attributable, to the
decrease in revenues volume, offset by decrease in gross research and
development expenses mentioned above.
Sales and Marketing. Sales and marketing expenses were $4.8 million in 2002, a
decrease of $0.7 million compared with sales and marketing expenses of $5.5
million in 2001. This decrease is primarily attributable to decrease in
promotional activities expenses and employees recruitment expenses. Sales and
marketing expenses, as a percentage of revenues, were 73% in 2002 compared to
39% in 2001 primarily attributable to the decrease in revenues volume.
General and Administrative. General and administrative expenses were $2.9
million in 2002, a decrease of $0.6 million compared with general and
administrative expenses of $3.5 million in 2001. This decrease is primarily
attributable to one time provision for litigation made in 2001, See "Item 8
- -Legal Proceedings" and decrease in professional expenses. Inclusive of stock
based compensation charges, General and administrative expenses were $3.2
million in 2002, a decrease of $0.7 million compared with general and
administrative expenses of $3.9 million in 2001. General and administrative
expenses as a percentage of revenues increased to 43% in 2002 from 25% in 2001
primarily attributable to the decrease in revenues volume. Inclusive of stock
based compensation charges, General and administrative expenses as a percentage
of revenues increased to 49% in 2002 from 27% in 2001.
Amortization of Deferred Stock Compensation. Amortization of deferred stock
compensation expenses were $799,000 in 2002, an increase of $54,000 compared
with amortization of deferred stock compensation expenses of $745,000 in 2001.
This change is primarily attributable to periodical amortization. Amortization
of deferred stock compensation expenses as a percentage of revenues increased to
12% in 2002 from 5% in 2001 primarily attributable to the decrease in revenues
volume.
Financial Income, net. Financial income, net was $2.3 million in 2002, a
decrease of $2.3 million compared with financial income, net of $4.6 million in
2001. This change is primarily attributable to general decline in interest rates
and decrease in total cash, short term and long term investments balance.
Year Ended December 31, 2001 Compared with Year Ended December 31, 2000
Revenues. Revenues in 2001 were $14 million, a decrease of $9.3 million compared
with revenues of $23.3 million in 2000. The decrease in revenues reflects
general economic conditions and increased weakness in the telecommunication
market in North America and Europe, and the fact that customers have reduced
orders while diminishing inventories previously purchased.
Cost of Revenues. Cost of revenues was $6.4 million in 2001, a decrease of $3.9
million compared with cost of revenues of $10.3 million in 2000. This decrease
is primarily attributable to the decrease in revenues. Cost of revenues as a
percentage of revenues increase to 46% in 2001 from 44% in 2000, primarily
attributable to the decrease in revenues volume and the fixed cost elements in
the cost of good sold.
Gross Research and Development Expenses. Gross research and development expenses
were $17 million in 2001, an increase of $4.4 million compared with gross
research and development expenses of $12.6 million in 2000. This increase is
primarily attributable to enhancement of our research and development focusing
in our SHDSL and VDSL products, including increase in personnel (increased
expenses of $3.1 million). Inclusive of stock based compensation charges, Gross
research and development expenses were $17.2 million in 2001, an increase of
$4.4 million compared with gross research and development expenses of $12.8
million in 2000. Gross research and development as a percentage of revenues
increased to 121% in 2001 from 54% in 2000 primarily attributable to the
decrease in revenues volume, and also the increase in gross research and
development expenses mentioned above. Inclusive stock based compensation
charges, Gross research and development as a percentage of revenues increased to
123% in 2001 from 55% in 2000. We expect to continue investing significant
resources in research and development programs for new products and enhancements
of existing products.
Research and Development, Net. Grants from the Office of the Chief Scientist,
totaling $3.5 million in 2001 compared with $3.4 million in 2000, are applied as
reductions to gross research and development expenses. Research and development
expenses (net) were $13.6 million in 2001, or 97% of revenues, compared with
$9.2 million in 2000, or 40% of revenues. As grants were approximately the same
in both 2000 and 2001, the increase in research and development, net, as a
percentage of revenue is attributable, to the decrease in revenues volume, and
also the increase in gross research and development expenses mentioned above.
Sales and Marketing. Sales and marketing expenses were $5.5 million in 2001, an
increase of $1.8 million compared with sales and marketing expenses of $3.7
million in 2000. This increase is primarily attributable to enhancement of sales
channels in North America and the resulting increase in personnel (increased
expenses of $1.1 million), travel expenses and promotional activities. Sales and
marketing expenses, as a percentage of revenues, were 39% in 2001 compared to
16% in 2000 primarily attributable to the decrease in revenues volume.
General and Administrative. General and administrative expenses were $3.5
million in 2001, an increase of $500,000 compared with general and
administrative expenses of $3 million in 2000. This increase is primarily
attributable to one time provision of $315,000 for litigation. See "Item 8
- -Legal Proceedings". Inclusive stock based compensation charges, General and
administrative expenses were $3.9 million in 2001, an increase of $600,000
compared with general and administrative expenses of $3.3 million in 2000.
General and administrative expenses as a percentage of revenues increased to 25%
in 2001 from 13% in 2000 primarily attributable to the decrease in revenues
volume, and increase of general and administrative expenses mentioned above.
Inclusive stock based compensation charges, General and administrative expenses
as a percentage of revenues increased to 27% in 2001 from 14% in 2000.
Amortization of Deferred Stock Compensation. Amortization of deferred stock
compensation expenses were $745,000 in 2001, a decrease of $46,000 compared with
amortization of deferred stock compensation expenses of $791,000 in 2000. This
change is primarily attributable to periodical amortization. Amortization of
deferred stock compensation expenses as a percentage of revenues increased to 5%
in 2001 from 3% in 2000 primarily attributable to the decrease in revenues
volume.
Financial Income (Expenses), Net. Financial income, net was $4.6 million in
2001, a decrease of $1.4 million compared with financial expenses, net of $6
million in 2000. This change is primarily attributable to general decline in
interest rates and changes in our investment mix in order to avoid Investment
Company Act constraints.
Impact of Inflation and Currency Fluctuations
The dollar cost of our operations is influenced by the extent to which any
increase in the rate of inflation in Israel is (or is not) offset, or is offset
on a lagging basis, by the devaluation of the NIS in relation to the dollar.
Inflation in Israel will have a negative effect on our profitability as we
receive payment in dollars or dollar-linked NIS for substantially all of our
sales while we incur a portion of our expenses, principally salaries and related
personnel expenses, in NIS, unless such inflation is offset by a devaluation of
the NIS.
In 2000 the NIS was appreciated against the dollar in the rate of 2.7% while the
rate of inflation was 0%. In 2001 the NIS was depreciated against the dollar in
the rate of 9.3% while the rate of inflation was 1.4%. In 2002 the NIS was
depreciated against the dollar in the rate of 7.3% while the rate of inflation
was 6.5%. We can not be certain that the trends which have benefited us in 2002
will continue. If the dollar costs of our operations in Israel increase, our
dollar-measured results of operations will be adversely affected. We cannot
assure you that we will not be materially adversely affected in the future if
inflation in Israel exceeds the devaluation of the NIS against the dollar or if
the timing of such devaluation lags behind increases in inflation in Israel or
if the NIS will be appreciated against the dollar.
A devaluation of the NIS in relation to the dollar has the effect of reducing
the dollar amount of any of our expenses or liabilities which are payable in NIS
(unless such expenses or payables are linked to the dollar). Such devaluation
also has the effect of decreasing the dollar value of any asset which consists
of NIS or receivables payable in NIS (unless such receivables are linked to the
dollar). Conversely, any increase in the value of the NIS in relation to the
dollar has the effect of increasing the dollar value of any unlinked NIS assets
and the dollar amounts of any unlinked NIS liabilities and expenses.
Because exchange rates between the NIS and the dollar fluctuate continuously
(albeit with a historically declining trend in the value of the NIS), exchange
rate fluctuations and especially larger periodic devaluations will have an
impact on our profitability and period-to-period comparisons of our results. The
effects of foreign currency remeasurements are reported in our consolidated
financial statements in current operations.
Corporate Tax Rate
Israeli companies are generally subject to tax at the rate of 36% of
taxable income. However, in 1994, our facility was granted "Approved Enterprise"
status under the Law for the Encouragement of Capital Investments, 1959, and
consequently we are eligible, subject to compliance with certain requirements,
for certain tax benefits beginning when such facility first generates taxable
income. In December 2000, our facility received an approval for extension of the
"Approved Enterprise" status, in the form of an additional capital investment.
We have derived, and expect to continue to derive, a substantial portion of our
income from our Approved Enterprise facility. Subject to compliance with
applicable requirements, the portion of our income derived from the Approved
Enterprise is tax-exempt for a period of two years commencing in the first year
in which there is taxable income and will be subject for the subsequent period
of five or eight years to a reduced company tax of up to 25% (the rate and
period of benefits will depend upon the percentage of non-Israeli holders of our
ordinary shares).
The period of tax benefits with respect to our Approved Enterprise has not yet
commenced, because we have yet to realize taxable income. As a result of the
foregoing, and of our accumulated tax loss carryforwards (which totaled
approximately $43.4 million at December 31, 2002), and based on the current tax
system in Israel, we do not anticipate being subject to income tax in Israel in
2003. Our effective corporate tax rate may substantially exceed the Israeli tax
rate. Our U.S. subsidiary will generally be subject to applicable federal,
state, local and foreign taxation, and we may also be subject to taxation in the
other foreign jurisdictions in which we own assets, have employees or conduct
activities. Our U.S. subsidiary had net loss carry- forwards of approximately
$3.9 million available at December 31, 2002 for federal tax purposes. These
carry-forwards will offset future taxable income. Because of the complexity of
these local tax provisions, it is not possible to anticipate the actual combined
effective corporate tax rate which will apply to us.
Government Grants
We conduct a substantial part of our research and development operations in
Israel. Our research and development efforts have been financed through internal
resources and grants per project from the Office of the Chief Scientist. The
Office of the Chief Scientist provided grants for research and development
efforts of approximately $1.3 million for the year ended December 31, 1998 (34%
of total research and development expenses), $2 million for the year ended
December 31, 1999 (32% of total research and development expenses), $3.4 million
for the year December 31, 2000 (27% of total research and development expenses),
$3.5 million for the year ended December 31, 2001 (20% of total research and
development expenses) and 3.2 million for the year ended December 31, 2002 (21%
of total research and development expenses). Under Israeli law, royalties on the
revenues derived from products and services developed using such grants are
payable to the Israeli Government. We are obligated to pay royalties at the rate
of 4%-4.5% of related revenues. The maximum aggregate royalties payable cannot
exceed 100%-300% of the dollar-linked value of the total grants received
depending on different factors as described below (we currently pay 100%-120%).
Royalties payable with respect to grants received under programs approved after
January 1, 1999, however, will be subject to interest on the dollar-linked value
of the total grants received at an annual rate of LIBOR applicable to dollar
deposits.
The Government of Israel does not own proprietary rights in technology
developed using its funding and there is no restriction on the export of
products manufactured using the technology. The technology is, however, subject
to other legal restrictions, including the obligation to manufacture the product
based on such technology in Israel and to obtain the consent of the Office of
the Chief Scientist to transfer the technology to a third party. The Office of
the Chief Scientist may consent to the manufacture of the products outside
Israel by identified manufacturers and, in such cases, may require the payment
of increased royalties, ranging from 120% to 300% of the amount of the grant,
depending on the percentage of foreign manufacture. Therefore, in 2001 and 2002
Metalink was required by the Office of the Chief Scientist to pay increased
royalties of 120% of the amount of years 2001 and 2002 grants in the years
mentioned. These restrictions continue to apply even after we shall have paid
the full amount of royalties payable in respect of the grants. Since our
manufacturing activities are performed by subcontractors outside of Israel, the
consent of the Office of the Chief Scientist is required for these activities.
See "Item 10-Additional Information-Taxation-Grants under the Law for the
Encouragement of Industrial Research and Development, 1984"
The Government of Israel, through the marketing fund, awards grants to Israeli
companies for overseas marketing expenses, including expenses for maintaining
branches, advertising, catalogs, exhibitions and surveys. We received grants
from the marketing fund totaling $126,000 in 1998 and $20,000 in 1999. In 2002
we refunded all grants received from the marketing fund of the Government of
Israel, and as of December 31, 2002 we have no liability towards the marketing
fund.
We paid or accrued to the Office of the Chief Scientist and to the marketing
fund $212,000 for the year ended December 31, 1998, $385,000 for the year ended
December 31, 1999, $469,000 for the year December 31, 2000, $414,000 for the
year December 31, 2001 and $94,000 for the year December 31, 2002.
B. Liquidity and Capital Resources
At December 31, 2002, we had cash and cash equivalents of $9.2 million
,short-term investments of $20.7 million and long-term investments of $46.2
million. At December 31, 2001, we had cash and cash equivalents of $16 million,
short-term investments of $65 million and long-term investments of $9.2 million.
In December 1999, we completed our initial public offering of 4,600,000 ordinary
shares, from which we received net proceeds of approximately $49.8 million. In
March 22, 2000, we completed our secondary offering of 1,500,000 ordinary
shares, from which we received net proceeds of approximately $62.7 million.
Our total proceeds, net of royalties paid or accrued, from royalty-bearing
government grants was $13.1 million as of December 31, 2002, $10 million as of
December 31, 2001, and $7 million as of December 31, 2000.
Capital expenditures were $5,373,000 for the year ended December 31, 2000,
$4,084,000 for the year ended December 31, 2001 and $838,000 for the year ended
December 31, 2002. These expenditures were principally for capital equipment and
software for our research and development activities. We expect to invest
additional resources for capital equipment and software.
Net cash used in operating activities was $12,094,000 for the year ended
December 31, 2002. Net cash used in operating activities during 2002 was
primarily due to net loss, an increase in inventories and to decrease in other
payables and accrued expenses, which were partially offset by decrease in trade
accounts receivable, depreciation and amortization, amortization of marketable
debt securities and deposit premium and amortization of deferred stock
compensation. Net cash used in operating activities was $7,019,000 for the year
ended December 31, 2001.
Net cash provided by operating activities was $1,989,000 in 2000. Net cash
provided by investing activities was $4.8 million for the year ended December
31, 2002. $177.3 million cash was provided from maturity and sales of marketable
debt securities and certificate of deposits held in Metalink's treasury offset
by $171.8 million cash used in purchase of marketable debt securities and
deposits, and by $0.8 million that was used for the purchase of property and
equipment. Net cash provided by investing activities was $22.9 million in 2001.
Net cash used in investing activities was $61 million in 2000.
Net cash provided by financing activities was $0.6 million for the year ended
December 31, 2002 and was primarily attributable to exercise of employees option
and shares. Net cash used in financing activities was $8.8 million for the year
ended December 31, 2001 and was primarily attributable to repurchase (buy-back)
of shares that then became treasury stock. Net cash provided by financing
activities was $63.5 million for the year ended December 31, 2000 and
was primarily attributable to the proceeds of our secondary public offering. We
believe that cash generated from operations, our unused cash balances,
governmental research and development in Israel and the net proceeds from our
initial public offering and our secondary offering will provide sufficient cash
resources to finance our operations and the projected expansion of our sales and
marketing and research and development activities for at least the next twelve
months. However, if our operations do not generate cash to the extent currently
anticipated or if we grow more rapidly than currently anticipated, it is
possible that we will require additional funds at some point in the future.
C. Research and Development, Patents and Licenses, etc.
See "Item 4 - Information on the Company - Business Overview - Research and
Development," "Item 4 - Information on the Company - Business Overview -
Proprietary Rights" and " - Operating Results."
D. Trend Information
Telecommunications service providers and their customers are the principal
end-users of substantially all of our products. Recently, the telecommunications
industry in much of the world, including in our principal geographic markets,
has been experiencing an apparent slowdown, resulting in decreases and delays in
the procurement and deployment of new telecommunications equipment. As a result,
we have experienced a significant decline in demand for our products in 2002
compared to 2001. It is likely that any prolonged and substantial curtailment of
growth in the telecommunications industry will have an adverse effect, which may
be material, upon us. Any such curtailment may result from circumstances
unrelated to us or our product offerings and over which we have no control.
E. Off-balance sheet arrangements
Not applicable
F. Tabular disclosure of Contractual Obligations.
Future aggregate minimum annual rental payments pursuant to the existing lease
commitments in effect as of December 31, 2002, are as follows:
Year Amount (in thousands)
2003 $ 1,008
2004 1,008
2005 890
2006 854
2007-on 3,203
In addition, on March 2003 the Company signed a long-term contract with one of
its suppliers, pursuant to which the Company's payment commitments are $718,000,
$956,000 and $956,000 for 2003, 2004 and 2005, respectively. Other than that,
the Company has no long-term debt, or other long-term contracts or obligations.
The Company owes royalties to Israel with respect to products developed using
Israeli research and development grants, but the levels of those payments are
contingent on the level of product sales and do not have to be paid if product
sales do not occur.
ITEM 6 DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES
A. Directors and Senior Management
The following table lists our current directors and executive officers:
Name Age Position
Tvzi Shukhman 42 Chairman of the Board of Directors and Chief Executive Officer
J. Francois Crepin 56 President, Member of the Office of the CEO and Director
Ofer Lavie 58 Chief Financial Officer
Ronen Avron 46 Vice President, International Sales
Daniel Manor 33 Vice President, Marketing
Aviva Gatt 49 Vice President of Human Resources
Guy Shochet............. 36 Vice President, Wireless Products
Shmulik Shemesh...... 34 Vice President, Operations
David Pereg............. 34 Vice President, Engineering
John Camagna.......... 35 Vice President, Engineering
Avi Nudler............... 39 Vice President, Business Development
Uzi Rozenberg 43 Director
Efi Shenhar 47 Director
Sarit Weiss-Firon 37 Director
Joe Markee 50 Director
Syrus Madavi 53 Director
Meir Bar-El 59 Director
Tzvi Shukhman, a co-founder of our company, has served as our Chief Executive
Officer and Chairman of our Board of Directors from our inception in 1992. Prior
to May 1999, Mr. Shukhman also served as our President. From March 1989 until
March 1993, Mr. Shukhman served as an independent consultant for RAD Data
Communications and ECI. Prior thereto, Mr. Shukhman served in the Israel Defense
Forces where he founded a group involved in digital signal processing
applications. Mr. Shukhman has an M.Sc. from The Technion, Israel Institute of
Technology.
J. Francois Crepin has served as our President, Member of the Office of the CEO,
since January 2001 and as a director since May 1999. Since May 1999 until
December 2000 Mr. Crepin served as our President and Chief Operating Officer.
From February 1997 to April l999, Mr. Crepin served as President of Bandwidth
Communications Management, a privately held consulting company focusing on
semiconductor companies. From January 1986 to February 1997, Mr. Crepin held
different Vice President positions at Level One, including marketing and sales
and business development. Prior to joining Level One, Mr. Crepin served as
Director of Strategic Planning for Information Communications for LSI Logic
Corporation. Mr. Crepin holds a B.Sc. in mathematics from Grenoble University
and an M.B.A. from the University of Paris.
Ofer Lavie has served as our Chief Financial Officer since November 1999. Mr.
Lavie has also served as a member of the board of Ophir Tours Ltd since August
2001. Prior thereto from April 1991, Mr. Lavie served as Chief Financial Officer
of Electro-Optics Industries Ltd., a company engaged in research and development
and production of military systems and other commercial business areas. From
October 1990 to March 1991, Mr. Lavie served as the President and Chief
Executive Officer of GMA Communications Ltd., a company engaged in the
manufacture of telephone key systems. From November 1984, to September 1990, Mr.
Lavie held different corporate positions at Tadiran Electronics Ltd. Mr. Lavie
has a B.Sc. in economics from Tel Aviv University.
Ronen Avron has served as our Vice President of International Sales since May
2002. From September 1999 till April 2002, Mr. Avron served as Regional Director
in Gilat Satellite Networks Ltd having business and sales responsibility for all
of the Pacific area. Prior thereto during the years 1995-1999, Mr. Avron was
stationed in Seoul Korea, managing the Korean and Taiwanese offices of Rafael
Armaments Development Authority of the state of Israel with responsibility for
Sales, Marketing and Business Development for that territory. Previous to that
during the years 1993- 1995 Mr. Avron was the Sales and Marketing Manager for
Asia and Pacific Rim of RND Ltd of the RAD Group. Mr. Avron served in the
Israeli Air Force as a pilot for 7 years, 1975-1982. Mr. Avron holds degrees of
BSEE from Tel Aviv University, and MBA from Boston University (London Branch).
Daniel Manor has served as our Vice President, Marketing since October 2001, and
as Associate Vice President, Marketing - Networking Solutions since March 2001.
From July 2000 to February 2001, Mr. Manor served as Director of Marketing in
Tioga Technologies Ltd. From 1995 to 2000, Mr. Manor held different marketing
and research and developments positions in Orckit Communications Ltd. Mr. Manor
holds a B.Sc. Degree in Math and Physics from the Jerusalem Hebrew University.
Aviva Gatt has served as our VP Human Resources since March, 2000. From 1998 to
2000 Ms. Gatt served as Director of Human Resources for Texas Instruments Cable
Broadband Communications. From 1994 to 1998 Ms. Gatt served as Director of Human
Resources at Nice Systems. From 1991 to 1998 Ms. Gatt served as recruitment
manager at Tadiran Telecommunications. Ms. Gatt holds a Bachelors in Social Work
from Jerusalem's Hebrew University and an MBA from New York's Polytechnic
University.
Guy Shochet has served as our Vice President of Wireless Products since June
2002. Mr. Shochet has been at Metalink since 1993, holding several R&D
positions, including a position of Associate Vice President, Engineering,
Networking Solutions since 2001. Prior to Metalink, Mr. Shochet was a member of
the technical staff in the Israel Communications Force from1984 to 1990. Mr.
Shochet holds a Master in Business Administration from Boston University and a
B.S.E.E. from the University of New-Haven.
Shmulik Shemesh has served as Vice President of Operations at Metalink since
June 2002. Mr. Shemesh held various positions at Metalink since 1998, including
Director of Quality & Reliability and Director of Products & Test Engineering.
Between 1990 and 1997 Mr. Shemesh served as a project officer in the Israel
Defense Forces. Mr. Shemesh holds an M.Sc. in Quality Assurance & Reliablity and
a B.S.E.E. from the Technion.
David Pereg has served as our Vice President of Engineering since June 2002. Mr.
Pereg has been at Metalink since 1999, holding several R&D positions including a
position of Associate Vice President for DSL Modem from 2001 to 2002. Between
1990 and 1998 Mr. Pereg served as a project officer in the Israel Defense
Forces. Mr. Pereg holds a B.S.E.E. and an M.S.E.E. from Tel Aviv University.
John Camagna has served as our Vice President of Engineering since June 2002.
Mr. Camagna joined us in 1999 as Director of Engineering, North America and
since then held several managerial R&D positions in the company. Before coming
to Metalink Mr. Camagna was a Design Manager at Level One Communications. Prior
to that he held positions at Crystal Semiconductor/Cirrus Logic and at Applied
Signal Technology. Mr. Camagna has a B.S. and an M.S. from the University of
California at Berkeley.
Avi Nudler has served as our Vice President Business Development since September
2002. Between 2001 and 2002 Mr. Nudler has served as Entrepreneur in Resident at
Benchmark VC. During 1999 to 2001 Mr. Nudler was the CEO of TelesciCom. From
1985 to 1999 Mr. Nudler held several executive positions at an elite R&D Unit in
the Israeli Intelligence Corps. Mr. Nudler holds a B.Sc. and M.Sc. from the Tel
Aviv University.
Uzi Rozenberg, a co-founder of our company, has served as a director from 1992
until 1997 and since August 1999. Mr. Rozenberg is also the founder and Chief
Executive Officer of USR Electronics Ltd. since February 1987. Mr. Rozenberg
served as a director of Orbot Ltd. from 1992 to 1996 and as a director of Gibor
Sport Ltd. from 1993 to 1997. Mr. Rozenberg and Mr. Shenhar are brothers.
Efi Shenhar has served as a director since July 1995. From March 1987 until
February 1999, Mr. Shenhar has served as a Vice President of USR Electronics
Systems (1987) Ltd., an electronic manufacturing services company. Mr. Shenhar
has a B.A. in accounting and economics from Tel Aviv University and an M.B.A.
from Herriot Watt University. Mr. Shenhar is a certified public accountant. Mr.
Shenhar and Mr. Rozenberg are brothers.
Sarit Weiss-Firon has served as a director since October 2000. Ms. Weiss-Firon
currently serves as the Chief Financial Officer of P-Cube, Inc. since 2000. From
1997 to 1999 Ms. Weiss-Firon served as Chief Financial Officer of Radcom. From
1995 to 1996, Ms. Weiss-Firon served as vice-comptroller at Rad Company for six
months before being appointed comptroller. From 1992 to 1994, Ms. Weiss-Firon
was an intern at Kesselmann & Kesselman Accountants. Ms. Weiss Firon has a B.A.
in Accounting and Economics from Tel Aviv University.
Joe Markee has served as a director since July 2001. Mr. Markee currently serves
as a member of the board of directors of Copper Mountain Networks. Mr. Markee is
the Founder and was Chairman of the Board of Copper Mountain. Prior to founding
Copper Mountain, Mr. Markee was a co-founder of Primary Access, a leading remote
access server company acquired by 3Com Corporation in 1995. At 3Com/Primary
Access, Mr. Markee was a member of the senior management team, serving as Vice
President of Operations and Vice President of Support. Mr. Markee began his
career in product management and engineering capacities at General Instrument
Corporation and M/A-Com Linkabit. Mr. Markee holds a B.S. Degree in Electrical
Engineering and Computer Science from the University of California at Davis.
Syrus Madavi has served as a director since October 2001. Mr. Madavi currently
serves as Chief Operating Officer and President of JDS Uniphase Corporation.
From April 2002 to July 2002 Mr. Madavi served as chairman of the Board, and
executive chairman for ON Semiconductor Corporation. From September 2000 to
March 2002 Mr. Madavi served as a senior vice president of Texas Instruments
Corporation. Until August 2000, Mr. Madavi was Chairman, CEO and President of
Burr-Brown Corporation. During September 2000, Burr-Brown was acquired by Texas
Instruments Corporation. Prior to joining Burr-Brown, Mr. Madavi was President
of Raytheon Semiconductor Corporation. Mr. Madavi's professional engineering
work experience includes employment with General Electric as well as several
other engineering positions. Mr. Madavi has a BSEE degree and a Masters degree
in Computer Science from Stevens Institute of Technology, as well as an MBA from
UCLA in Finance.
Meir Bar-El has served as a director since November 2002. Mr. Bar-El currently
serves as the Deputy General Director, and Director of the General Division of
the Manufacturers' Association of Israel, a General Director of the Israeli
Plastics & Rubber Industry, and a General Director of the Israeli Furniture
Industries Association. Mr. Bar-El also has served as External Director for
Mifalley Etz Carmiel Ltd since June 1998, External Director for Ophir Tours Ltd
since August 1998, and as a Director for the Wood Products & Furniture Export
Economic Company. Mr. Bar-El has a B.A. in Economics from Jerusalem University.
B. Compensation
The aggregate remuneration we paid for the year ended December 31, 2002 to all
executive officers as a group (17 persons), was approximately $1,799,000 in
salaries, fees, commissions and bonuses. This amount includes approximately
$160,000 set aside or accrued to provide for pension, retirement or similar
benefits provided to our directors and executive officers. Members of our board
of directors (other than external directors) who are not executive officers do
not receive compensation for their service on the board of directors or any
committee of the board of directors, but they are reimbursed for their expenses
for each board of directors meeting attended. Other than officers of the Company
who serve as directors, no directors have arrangements to receive benefits upon
termination of employment. Regarding officers of the Company who are board
members, see the discussion under the caption "Management Employment Agreements"
below.
During 2002 we granted to our directors and executive officers options to
purchase 145,000 ordinary shares under our option plans. The weighted average
exercise price of these options was $3.43 per share and they expire within 10
years from the date they were issued. C. Board Practices Our directors, other
than our external directors, are elected at annual general meetings by the vote
of the holders of a majority of the voting power represented at such meeting in
person or by proxy and voting on the election of directors. Each director shall
serve, subject to our articles of association, until the annual general meeting
next following the annual general meeting at which such director was elected.
External Directors
We are subject to the provisions of the Israeli Companies Law, 5759-1999 (the
"Companies Law"). The Companies Law authorizes the Minister of Justice to adopt
regulations exempting from the provisions described below companies, like us,
whose shares are traded outside of Israel.
Under the Companies Law, companies incorporated under the laws of Israel whose
shares have been offered to the public in or outside of Israel are required to
appoint two external directors. The Companies Law provides that a person may not
be appointed as an external director if the person or the person's relative,
partner, employer or any entity under the person's control, has, as of the date
of the person's appointment to serve as external director, or had, during the
two years preceding that date, any affiliation with the company, any entity
controlling the company or any entity controlled by the company or by this
controlling entity. The term affiliation includes:
o an employment relationship;
o a business or professional relationship maintained on a regular basis;
o control; and
o service as an office holder.
No person can serve as an external director if the person's position or other
business creates, or may create, conflict of interests with the person's
responsibilities as an external director. Until the lapse of two years from
termination of office, a company may not engage an external director to serve as
an office holder and cannot employ or receive services from that person, either
directly or indirectly, including through a corporation controlled by that
person.
External directors are to be elected by a majority vote at a
shareholders meeting, provided that either:
o a majority of the shares voted at the meeting, including at least one third of
the shares of non-controlling shareholders, vote in favor of the election; or
o the total number of shares voted against the election of the external director
does not exceed one percent of the aggregate number of voting shares of the
company.
The initial term of an external director is three years and may be extended for
an additional three years. Each committee of a company's board of directors is
required to include at least one external director. Mr. Meir Bar-El and Ms.
Sarit Weiss-Firon are our external directors. Ms. Sarit Weiss-Firon was elected
as an external director at the 2000 annual shareholders meeting, held on October
2000. Mr. Bar-El was elected as an external director at the 2002 annual
shareholders meeting, held on November 26, 2002.
Audit Committee
Under the Companies Law, the board of directors of any company that is required
to nominate external directors must also appoint an audit committee, comprised
of at least three directors including all of the external directors, but
excluding a:
o chairman of the board of directors;
o general manager;
o chief executive officer; and
o controlling shareholder and any director employed by the company or who
provides services to the company on a regular basis.
The role of the audit committee is to examine flaws in the business management
of the company, in consultation with the internal auditor and the company's
independent accountants and suggest appropriate course of action. In addition,
the approval of the audit committee is required to effect specified actions and
transactions with office holders and interested parties.
An interested party is defined in the Companies Law as a 5% or greater
shareholder, any person or entity who has the right to designate one director or
more or the general manager of the company or any person who serves as a
director or as a general manager.
An audit committee may not approve an action or a transaction with an interested
party or with an office holder unless at the time of approval the two external
directors are serving as members of the audit committee and at least one of whom
was present at the meeting in which an approval was granted.
Under the Companies Law, the board of directors must also appoint an internal
auditor proposed by the audit committee. The role of the internal auditor is to
examine, whether the company's actions comply with the law, integrity and
orderly business procedure. Under the Companies Law, the internal auditor may
not be an interested party, an office holder, or an affiliate, or a relative of
an interested party, an office holder or affiliate, nor may the internal auditor
be the company's independent accountant or its representative. On April 2001, we
appointed Mr. Jonathan Glazer as our internal auditor. See "-Committees" for
information relating to our audit committee.
Approval of Specified Related Party Transactions Under Israeli Law Fiduciary
Duties of Office Holders
The Companies Law imposes a duty of care and a duty of loyalty on all office
holders of a company, including directors and executive officers. The duty of
care requires an office holder to act with the level of care with which a
reasonable office holder in the same position would have acted under the same
circumstances. The duty of care includes a duty to use reasonable means to
obtain:
o information on the appropriateness of a given action brought for his approval
or performed by him by virtue of his position; and
o all other important information pertaining to the previous actions.
The duty of loyalty of an office holder includes a duty to:
o refrain from any conflict of interest between the performance of his duties in
the company and his personal affairs;
o refrain from any activity that is competitive with the company;
o refrain from exploiting any business opportunity of the company to receive a
personal gain for himself or others; and
o disclose to the company any information or documents relating to a company's
affairs which the office holder has received due to his position as an office
holder.
Each person listed in the table under "Directors and Senior Management"
above is an office holder. Directors' compensation arrangements also require
audit committee approval before board approval and shareholder approval.
The Companies Law requires that an office holder of a company promptly disclose
any personal interest that he may have and all related material information
known to him in connection with any existing or proposed transaction by the
company. A personal interest of an office holder includes an interest of a
company in which the office holder is, directly or indirectly, a 5% or greater
shareholder, director or general manager or in which he has the right to appoint
at least one director or the general manager. In the case of an "extraordinary
transaction", the office holder's duty to disclose applies also to a personal
interest of the office holder's relative. The office holder must also disclose
any personal interest held by the office holder's spouse, siblings, parents,
grandparents, descendants, spouse's descendants and the spouses of any of the
foregoing.
Under Israeli law, an extraordinary transaction is a transaction:
o other than in the ordinary course of business;
o other than on market terms; or
o that is likely to have a material impact on the company's profitability,
assets or liabilities.
Under the Companies Law, once an office holder complies with the above
disclosure requirement the board of directors may approve a transaction between
the company and such office holder or a third party in which such office holder
has a personal interest, unless the articles of association provide otherwise. A
transaction that is adverse to the company's interest cannot be approved.
If the transaction is an extraordinary transaction, both the audit
committee and the board of directors must approve the transaction. Under
specific circumstances, shareholder approval may also be required. An office
holder who has a personal interest in a matter which is considered at a meeting
of the board of directors or the audit committee may not be present at the
meeting or vote on the matter.
Disclosure of Personal Interests of a Controlling Shareholder
Under the Companies Law, the disclosure requirements which apply to an
office holder also apply to a controlling shareholder of a public company. A
controlling shareholder includes a shareholder that holds 25% or more of the
voting rights in a public company if no other shareholder owns more than 50% of
the voting rights in the company. Extraordinary transactions with a controlling
shareholder or in which a controlling shareholder has a personal interest, and
the terms of compensation of a controlling shareholder who is an office holder,
require the approval of the audit committee, the board of directors and the
shareholders of the company. Shareholder approval is satisfied by the vote of a
majority of the voting power present and voting (in person, by proxy or by
written ballot) at a shareholder meeting, so long as either:
o the approving majority includes at least one-third of the shareholders who
have no personal interest in the transaction; or
o the shareholders who have no personal interest in the transaction who vote
against the transaction do not represent more than one percent of the voting
rights in the company.
For information concerning the direct and indirect personal interests
of certain of our office holders and principal shareholders in certain
transactions with us, see "Item 7- Major Shareholders and Related Party
Transactions."
Exculpation, Insurance and Indemnification of Directors and Officers
Under the Companies Law, an Israeli company may not exempt an office holder from
liability with respect to a breach of his duty of loyalty, but may exempt in
advance an office holder from his liability to the company, in whole or in part,
with respect to a breach of his duty of care.
Office Holder Insurance
Our articles of association provide that, subject to the provisions of the
Companies Law, we may enter into a contract for the insurance of the liability
of any of our office holders with respect to:
o a breach of his duty of care to us or to another person;
o a breach of his duty of loyalty to us, provided that the office holder acted
in good faith and had reasonable cause to assume that his act would not
prejudice our interests; or
o a financial liability imposed upon him in favor of another person concerning
an act performed by him in his capacity as an office holder.
Indemnification of Office Holders Our articles of association provide that we
may indemnify an office holder against:
o a financial liability imposed on him in favor of another person by any
judgement, including a settlement or an arbitrator's award approved by a court
concerning an act performed in his capacity as an office holder; and
o reasonable litigation expenses, including attorneys' fees, expended by the
office holder or charged to him by a court, in proceedings we institute against
him or instituted on our behalf or by another person, or in a criminal charge
from which he was acquitted, or a criminal charge in which he was convicted for
a criminal offense that does not require proof of intent, in each case relating
to an act performed in his capacity as an office holder.
Under the Companies Law, these provisions are subject to shareholder approval.
Limitations on Insurance and Indemnification The Companies Law provides that a
company may not indemnify an office holder nor enter into an insurance contract
which would provide coverage for any monetary liability incurred as a result of
any of the following:
o a breach by the office holder of his duty of loyalty unless the office holder
acted in good faith and had a reasonable basis to believe that the act would not
prejudice the company;
o a breach by the office holder of his duty of care if the breach was done
intentionally or recklessly;
o any act or omission done with the intent to derive an illegal personal
benefit; or
o any fine levied against the office holder.
In addition, under the Companies Law, indemnification of, and procurement of
insurance coverage for, our office holders must be approved by our audit
committee and our board of directors and, in specified circumstances, by our
shareholders.
We have obtained director's and officer's liability insurance. In addition we
entered into indemnification agreements with our directors and executive
officers in accordance with our articles of association.
Committees
Our board of directors has formed an executive committee, an audit committee and
a share incentive committee. The executive committee exercises the power of the
board of directors with respect to matters that require the action of the board
of directors, between meetings of the board of directors subject to section 112
of the Companies Law. The audit committee, which consists of Mr. Joe Markee, Ms.
Weiss-Firon, and Mr. Meir Bar-El, exercises the powers of the board of directors
with respect to our accounting, reporting and financial control practices. Our
share incentive committee administers our share option plans but pursuant to
Section 122 of the Companies Law, may only advise our Board of Directors with
regard to the granting of options and the actual grants must be performed by the
Board of Directors. The members of the share incentive committee are Mr. Tzvika
Shukhman and Mr. Uzi Rozenberg. No other remuneration committee exists.
Management Employment Agreements
We have entered into employment agreements with each of our executive officers,
other than our chief executive officer. These agreements contain various
provisions, including provisions relating to assignment of intellectual property
rights to us and confidentiality and are in effect until terminated by either
party upon advance notice or otherwise in accordance with the terms of the
particular agreement. All of these agreements also contain non-competition
provisions. Under the Companies Law, in a company whose shares are traded on a
stock exchange the company's chairman of the board may not be the person serving
as chief executive officer. However, the shareholders of the company may approve
the service of the chief executive officer also as a chairman of the board for a
period of up to three years, provided, that at least two-thirds of the votes of
non-controlling shareholders present and voting at the meeting vote
affirmatively. Accordingly, on October 2000, our shareholders approved the
service of Tzvi Shukhman as our chief executive officer and chairman of the
board.
D. Employees
As of May 31, 2003, we had 159 employees worldwide, of which 99 were employed in
research and development, 26 in sales and marketing, 15 in management and
administration, and 19 in operations and quality assurance. As of May 31, 2003,
134 of our employees were based in Israel and 25 were based in the United
States. We had 152 employees worldwide as of December 31, 2002, 141 employees
worldwide as of December 31, 2001, and 133 employees worldwide as of December
31, 2000. We have standard employment agreements with all of our employees,
other than our chief executive officer. All of our employees, other than our
chief executive officer, have executed employment agreements, including
confidentiality and non-compete provisions with us.
We are subject to labor laws and regulations in Israel and the United States. We
and our Israeli employees are also subject to certain provisions of the general
collective bargaining agreements between the Histadrut (General Federation of
Labor in Israel) and the Coordination Bureau of Economic Organizations
(including the Industrialists Association) by order of the Israeli Ministry of
Labor and Welfare. None of our employees is represented by a labor union and we
have not experienced any work stoppages.
E. Share Ownership
The following table sets forth certain information regarding the ownership of
our ordinary shares by our directors and officers as of May 31, 2003. The
percentage of outstanding ordinary shares is based on 18,655,413 ordinary shares
outstanding as of May 31, 2003.
Name Number of Percentage of Number of Options
Ordinary shares Outstanding Ordinary
Beneficially Owned(1) shares(2)
Tzvi Shukhman 5,681,356 30.5% -
Uzi Rozenberg 4,986,095 26.8% -
J. Francois Crepin(3) * * 382,500
Ofer Lavie - - *
Ronen Avron - - *
Danny Manor - - *
Aviva Gatt - - *
Guy Shochet - - *
Shmuel Shemesh * * *
David Pereg * * *
John Camagna - - *
Avi Nudler - - *
Efi Shenhar * * *
Sarit Weiss-Firon - - -
Joe Markee - - *
Syrus Madavi - - *
Meir Bar-El - - -
- ------------------------
* Less than 1%.
(1) Except as otherwise noted and pursuant to applicable community property
laws, each person named in the table has sole voting and investment power with
respect to all ordinary shares listed as owned by such person. Shares
beneficially owned include shares that may be acquired pursuant to options that
are exercisable within 60 days of May 31, 2003. As of June 15, 2003, Mr.
Shukhman owned 5,731,356 shares as a result of open market purchases.
(2) Ordinary shares deemed beneficially owned by virtue of the right of any
person or group to acquire such shares within 60 days of May 31, 2003, are
treated as outstanding only for the purposes of determining the percent owned by
such person or group.
(3) Includes (i) options to purchase 370,000 ordinary shares which are
exercisable as of May 31, 2003, at an exercise price of $5.00 per share, (ii)
options to purchase 9,500 ordinary shares, which are exercisable as of May 31,
2003, at an exercise price of $21.625 per share, and (iii) options to purchase
3,000 ordinary shares, which are exercisable as of May 31, 2003, at an exercise
price of $2.29 per share.
Since November 2001, Tzvi Shukhman has acquired 1,335,932 shares (7.2%)
in open market transactions and Uzi Rozenberg has acquired beneficial ownership
of 1,000,000 shares (5.3%) in block trades from public securities holders.
Messrs. Shukhman and Rozenberg have filed a registration statement with the
Securities and Exchange Commission relating to 10,565,651 shares.
As of May 31, 2003 409,125 MTLK shares were registered for trading in the
Tel-Aviv Stock Exchange. We have no information regarding the beneficial owners
of such shares.
Share Option Plans
We have seven employee share option plans and one additional option plan, Share
Option Plan (2000), for our advisors and independent contractors. The expiration
dates of the options range from 10 to 25 years from the date of grant. Our share
option plans are administered by the share incentive committee of our board of
directors or, if the board of directors deems fit, by our board of directors.
Under section 112 of the Israeli Companies Law, the share incentive committee
may only advise our board of directors with regard to the grant of options, and
the actual grant is performed by our board of directors. All of our employees
and directors are eligible to participate in our employee option plans. Members
of our advisory board and our independent contractors are eligible to receive
options under our Share Option Plan (2000).
As of May 31, 2003, options to purchase 3,672,225 ordinary shares under our
share option plans were outstanding. As of May 31, 2003, an additional 1,014,141
ordinary shares were reserved for issuance pursuant to options issuable under
our share option plans. We may increase the number of ordinary shares reserved
for issuance pursuant to options issuable under our plans.
Stock Purchase Plan
On October 2000 we initiated our 2000 Employee Stock Purchase Plan ("ESPP"). The
plan is implemented by consecutive offering periods with new offering periods
commencing on the first trading day on or after November 14 and May 14 each
year, or on such other date as our board shall determine, and continuing
thereafter until terminated. The plan enables eligible employees who elect to
participate in the plan to purchase ordinary shares through payroll deductions
at a price of 85% of the fair market value of the ordinary shares on the first
or the last day of each offering period, which ever is lower. Participants will
be limited to a maximum of $25,000 deducted from their compensation under the
plan during each calendar year. The maximum number of ordinary shares which
shall be available for sale under the plan shall be 160,000 shares, plus an
annual increase to be added by the first day of the year commencing 2001 equal
to the lesser of (i) 140,000 shares or (ii) 3/4% of the outstanding shares on
such date or (iii) a lesser amount determined by our board. The plan shall be
administered by our board or a committee appointed by the board. The plan shall
terminate on October 31, 2010. As of May 31, 2003, 271,713 ordinary shares were
issued under the ESPP, and an additional 165,510 ordinary shares are reserved
for issuance. As of November 14, 2002 the Board of Directors of the Company
resolved to suspend the ESPP until further notice.
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS
A. Major Shareholders
The following table sets forth certain information regarding the beneficial
ownership of our ordinary shares as of June 15, 2003, by each person or entity
known to own beneficially more than 5% of our outstanding ordinary shares based
on information provided to us by the holders or disclosed in public filings with
the Securities and Exchange Commission.
Name Number of Ordinary Percentage of Outstanding
shares Beneficially Owned(1) Ordinary shares(2)
Tzvi Shukhman(3) 5,731,356 30.7%
Uzi Rozenberg(3)(4) 4,986,095 26.7%
Although the shares they own do not possess voting rights different from those
of other shares, due to the size of their shareholdings Messrs. Tzvi Shukhman
and Uzi Rozenberg will control the outcome of various actions that require
shareholder approval. For example, these shareholders could elect most of our
directors, delay or prevent a transaction in which shareholders might receive a
premium over the prevailing market price for their shares and prevent changes in
control or management. Messrs. Shukhman and Rozenberg are also parties to a
voting agreement, pursuant to which they will act in concert with respect to the
nomination and election of directors. See " 3/4 Related Party Transactions".
- -------------- (1) Except as otherwise noted and pursuant to applicable
community property laws, each person named in the table has sole voting and
investment power with respect to all ordinary shares listed as owned by such
person.
(2) The percentage of outstanding ordinary shares is based on 18,655,413
ordinary shares outstanding as of May 31, 2003.
(3) Our major shareholders do not have voting rights different from the voting
rights of our other shareholders.
(4) The record holder of 1,000,000 shares out of the 4,986,095 is not Uzi
Rozenberg, but U.S.R. Electronic Systems (1987) Ltd., an Israeli company wholly
owned by Mr. Rozenberg and his wife, Shoshana Rozenberg.
B. Related Party Transactions
Voting Agreement
As of June 15, 2003, Messrs. Shukhman and Rozenberg, who together own an
aggregate of 10,717,451 ordinary shares (representing approximately 57.4% of our
ordinary shares outstanding as of May 31, 2003), are parties to a voting
agreement. Pursuant to the voting agreement, they will act in concert with
respect to the nomination and election of directors.
Employment Agreements
We have entered into employment agreements with each of our executive officers,
other than our chief executive officer. See "Item 6-Board Practices-Management
Employment Agreements."
Indemnification Agreements
We have entered into indemnification agreements with each of our executive
officers and directors. See "Item 6 - Directors, Senior Management and Employees
- - Board Practices-Exculption, Insurance and Indemnification of Directors and
Officers."
C. Interests of Exports and Counsel
Not applicable.
ITEM 8. FINANCIAL INFORMATION
A. Consolidated Statements and Other Financial Information
Consolidated Financial Statements
The financial statements required by this item are incorporated by reference to
the Company's filing with the Securities and Exchange Commission on Form 6-K on
June 16, 2003. Other Financial Information In the year ended December 31, 2002
the amount of our export sales was approximately $3.46 million which represents
52.2% of our total sales.
Legal Proceedings
On July 9, 1998, a former employee filed a claim against us in the Tel Aviv
District Labor Court stating that we are obligated to issue to him ordinary
shares and to pay on his behalf any taxes relating to such issuance. In
addition, this former employee stated that we are obligated to pay him statutory
severance pay together with the statutory penalty for late payment of such
severance pay and travel expenses. The former employee also demanded that we
release his manager insurance and continuing education fund. We filed a
counterclaim against this former employee. In November 2000 we started mediation
proceedings. In March 2001, pursuant to previous agreements with the former
employee, the Tel Aviv District Labor Court ordered that certain of the disputes
between the parties, which were not settled, be referred to arbitration, to be
conducted in two stages. According to the court's order, and based on agreements
between the parties, we issued 75,765 ordinary shares (which are held in trust)
in favor of the former employee in March 2001. The Company had previously
granted this employee options to purchase said shares. In addition, in January
2002, the Company paid the former employee $15,797 in payment of statutory
severance pay and reimbursement of travel expenses. In August 2002, the
arbitrators issued their judgment in the first stage of the arbitration, in
which they accepted certain of the claims made by each of the parties and
awarded $ 390,761 to the former employee (we paid this amount to the former
employee in September 2002). The former employee will be entitled to file a
second claim before the arbitrators if, by October 10, 2003, the market price of
Company's ordinary shares does not reach the price of $25.00 per share, or if
the Company does not repurchase the shares issued on behalf of the former
employee at said price (pursuant to an option we have to do so). Such second
claim, if filed, will be limited to financial damages in connection with the
alleged delay in issuing the shares to the former employee. If such second claim
is filed, we will be entitled to file a counter claim against the former
employee. In addition, if such second claim is filed, the parties are obligated
to conduct mediation proceedings before the arbitration proceedings commence. We
believe that the resolution of this matter will not have a material adverse
effect on our financial condition nor cause a material change in the number of
our outstanding ordinary shares. However, there can be no assurance that we will
necessarily prevail if a second claim is filed, due to the inherent
uncertainties in litigation.
We are not a party to any material legal proceedings.
Dividend Policy
We have never declared or paid any cash dividends on our ordinary shares. We do
not anticipate paying any cash dividends on our ordinary shares in the
foreseeable future. We currently intend to retain all future earnings for use in
the development of our business.
B. Significant Changes
Not applicable.
ITEM 9. THE OFFER AND LISTING
A. Offer and Listing Details LISTING DETAILS
The following table sets forth the high and low closing prices for our ordinary
shares as reported by the Nasdaq National Market for the periods indicated:
High Low
1999
Fourth Quarter (commencing December 2) $ 23.81 $ 19.19
2000
First Quarter 72.00 16.50
Second Quarter 38.75 15.75
Third Quarter 34.00 18.00
Fourth Quarter 18.50 9.25
2001
First Quarter 17.38 7.31
Second Quarter 10.00 6.19
Third Quarter 6.97 2.25
Fourth Quarter 5.95 2.04
2002
First Quarter 6.50 4.21
Second Quarter 4.48 2.23
Third Quarter 2.46 1.84
July 2.40 2.06
August 2.40 1.95
September 2.46 1.84
Fourth Quarter 2.84 1.71
October 1.94 1.71
November 2.72 1.99
December 2.84 2.59
2003
First Quarter 3.80 2.74
January 3.18 2.74
February 3.75 3.00
March 3.80 3.39
Second Quarter (Until June 25) 6.29 3.38
April 3.77 3.38
May 5.82 3.62
June 6.29 4.79
The following table sets forth the
high and low closing prices for our ordinary shares as reported by the Tel Aviv
Stock Exchange for the periods indicated. The translation into dollars is based
on the daily representative rate of exchange on the date of the relevant closing
price, as published by the Bank of Israel:
High Low
$ NIS $ NIS
2000
Fourth Quarter (commencing December 3) 14.17 58.00 9.51 38.54
2001
First Quarter 17.54 72.70 7.47 31.48
Second Quarter 9.86 41.20 5.99 25.02
Third Quarter 7.53 31.45 5.51 23.16
Fourth Quarter 2.42 10.41 2.10 9.16
2002
First Quarter 6.33 28.59 4.00 18.91
Second Quarter 4.23 20.22 2.17 10.51
Third Quarter 2.52 11.95 2.01 9.58
Fourth Quarter 2.75 13.05 1.67 8.00
October 1.98 9.62 1.67 8.00
November 2.74 12.76 1.91 9.12
December 2.75 13.05 2.56 12.14
2003
First Quarter 3.79 18.40 2.55 12.11
January 3.11 15.00 2.55 12.11
February 3.74 18.25 2.86 13.85
March 3.79 18.40 3.39 15.98
Second Quarter (Until June 25) 6.33 27.72 3.46 16.14
April 3.71 16.99 3.46 16.14
May 5.77 25.44 3.68 16.53
June 6.33 27.72 4.58 20.24
B. Plan of Distribution
Not applicable.
C. Markets
Our ordinary shares began trading on the Nasdaq National Market on December 2,
1999 under the symbol "MTLK". Prior to that date, there had been no market for
our ordinary shares. As of December 3, 2000, our ordinary shares began trading
also on the Tel-Aviv Stock Exchange under the symbol "MTLK."
D. Selling shareholders.
Not applicable.
E. Dilution.
Not applicable.
F. Expenses of the Issue.
Not applicable.
ITEM 10. ADDITIONAL INFORMATION
A. Share Capital
Not applicable.
B. Memorandum and Articles of Association
Previously reported in the Company Report on Form 20-F for fiscal year 2001.
C. Material Contracts
For a summary of our material contracts, see "Item 7-Major Shareholders and
Related Party Transactions-Related Party Transactions" and "Item 4 - Information
on the Company - Property, Plants and Equipment."
D. Exchange Controls
Israeli law and regulations do not impose any material foreign exchange
restrictions on non-Israeli holders of our ordinary shares. In May 1998, a new
"general permit" was issued under the Israeli Currency Control Law, 1978, which
removed most of the restrictions that previously existed under the law, and
enabled Israeli citizens to freely invest outside of Israel and freely convert
Israeli currency into non-Israeli currencies.
Dividends, if any, paid to holders of our ordinary shares and any amounts
payable upon our dissolution, liquidation or winding up, as well as the proceeds
of any sale in Israel of our ordinary shares to an Israeli resident, may be paid
in non-Israeli currency or, if paid in Israeli currency, may be converted into
freely repatriable dollars at the rate of exchange prevailing at the time of
conversion.
E. Taxation
Israeli Tax Considerations and Government Programs
The following is a summary of the current tax structure applicable to companies
in Israel, with special reference to its effect on us. The following also
contains a discussion of material Israeli and United States tax consequences to
purchasers of our ordinary shares and certain Israeli Government programs
benefiting us. To the extent that the discussion is based on new tax legislation
which has not been subject to judicial or administrative interpretation, there
can be no assurance that the views expressed in the discussion will be accepted
by the tax authorities in question. The discussion is not intended, and should
not be construed, as legal or professional tax advice and is not exhaustive of
all possible tax considerations.
Holders of our ordinary shares are encouraged to consult their own tax advisors
as to the United States, Israeli or other tax consequences of the purchase,
ownership and disposition of ordinary shares, including, in particular, the
effect of any foreign, state or local taxes.
Tax Reform
On January 1, 2003, the Law for Amendment of the Income Tax Ordinance (Amendment
No. 132), 5762-2002, known as the Tax Reform, came into effect, following its
enactment by the Israeli Parliament on July 24, 2002. On December 17, 2002, the
Israeli Parliament approved a number of amendments to the Tax Reform, which came
into effect on January 1, 2003.
The Tax Reform, aimed at broadening the categories of taxable income and
reducing the tax rates imposed on employment income, introduced the following
changes, among others:
(i) Reduction of the tax rate levied on real capital gains (other than gains
deriving from the sale of listed securities) derived after January 1, 2003, to a
general rate of 25% for both individuals and corporations. Regarding assets
acquired prior to January 1, 2003, the reduced tax rate will apply to a
proportionate part of the gain, in accordance with the holding periods of the
asset, before or after January 1, 2003, on a linear basis;
(ii) Imposition of Israeli tax on all income of Israeli residents, individuals
and corporations, regardless of the territorial source of income, including
income derived from passive sources such as interest, dividends and royalties;
(iii) Introduction of controlled foreign corporation (CFC) rules into the
Israeli tax structure. Generally, under such rules, an Israeli resident who
holds, directly or indirectly, 10% or more of the rights in a foreign
corporation whose shares are not publicly traded, in which more than 50% of the
rights are held directly or indirectly by Israeli residents, and a majority of
whose income in a tax year is considered passive income, will be liable for tax
on the portion of such income attributed to his or her holdings in such
corporation, as if such income were distributed to him or her as a dividend;
(iv) Imposition of capital gains tax on capital gains, realized by individuals
as of January 1, 2003, from the sale of shares of publicly traded companies
(such gain was previously exempt from capital gains tax in Israel). For
information with respect to the applicability of Israeli capital gains taxes on
the sale of ordinary shares, see "Capital Gains Tax" below; and
(v) Introduction of a new regime for the taxation of shares and options issued
to employees and officers (including directors).
General Corporate Tax Structure
Israeli companies are generally subject to company tax at the rate of 36% of
taxable income, and are subject to capital gains tax at a rate of 25% for
capital gains derived after January 1, 2003. However, the effective tax rate
payable by a company which derives income from an Approved Enterprise (as
further discussed below) may be considerably less.
Tax Benefits and Grants for Research and Development
Israeli tax law allows, under certain conditions, a tax deduction in
the year incurred for expenditures, including depreciation on capital
expenditures, in scientific research and development projects, if the
expenditures are approved by the relevant Israeli government ministry,
determined by field of research, and the research and development is for the
promotion of the enterprise and is carried out by, or on behalf of, the company
seeking such deduction. Expenditures not so approved or funded, are deductible
over a three-year period. However, expenditures made out of proceeds of
government grants are not deductible.
Tax Benefits Under the Law for the Encouragement of Capital Investments, 1959
The Law for the Encouragement of Capital Investments, 1959 (the "Investment
Law"), provides that a proposed capital investment in eligible facilities may,
upon application to the Investment Center of the Ministry of Industry and Trade
of the State of Israel (the "Investment Center"), be designated as an "Approved
Enterprise". Such approvals may be granted only for applications submitted until
December 31, 2003. Each certificate of approval for an Approved Enterprise
relates to a specific investment program delineated both by its financial scope,
including its capital sources, and by its physical characteristics, for example,
the equipment to be purchased and utilized pursuant to the program.
Taxable income of a company derived from an Approved Enterprise is subject to
company tax at the maximum rate of 25% (rather than 36%) for the benefit period,
such income includes income derived in the years 2003 to 2005 from interest
accrued on funds obtained in a public offering outside of Israel, provided
however that such funds are held in a banking institution outside of Israel and
have yet to be utilized by such company. This period is seven or ten years
(depending on the extent of foreign shareholders holding of our ordinary shares)
commencing with the year in which the Approved Enterprise first generates
taxable income, and is limited to the earlier of twelve years from commencement
of production or fourteen years from the date of approval, whichever is earlier.
The Investment Law also provides that a company that has an Approved Enterprise
is entitled to accelerated depreciation on its property and equipment that are
included in an approved investment program.
The tax benefits derived from any such certificate of approval relate only to
taxable income attributable to the specific Approved Enterprise. In the event
that a company is operating under more than one approval or that its capital
investments are only partly approved, its effective company tax rate is the
result of a weighted combination of the various applicable rates. A company
owning an Approved Enterprise may elect to forego certain government grants
extended to Approved Enterprises in return for an alternative package of
benefits. Under the alternative package, a company's undistributed income
derived from an Approved Enterprise will be exempt from company tax for a period
of between two and ten years from the first year of taxable income, depending on
the geographic location of the Approved Enterprise within Israel, and such
company will be eligible for a reduced tax rate for the remainder of the
benefits period. Under an amendment to the Investments Law that was made within
the framework of the tax reform, it was clarified that tax benefits under the
Investments Law shall also apply to income generated by a company from the grant
of a usage right with respect to know-how developed by the Approved Enterprise,
income generated from royalties, and income derived from a service which is
auxiliary to such usage right or royalties, provided that such income is
generated within the Approved Enterprise's ordinary course of business In 1994,
our request for designation of our capital investment at our facility as an
"Approved Enterprise" program was approved under the Investment Law. For this
Approved Enterprise, we elected the alternative package of benefits. On December
2000, we received an approval for additional capital investment in our Approved
Enterprise under the alternative package of benefits. We have derived, and
expect to continue to derive, a substantial portion of our income from our
Approved Enterprise facilities.
A company that has elected the alternative package of benefits and that
subsequently pays a dividend out of income derived from the Approved Enterprise
during the tax exemption period
will be subject to tax in respect of the amount distributed (including the tax
thereon) at the rate which would have been applicable had it not elected the
alternative package of benefits (generally 10%-25%, depending on the extent of
foreign shareholders holding our ordinary shares). The dividend recipient is
taxed at the reduced rate applicable to dividends from Approved Enterprises
(15%), if the dividend is distributed during the tax exemption period or within
12 years thereafter. We must withhold this tax at source, regardless of whether
the dividend is converted into foreign currency.
Subject to certain provisions concerning income under the alternative package of
benefits, all dividends are considered to be attributable to the entire
enterprise and their effective tax rate is the result of a weighted combination
of the various applicable tax rates. We are not obliged to distribute exempt
retained profits under the alternative package of benefits, and we may generally
decide from which year's profits to declare dividends. We currently intend to
reinvest the amount of our tax-exempt income and not to distribute such income
as a dividend. The Investment Center bases its decision as to whether or not to
approve an application, on the criteria set forth in the Investment Law and
regulations, the then prevailing policy of the Investment Center, and the
specific objectives and financial criteria of the applicant. Accordingly, there
can be no assurance that any such application will be approved. In addition, the
benefits available to an Approved Enterprise are conditional upon the
fulfillment of conditions stipulated in the Investment Law and its regulations
and the criteria set forth in the specific certificate of approval, as described
above. In the event that a company does not meet these conditions, it would be
required to refund the amount of tax benefits, with the addition of the consumer
price index linkage adjustment and interest.
The Ministry of Finance has announced that it may seek to reduce, or even
cancel, some or all of the benefits under the Investment Law. Grants under the
Law for the Encouragement of Industrial Research and Development, 1984 Under the
Law for the Encouragement of Industrial Research and Development, 1984 (the "R&D
Law"), research and development programs performed until year 2002, which meet
certain criteria and are approved by a governmental committee of the Office of
the Chief Scientist ("Chief Scientist") were eligible for grants of up to 50% of
the project's expenditure, as determined by the research committee, in return
for the payment of royalties from the sale of the product developed in
accordance with the program.
Regulations promulgated under the Research Law generally provide for the payment
of royalties to the Chief Scientist ranging from 3% to 3.5% or in some cases,
such as ours, ranging from 4% to 4.5%, on revenues from products developed using
such grants until 100-120% of the dollar-linked grant is repaid. Following the
full repayment of the grant, there is no further liability for payment. See
"Item 5-Operating and Financial Review and Prospects". The terms of the grants
we received from the Office of Chief Scientist require that the manufacture of
products developed under the funded plans be performed in Israel, unless prior
approval is received from the Office of the Chief Scientist to the manufacture
of such products outside Israel. Ordinarily, any such approval requires the
payment of increased aggregate royalties, ranging from 120% to 300% of the U.S.
dollar-linked value of the total grants, depending on the percentage of the
manufacturing volume to be performed outside Israel, and the acceleration of the
royalty payment rate.
In November 2002, the Israeli parliament approved an amendment to
the R&D Law. The amendment became effective on April 1, 2003. As opposed to the
R&D Law prior to the amendment, which requires an undertaking in the application
that all manufacturing will be performed in Israel, the amendment to the R&D Law
allows for the approval of grants in cases in which the applicant declares that
part of the manufacturing will not be performed in Israel. This declaration is
required to include details regarding the locations in which the manufacture of
the product will be performed in Israel and out of Israel, the manufacture
activities to be performed in such locations (including the reasons for
performing such manufacture activities out of Israel) and the proportionate
manufacturing expenditures in Israel and out of Israel. This declaration will be
a significant factor in the determination of the Chief Scientist whether to
approve a plan and the amount and other terms of benefits to be granted.
In accordance with the amendment to the R&D Law, a plan will be approved if the
applicant is an Israeli corporation and as a result of the plan the applicant
will develop in Israel, by Israeli residents, a new product or a significant
improvement to an existing product, unless the Chief Scientist is convinced that
it is essential for the execution of the plan that part of it will be performed
out of Israel or by non-Israeli residents.
The amendment to the R&D Law further allows the Chief Scientist to provide
grants for portions of 20%, 30%, 40% or 50% of certain approved expenditures of
a research and development. The R&D Law prior to the amendment only allowed for
grants covering 50% of such expenditures. This amendment and the budget of the
Chief Scientist may affect the rate of additional grants that may be requested
by us in the future.
In addition, the amendment to the R&D Law adds reporting requirements with
respect to certain changes in the ownership of a grant recipient. The amendment
requires the grant recipient and its controlling shareholders and interested
parties to notify the Chief Scientist of any change in control of the recipient
or a change in the holdings of the means of control of the recipient that
results in a non-Israeli becoming an interested party directly in the recipient
and requires the new interested party to undertake to the Chief Scientist to
comply with the R&D Law. For this purpose, "control" is defined as the ability
to direct the activities of a company other than any ability arising solely from
serving as an officer or director of the company. A person is presumed to have
control if such person holds 50% or more of the means of control of a company.
"Means of control" refers to voting rights and the right to appoint directors or
the chief executive officer. An "interested party" of a company includes a
holder of 5% or more of its outstanding share capital or voting rights, its
chief executive officer and directors, someone who has the right to appoint its
chief executive officer or at least one director, and a company with respect to
which any of the foregoing interested parties owns 25% or more of the
outstanding share capital or voting rights or has the right to appoint 25% or
more of the directors. Accordingly, absent an exemption, any non-Israeli who
acquires 5% or more of our ordinary shares will be required to notify the Chief
Scientist that it has become an interested party and to sign an undertaking to
comply with the R&D Law.
The proposed amendment to the R&D Law that would have allowed in certain
circumstances the transfer of the ownership of the technology developed with the
funding of the Chief Scientist to third parties outside of Israel was not
approved at this time.
The Company's manufacturing operations outside Israel have always been disclosed
in the
Company's applications for grants, which were filed, received and approved on a
yearly basis, including the details of the subcontractors abroad. The
application did not contain a mechanism to demonstrate formally the consent of
the Chief Scientist to overseas manufacturing operations, but we believe that
the implicit annual consent of the Chief Scientist to these operations is
represented by the awarding of the approved grant itself for the past 8 years.
We have sought, and received, grants for the past 8 years. The impact of such
grants has been to reduce the effective research and development expense for the
Company, even after taking into account that the royalty rate on the grants is
higher than for companies with Israel-only manufacturing operations. If, for any
reason, the Chief Scientist withdrew its support for our grant applications, or
if is determined that we have not complied with the terms of our grants or the
R&D Law, or it is determined that an approval for a grant was knowingly obtained
due to false or misleading statements, we could be exposed to penalties,
suspension or cancellation of the grant approvals, the refund of benefits
previously granted (plus linkage to the consumer price index and interest) and
denial of any future applications for grants or these consents, and the savings
that have been previously realized in our research and development programs as a
result of these grants would no longer be available to us, potentially
increasing our operating expenses. See "Item 5-Operating and Financial Review
and Prospects-Operating Results-Government Grants".
The funds available for Chief Scientist grants were reduced in 1998, and the
Israeli authorities have indicated that the government may further reduce or
abolish Chief Scientist grants in the future. Even if these grants are
maintained, we cannot presently predict what would be the amounts of future
grants, if any, that we might receive.
Tax Benefits and Grants for Research and Development
According to the Law for the Encouragement of Industry (Taxes), 1969, or the
"Industry Encouragement Law", an "Industrial Company" is a company resident in
Israel, at least 90% of the income of which, in any tax year, determined in
Israeli currency (exclusive of income from certain government loans, capital
gains, interest and dividends), is derived from an "Industrial Enterprise" owned
by it. An "Industrial Enterprise" is defined as an enterprise whose major
activity in a given tax year is industrial production activity. We believe that
we currently qualify as an "Industrial Company" within the definition of the
Industry Encouragement Law. Under the Industry Encouragement Law, if we qualify
as an "Industrial Company" we are entitled to the following preferred corporate
tax benefits, among others:
(a) amortization of the cost of purchased know-how and patents over an
eight-year period for tax purposes;
(b) right to elect under certain conditions to file a consolidated tax return
with additional related Israeli Industrial Companies;
(c) accelerated depreciation rates on equipment and buildings; and (d)
deduction over a three-year period of expenses involved with the issuance and
listing of shares on a stock exchange.
Eligibility for the benefits under the Industry Encouragement Law is not subject
to receipt of prior approval from any governmental authority. No assurance can
be given that we will continue to qualify as an "Industrial Company" or that the
benefits described above will be available in the future.
Special Provisions Relating to Taxation Under Inflationary Conditions
The Income Tax Law (Inflationary Adjustments), 1985, generally referred to as
the "Inflationary Adjustments Law," represents an attempt to overcome the
problems presented to a traditional tax system by an economy undergoing rapid
inflation. The Inflationary Adjustments Law is highly complex. Its features
which are material to us can be described as follows:
(a) There is a special tax adjustment for the preservation of equity
whereby certain corporate assets are classified broadly into Fixed Assets (as
defined in the Inflationary Adjustments Law) and non-fixed (soft) assets. Where
a company's equity, as defined in such law, exceeds the depreciated cost of
Fixed Assets, a deduction from taxable income that takes into account the effect
of the applicable annual rate of inflation on such excess is allowed (up to a
ceiling of 70% of taxable income in any single tax year, with the unused portion
permitted to be carried forward on a linked basis).
(b) If the depreciated cost of Fixed Assets exceeds a company's equity, then
such excess multiplied by the applicable annual rate of inflation is added to
taxable income.
(c) Subject to certain limitations, depreciation deductions on Fixed
Assets and losses carried forward are adjusted for inflation based on the
increase in the consumer price index.
(d) Taxable gains on certain traded securities (which were previously
exempt from tax), are taxable at a reduced rate following the Tax Reform.
However, dealers in securities are subject to the regular tax rules applicable
to business income in Israel. Capital Gains Tax Israeli law generally imposes on
residents and non-residents of Israel a capital gains tax on the sale of capital
assets in Israel, including our ordinary shares, unless a specific exemption is
available or unless a tax treaty between Israel and the shareholder's country of
residence provides otherwise. The law distinguishes between the real gain and
inflationary surplus. Real gain is the difference between the total capital gain
and the inflationary surplus. The inflationary surplus is computed on the basis
of the difference between the Israeli consumer price index in the month of sale
and the month of purchase.
Prior to the Tax Reform, gains on sales of our ordinary shares by individuals
were, generally, exempt from Israeli capital gains tax for so long as: (1) our
shares were quoted on Nasdaq or another stock exchange recognized by the Israeli
Controller of Foreign Currency and (2) we qualified as an Industrial Company.
Pursuant to the Tax Reform, generally, capital gains tax is imposed at a rate of
15% on real gains derived on or after January 1, 2003, from the sale of shares
in (i) companies publicly traded on the Tel Aviv Stock Exchange ("TASE"), or
(ii) subject to a necessary determination by the Israeli Minister of Finance,
Israeli companies publicly traded on a recognized stock exchange outside of
Israel. This tax rate is contingent upon the shareholder not claiming a
deduction for financing expenses (in which case the gain will be taxed at a rate
of 25%), and does not apply to: (i) dealers in securities (who will be taxed at
a rate of 36% for corporations and at a marginal tax rate of up to 50% for
individuals); (ii) shareholders that report in accordance with the Inflationary
Adjustment Law (who will be taxed at a rate of 36% for corporations and at a
marginal tax rate of up to 50% for individuals); or (iii) shareholders who
acquired their shares prior to an initial public offering (that are subject to a
different tax arrangement). The tax basis of shares acquired prior to January 1,
2003 will be determined in accordance with the average closing share price in
the three trading days preceding January 1, 2003. However, a request may be made
to the tax authorities to consider the actual adjusted cost of the shares as the
tax basis if it is higher than
such average price.
Non-Israeli residents are exempt from Israeli capital gains tax on any gains
derived from the sale of shares publicly traded on the TASE, and are exempt from
Israeli capital gains tax on any gains derived from the sale of shares of
Israeli companies publicly traded on a recognized stock exchange outside of
Israel, provided that such capital gains are not derived from a permanent
establishment in Israel and that such shareholders did not acquire their shares
prior to the issuer's initial public offering. However, non-Israeli corporations
will not be entitled to such exemption if an Israeli resident (i) has a
controlling interest of 25% or more in such non-Israeli corporation, or (ii) is
the beneficiary of or is entitled to 25% or more of the revenues or profits of
such non-Israeli corporation, whether directly or indirectly.
In any event, the provisions of the Tax Reform shall not effect the exemption
from capital gains tax for gains accrued before January 1, 2003, as described
above. In some instances where our shareholders may be liable to Israeli tax on
the sale of their ordinary shares, the payment of the consideration may be
subject to the withholding of Israeli tax at the source.
Application of the U.S.-Israel Tax Treaty to Capital Gains Tax
Subject to the U.S.-Israel Tax Treaty, the sale, exchange or disposition of our
ordinary shares by a person who qualifies as a resident of the United States and
is entitled to claim the benefits afforded to a resident, or a Treaty U.S.
Resident, will not be subject to Israeli capital gains tax unless (i) that
Treaty U.S. Resident held, directly or indirectly, shares representing 10% or
more of our voting power during any part of the 12-month period preceding the
sale, exchange or disposition; or (ii) the capital gains from such sale can be
allocated to a permanent establishment in Israel. A sale, exchange or
disposition of our ordinary shares by a Treaty U.S. Resident who held, directly
or indirectly, shares representing 10% or more of our voting power at any time
during the 12-month period preceding the sale, exchange or disposition will be
subject to Israeli capital gains tax, to the extent applicable. However, under
the U.S.-Israel Tax Treaty, this Treaty U.S. Resident would be permitted to
claim credit for these taxes if required to be paid against U.S. income tax
imposed with respect to such sale, exchange or disposition, subject to the
limitations set in U.S. laws applicable to foreign tax credits.
Taxation of Non-Residents on Receipt of Dividends
Nonresidents of Israel will be subject to Israeli income tax on the receipt of
dividends paid on the ordinary shares at the rate of 25%, which tax will be
withheld at source, unless the dividends are paid from income derived from an
approved enterprise during the applicable benefit period, or a different rate is
provided in a treaty between Israel and the shareholder's country of residence.
Under the U.S.-Israel Tax Treaty, the maximum tax on dividends paid to a holder
of the ordinary shares who is a Treaty U.S. Resident will be 25%. However, when
dividends are paid from income derived during any period for which the Israeli
company is not entitled to the reduced tax rate applicable to an Approved
Enterprise under Israel's Law for the Encouragement of Capital Investments,
1959, the maximum tax will be 12.5% if the holder is a U.S. company holding
shares representing 10% or more of the voting power during the part of the
taxable year preceding the date of payment of dividends and during the whole of
its prior taxable year, if any, and provided that not more than 25% of the
Israeli company's gross income consists of interest or dividends. When dividends
are paid from income derived during any period for which the Israeli company is
entitled to the reduced tax rate applicable to an Approved Enterprise, then the
tax
will be 15% if the conditions in the preceding sentence are met.
United States Federal Income Tax Considerations
General
Subject to the limitations described below, the following discussion describes
the material United States federal income tax consequences to a U.S. Holder (as
defined below) that is a beneficial owner of our ordinary shares and that holds
them as capital assets. For purposes of this summary, a "U.S. Holder" is a
beneficial owner of our ordinary shares who or that is for United States federal
income tax purposes:
o a citizen or resident of the United States;
o a corporation (or other entity treated as a corporation for United States
federal tax purposes) created or organized in the United States or under the
laws of the United States or of any state or the District of Columbia;
o an estate, the income of which is Includable in gross income for United States
federal income tax purposes regardless of its source; or
o a trust, if a court within the United States is able to exercise primary
supervision over the administration of the trust and one or more U.S. persons
have the authority to control all substantial decisions of the trust.
This summary is for general information purposes only. It does not purport to be
a comprehensive description of all of the tax considerations that may be
relevant to each person's decision to purchase ordinary shares. As this is a
general summary, prospective owners of our ordinary shares are advised to
consult their own tax advisers with respect to the U.S. federal, state and local
tax consequences, as well as to non-U.S. tax consequences, of the acquisition,
ownership and disposition of our ordinary shares applicable to their particular
tax situations. This discussion is based on current provisions of the U.S.
Internal Revenue Code of 1986, as amended, current and proposed U.S. Treasury
regulations promulgated thereunder, and administrative and judicial decisions,
as of the date hereof, all of which are subject to change, possibly on a
retroactive basis. This discussion does not address all aspects of United States
federal income taxation that may be relevant to any particular holder based on
such holder's individual circumstances. In particular, this discussion does not
address the potential application of the alternative minimum tax or the United
States federal income tax consequences to U.S. Holders that are subject to
special treatment, including:
o broker-dealers, including dealers in securities or currencies;
o insurance companies;
o taxpayers that have elected mark-to-market accounting;
o tax-exempt organizations; o financial institutions or "financial services
entities";
o taxpayers who hold the ordinary shares as part of a straddle, "hedge" or
"conversion transaction" with other investments;
o holders owning directly, indirectly or by attribution at least 10% of our
voting power;
o taxpayers whose functional currency is not the U.S. dollar; and
o taxpayers who acquire our ordinary shares as compensation.
This discussion does not address any aspect of United States federal gift or
estate tax, or state, local or non-United States tax laws. Additionally, the
discussion does not consider the tax
treatment of partnerships or persons who hold our ordinary shares through a
partnership or other pass-through entity. Certain material aspects of United
States federal income tax relevant to a beneficial owner other than a U.S.
Holder, or a Non-U.S. Holder, are also discussed below. Each prospective
investor is advised to consult such person's own tax advisor with respect to the
specific tax consequences to such person of purchasing, holding or disposing of
our ordinary shares.
Taxation of Dividends Paid on Ordinary Shares
We have never paid cash dividends, and we currently do not intend to pay cash
dividends in the foreseeable future. In the event that we do pay a dividend, and
subject to the discussion of the passive foreign investment company, or PFIC,
rules below, a U.S. Holder will be required to include in gross income as
ordinary income the amount of any distribution paid on our ordinary shares,
including any Israeli taxes withheld from the amount paid, on the date the
distribution is received to the extent the distribution is paid out of our
current or accumulated earnings and profits, as determined for United States
federal income tax purposes. Distributions in excess of such earnings and
profits will be applied against and will reduce the U.S. Holder's basis in the
ordinary shares and, to the extent in excess of such basis, will be treated as a
gain from the sale or exchange of the ordinary shares.
Distributions of current or accumulated earnings and profits paid in foreign
currency to a U.S. Holder will be includable in the income of a U.S. Holder in a
U.S. dollar amount calculated by reference to the exchange rate on the date the
distribution is received. A U.S. Holder that receives a foreign currency
distribution and converts the foreign currency into U.S. dollars subsequent to
receipt will have foreign exchange gain or loss based on any appreciation or
depreciation in the value of the foreign currency against the U.S. dollar, which
will generally be U.S. source ordinary income or loss.
U.S. Holders will have the option of claiming the amount of any Israeli income
taxes withheld at source either as a deduction from gross income or as a
dollar-for-dollar credit against their United States federal income tax
liability. Individuals who do not claim itemized deductions, but instead utilize
the standard deduction, may not claim a deduction for the amount of any Israeli
income taxes withheld, but such individuals may still claim a credit against
their United States federal income tax liability. The amount of foreign income
taxes which may be claimed as a credit in any year is subject to complex
limitations and restrictions, which must be determined on an individual basis by
each shareholder. The total amount of allowable foreign tax credits in any year
cannot exceed the pre-credit U.S. tax liability for the year attributable to
foreign source taxable income.
A U.S. Holder will be denied a foreign tax credit with respect to Israeli income
tax withheld from dividends received on the ordinary shares: o if such U.S.
Holder has not held the ordinary shares for at least 16 days of the 30-day
period beginning on the date which is 15 days before the ex-dividend date; or o
to the extent such U.S. Holder is under an obligation to make related payments
on substantially similar or related property.
Any days during which a U.S. Holder has substantially diminished its risk of
loss on the ordinary shares are not counted toward meeting the 16 day holding
period required by the statute. In addition, distributions of current or
accumulated earnings and profits will be foreign source passive income for
United States foreign tax credit purposes and will not qualify for the
dividends received deduction otherwise available to corporations.
Taxation of the Disposition of Ordinary Shares
Subject to the discussion of the PFIC rules below, upon the sale, exchange or
other disposition of our ordinary shares, a U.S. Holder will recognize capital
gain or loss in an amount equal to the difference between such U.S. Holder's
basis in the ordinary shares, which is usually the U.S. dollar cost of such
shares, and the amount realized on the disposition. If the ordinary shares are
publicly traded, a disposition of the ordinary shares will be considered to
occur on the "trade date," regardless of the U.S. Holder's method of accounting.
A U.S. Holder that uses the cash method of accounting calculates the U.S. dollar
value of the proceeds received on the sale as of the date that the sale settles.
However, a U.S. Holder that uses the accrual method of accounting is required to
calculate the value of the proceeds of the sale as of the "trade date" and may
therefore realize foreign currency gain or loss, unless such U.S. Holder has
elected to use the settlement date to determine its proceeds of sale for
purposes of calculating such foreign currency gain or loss. Capital gain from
the sale, exchange or other disposition of the ordinary shares held more than
one year is long-term capital gain. Gain or loss recognized by a U.S. Holder on
a sale, exchange or other disposition of our ordinary shares generally will be
treated as United States source income or loss for United States foreign tax
credit purposes. The deductibility of a capital loss recognized on the sale,
exchange or other disposition of the ordinary shares is subject to limitations.
In addition, a U.S. Holder that receives foreign currency upon disposition of
the ordinary shares and converts the foreign currency into U.S. dollars
subsequent to receipt will have foreign exchange gain or loss based on any
appreciation or depreciation in the value of the foreign currency against the
U.S. dollar, which will generally be United States source ordinary income or
loss.
Passive Foreign Investment Company Considerations
Generally a foreign corporation is treated as a passive foreign investment
company, or PFIC, for United States federal income tax purposes, if either, (i)
75% or more of its gross income in a taxable year, including the pro-rata share
of the gross income of any company, U.S. or foreign, in which such corporation
is considered to own 25% or more of the shares by value, is passive income, or
(ii) 50% or more of the assets in a taxable year, averaged over the year and
ordinarily determined based on fair market value and including the pro-rata
share of the assets of any company in which such corporation is considered to
own 25% or more of the shares by value, are held for the production of, or
produce, passive income. This characterization as a PFIC could result in adverse
U.S. tax consequences to our shareholders.
As previously announced, we believe that we were characterized as a PFIC for
2001 and 2002. Although we will endeavor to avoid such characterization in the
future, we may not be able to do so. Any U.S. person who held our shares at any
time during 2001 or 2002 was eligible to mitigate the consequences of our PFIC
characterization by electing to treat us as a "qualified electing fund" or QEF
under the Internal Revenue code as specified below. Alternatively, U.S.
taxpayers were also able to make a "mark-to-market" election under the Internal
Revenue Code as specified below.
A U.S. Holder who did not make a qualifying election either to (i) treat us as a
"qualified electing fund", or a QEF, or (ii) mark our ordinary shares to market
will be subject to the following:
o gain recognized by the U.S shareholder upon the disposition of, as well as
income
recognized upon receiving certain dividends on the shares would be taxable as
ordinary income;
o the U.S shareholder would be required to allocate such dividend income and/or
disposition gain ratably over such shareholder's entire holding period for such
Metalink ordinary shares;
o the amount allocated to each year other than the year of the dividend payment
or disposition would be subject to tax at the highest applicable tax rate, and
an interest charge would be imposed with respect to the resulting tax liability;
o the U.S shareholder would be required to file an annual return on IRS Form
8621 regarding distributions received on, gain recognized on dispositions of,
Metalink shares; and
o any U.S. shareholder who acquired the ordinary shares upon the death of the
shareholder would not receive a step-up to market value of his income tax basis
for such shares.
Instead such U.S shareholder beneficiary would have a tax basis equal to
the decedent's basis, if lower. Although the determination of Metalink's status
as a PFIC for years 2001 and 2002 was made only with respect to those years, and
will be revisited annually, the above described consequences shall apply for all
future years to U.S shareholders who held shares in the corporation at any time
during years 2001 and 2002, and who neither made a QEF election nor a
mark-to-market election (as discussed below) with respect to such shares with
their tax return that included the last day of the corporation's first taxable
year as a PFIC. This will be true even if the corporation ceases to be a PFIC in
later years. However, with respect to a PFIC that does not make any
distributions or deemed distributions, the above tax treatment would apply only
to U.S shareholders who realize gain on their disposition of the shares in the
PFIC. With respect to the treatment of Metalink as a PFIC for 2001 and/or 2002 ,
if a U.S shareholder made a valid QEF election for 2001 and/or 2002 with respect
to Metalink shares:
o the U.S shareholder would be required for each taxable year for which Metalink
is a PFIC to include in income a pro-rata share of Metalink's (i) net ordinary
earnings as ordinary income and (ii) net capital gain as long-term capital gain,
subject to a separate election to defer payment of taxes, which deferral is
subject to an interest charge.
o the U.S shareholder would not be required under these rules to include any
amount in income for any taxable year during which Metalink does not have net
ordinary earnings or capital gains; and
o the U.S shareholder would not be required under these rules to include any
amount in income for any taxable year for which Metalink is not a PFIC.
Metalink did not have net ordinary earnings or net capital gain for 2001 and
2002 tax years. Therefore, any U.S shareholder who makes a QEF election for 2001
and/or 2002 will not be required to include any amount in income as a result of
such election. The QEF election is made on a shareholder-by-shareholder basis
and can be revoked only with the consent of the IRS. A QEF election applies to
all shares of the PFIC held or subsequently acquired by an electing U.S holder.
A shareholder makes a QEF election by attaching a completed IRS Form 8621,
including the PFIC annual information statement, to a timely filed United States
federal income tax return and by filing such form with the IRS Service Center in
Philadelphia, Pennsylvania. Even if a QEF election is not made, a shareholder in
a PFIC who is a U.S. person must file a completed IRS Form 8621 every year.
During January 2002 and 2003 Metalink sent to its shareholders the required
information to report income and gain under a
QEF election - a "PFIC ANNUAL INFORMATION STATEMENT" for the years 2001 and 2002
respectively. Any U.S shareholder who would like to receive PFIC ANNUAL
INFORMATION STATEMENT for years 2001 and/or 2002 can contact Mr. Ofer Lavie,
Metalink Ltd, Yakum Business park, Yakum 60972, Israel.
Alternatively, a U.S. Holder of PFIC stock which is publicly traded could elect
to mark the stock to market annually, recognizing as ordinary income or loss
each year the shares are held, as well as on the disposition of the shares, an
amount equal to the difference between the U.S. Holder's adjusted tax basis in
the PFIC stock and its fair market value. Losses would be allowed only to the
extent of net mark-to-market gain previously included by the U.S. Holder under
the election for prior taxable years. As with the QEF election, a U.S
shareholder who makes a mark-to-market election for 2001 or 2002 with respect to
Metalink shares would not be subject to deemed ratable allocations of gain, the
interest charge, and the denial of basis step-up at death described above.
Subject to shares of Metalink ever ceasing to be marketable, a mark-to-market
election is irrevocable without obtaining the consent of the IRS and would
continue to apply even in years that Metalink was no longer a PFIC.
U.S. Holders of Metalink shares are strongly urged to consult their tax advisors
about the PFIC rules, including the advisability, procedure and timing of making
a mark-to-market or QEF election with respect to their holding of Metalink
ordinary shares, including warrants or rights to acquire Metalink ordinary
shares.
Tax Consequences for Non-U.S. Holders of Ordinary Shares
Except as described in "U.S. Information Reporting and Back-up Withholding"
below, a Non-U.S. Holder who is a beneficial owner of our ordinary shares will
not be subject to United States federal income or withholding tax on the payment
of dividends on, and the proceeds from the disposition of, the ordinary shares,
unless:
o such item is effectively connected with the conduct by the Non-U.S. Holder of
a trade or business in the United States and, in the case of a resident of a
country which has a treaty with the United States, such item is attributable to
a permanent establishment or, in the case of an individual, a fixed place of
business, in the United States;
o the Non-U.S. Holder is an individual who holds the ordinary shares as capital
assets and is present in the United States for 183 days or more in the taxable
year of the disposition and does not qualify for an exemption; or
o the Non-U.S. Holder is subject to tax pursuant to the provisions of United
States tax law applicable to U.S. expatriates.
U.S. Information Reporting and Backup Withholding
U.S. Holders generally are subject to information reporting requirements with
respect to dividends paid in the United States on our ordinary shares. In
addition, U.S. Holders are subject to U.S. backup withholding at a rate of up to
31% on dividends paid in the United States on the ordinary shares unless the
U.S. Holder provides an IRS Form W-9 or otherwise establishes an exemption. U.S.
Holders are subject to information reporting and backup withholding at a rate of
up to 31% on proceeds paid from the sale, exchange, redemption or other
disposition of the ordinary shares unless the U.S. Holder provides an IRS Form
W-9 or otherwise establishes an exemption.
Non-U.S. Holders generally are not subject to information reporting or back-up
withholding with respect to dividends paid on, or proceeds upon the sale,
exchange, redemption or other disposition of, the ordinary shares, provided that
such Non-U.S. Holder provides a taxpayer identification number, certifies to its
foreign status, or otherwise establishes an exemption. The amount of any backup
withholding will be allowed as a credit against such U.S. Holder's or Non-U.S.
Holder's United States federal income tax liability and may entitle such holder
to a refund, provided that the required information is furnished to the U.S.
Internal Revenue Service.
F. Dividends and Paying Agents
Not applicable.
G. Statements by Exports.
Not applicable.
H. Documents on Display
We are subject to the informational requirements of the Securities Exchange Act
of 1934, as amended, applicable to foreign private issuers and fulfill the
obligation with respect to such requirements by filing reports with the
Securities and Exchange Commission. You may read and copy any document we file
with the Securities and Exchange Commission without charge at the Securities and
Exchange Commission's public reference room at 450 Fifth Street, N.W,
Washington, D.C. 20549. Copies of such material may be obtained by mail from the
Public Reference Branch of the Securities and Exchange Commission at such
address, at prescribed rates. Please call the Securities and Exchange Commission
at l-800-SEC-0330 for further information on the public reference room.
As a foreign private issuer, we are exempt from the rules under the Exchange Act
prescribing the furnishing and content of proxy statements, and our officers,
directors and principal shareholders are exempt from the reporting and
"short-swing" profit recovery provisions contained in Section 16 of the Exchange
Act. In addition, we are not be required under the Exchange Act to file periodic
reports and financial statements with the Securities and Exchange Commission as
frequently or as promptly as United States companies whose securities are
registered under the Exchange Act. A copy of each report submitted in accordance
with applicable United States law is available for public review at our
principal executive offices.
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT
MARKET RISK
Foreign Currency Risk
All of our sales are made in US dollars. In addition, a substantial portion of
our costs is incurred in dollars. Since the dollar is the primary currency of
the economic environment in which we operate, the dollar is our functional
currency, and accordingly, monetary accounts maintained in currencies other than
the dollar (principally cash and cash equivalents, short-term deposits and
liabilities) are remeasured using the foreign exchange rate at the balance sheet
date. Operational accounts and non-monetary balance sheet accounts are measured
and recorded at the rate in effect at the date of the transaction. The effect of
foreign currency remeasurement is reported in current operations.
We do not presently engage in any hedging or other transactions intended to
manage risks relating to foreign currency exchange rate or interest rate
fluctuations. At December 31, 2002 and
December 31, 2001, we did not own any market risk sensitive instruments.
However, we may in the future undertake hedging or other similar transactions or
invest in market risk sensitive instruments if management determines that it is
necessary to offset these risks. See "Item 3-Key Information-Risk Factors-Risks
Relating to our location in Israel."
Interest Rate Risk
Our exposure to market
risk with respect to changes in interest rates relates primarily to our short-
and long-term investments. Our short- and long-term investments consist of
primarily, certificates of deposits and marketable debt securities of
highly-rated corporations. The fair value of our short- and long-term
investments is based upon their market value as of December 31, 2002.
The table below present principal amounts and related weighted average rates by
date of maturity for our short- and long-term investments:
Short-Term
(U.S. dollars in thousands)
Marketable debt securities Maturity date at year 2003
U.S. dollar debt securities and 20,691
certificates of deposit with
fixed interest rate
Weighted Average Interest Rate 2.39%
Long-Term
(U.S. dollars in thousands)
Marketable debt securities Maturity date at year 2004-on
U.S. dollar debt securities
with fixed interest rate 46,197
Weighted average interest rate 3.09%
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES
Not applicable.
PART II
ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES
Not applicable.
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF
PROCEEDS
Use of Proceeds Our initial public offering commenced on December 1,
1999, and terminated after the sale of all the securities registered. The
managing underwriter of the offering was Banc of America
Securities LLC. We registered 4,600,000 ordinary shares in the offering,
including shares issued pursuant to the exercise of the underwriter's
over-allotment option. Of such shares, we sold 4,600,000 ordinary shares at an
aggregate offering price of $55.2 million ($12.00 per share). Under the terms of
the offering, we incurred underwriting discounts of approximately $3.86 million.
We also incurred estimated expenses of $1.54 million in connection with the
offering. None of the expenses consisted of amounts paid directly or indirectly
to any of our directors, officers, general partners or their associates, any
persons owning 10% or more of any class of our equity securities, or any of our
affiliates. The net proceeds that we received as a result of the offering were
approximately $49.8 million. As of December 31, 2002, approximately $38 million
of the net proceeds have been used mainly for the enhancement of our operating
expenses, capital investments, and buy-back of Metalink shares. None of the use
of proceeds consisted of amounts paid directly or indirectly to any of our
directors, officers, general partners or their associates, any persons owning
10% or more of any class of our equity securities, or any
of our affiliates.
ITEM 15. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Based on their evaluation as of a date within 90 days of the filing date of this
Report, our Chief Executive Officer and Chief Financial Officer have concluded
that our disclosure controls and procedures (as defined in Rules 13a-14(c) and
15d-14(c) under the Securities Exchange Act of 1934 (the "Exchange Act")) are
effective to ensure that information required to be disclosed by the Company in
reports that it files or submits under the Exchange Act is recorded, processed,
summarized and reported in a timely manner.
Changes in internal controls
There were no significant changes in the Company's internal controls or in other
factors that could significantly affect these controls subsequent to the date of
their evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.
ITEM 16. [RESERVED]
PART III
ITEM 17. FINANCIAL STATEMENTS
We have responded to Item 18 in lieu of this item.
ITEM 18. FINANCIAL STATEMENTS
The financial statements required by this item are incorporated by reference to
the Company's filing with the Securities and Exchange Commission on Form 6-K on
June 16, 2003.
ITEM 19. EXHIBITS
The exhibits filed with or incorporated into this annual report are listed on
the index of exhibits below. Exhibit No. Description 1.1* Memorandum of
Association, as amended, (English translation accompanied by Hebrew original)
(incorporated herein by reference to Exhibit 4.2 to the Registrant's
Registration Statement on Form S-8, filed with the Securities and Exchange
Commission on April 17, 2001). 1.2* Articles of Association, as amended,
(English translation accompanied by Hebrew original) (incorporated herein by
reference to Exhibit 4.3 to the Registrant's Registration Statement on Form S-8,
filed with the Securities and Exchange Commission on April 17, 2001). 3* Voting
Agreement, dated August 11, 1999, between Tzvi Shukhman and Zvi Rosenberg
(incorporated herein by reference to Exhibit 10.1 to the Registrant's
Registration Statement on Form F-1 (No. 333-11118) filed with the Securities and
Exchange Commission on November 10, 1999).
4.1* Employee Share Option Plan (1997) (incorporated herein by reference to
Exhibit 10.2 to the Registrant's Registration Statement on Form F-1 (No.
333-11118) filed with the Securities and Exchange Commission on November 10,
1999).
4.2* Employee Share Option Plan (1997), Section 102 (incorporated herein by
reference to
Exhibit 10.3 to the Registrant's Registration Statement on Form F-1 (No.
333-11118) filed with the Securities and Exchange Commission on November 10,
1999). 4.3* International Employee Stock Option Plan (incorporated herein by
reference to Exhibit 10.4 to the Registrant's Registration Statement on Form F-1
(No. 333-11118) filed with the Securities and Exchange Commission on November
10, 1999).
4.4* Employee Share Option Plan (1999) (incorporated herein by reference to
Exhibit 10.5 to the Registrant's Registration Statement on Form F-1 (No.
333-11118) filed with the Securities and Exchange Commission on November 10,
1999).
4.5* Employee Share Option Plan (1999a) (incorporated herein by reference to
Exhibit 10.6 to the Registrant's Registration Statement on Form F-1 (No.
333-11118) filed with the Securities and Exchange Commission on November 10,
1999).
4.6* Unprotected Lease Agreement, dated June 6, 2000, between Yakum Development
Ltd. and the Registrant (English summary accompanied by Hebrew original)
(incorporated herein by reference to Exhibit 4.6 to the Registrant's Annual
Report on Form 20-F for the fiscal year ended December 31, 1999).
4.7* Standard Industrial/Commercial Multi-Tenant Lease - Net, dated December 12,
1999, between Garaventa Properties and Metalink, Inc. (incorporated herein by
reference to Exhibit 4.7 to the Registrant's Annual Report on Form 20-F for the
fiscal year ended December 31, 1999). 4.8* 2000 Employee Stock Purchase Plan
(incorporated herein by reference to Exhibit 4.5 to the Registrant Registration
Statement on Form S-8, filed with the Securities and Exchange Commission on
April 17, 2001).
4.9* Share Option Plan (2000) (incorporated herein by reference to Exhibit 4.9
to the Registrant's Registration Statement on Form 20-F, filed with the
Securities and Exchange Commission on June 29, 2001).
4.10 2003 Share Option Plan
4.11 2003 International Employee Stock Option Plan
10.1 Consent of Brightman Almagor & Co., independent auditors.
8* List of Subsidiaries (incorporated herein by reference to Exhibit 2.1 to the
Registrant's Registration Statement on Form F-1 (No. 333-11118) filed with the
Securities and Exchange Commission on November 10, 1999).
99.1 Certification by Chief Executive Officer pursuant to 18 U.S.C. Section
1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002. 99.2
Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.
- -----------------
* Incorporated by reference.
SIGNATURE
The registrant hereby certifies that it meets all of the requirements for filing
on Form 20-F and that it has duly caused and authorized the undersigned to sign
this annual report on its behalf.
METALINK LTD.
By:/s/ Ofer Lavie______
Name: Ofer Lavie
Title: Chief Financial Officer
Date: June 26, 2003
CERTIFICATION PURSUANT TO
SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002
I, Tzvika Shukhman, certify that:
1. I have reviewed this annual report on Form 20-F of Metalink Ltd.;
2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;
3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;
4. The
registrant's other certifying officers and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-14 and 15d-14) for the registrant and have:
i. designed such
disclosure controls and procedures to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us
by others within those entities, particularly during the period in which this
annual report is being prepared;
ii. evaluated the effectiveness of the
registrant's disclosure controls and procedures as of a date within 90 days
prior to the filing date of this annual report (the "Evaluation Date"); and
iii.
presented in this annual report our conclusions about the effectiveness of the
disclosure controls and procedures based on our evaluation as of the Evaluation
Date;
5. The registrant's other certifying officers and I have disclosed, based
on our most recent evaluation, to the registrant's auditors and the audit
committee of registrant's board of directors (or persons performing the
equivalent function):
i. all significant deficiencies in the design or operation
of internal controls which could adversely affect the registrant's ability to
record, process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and
ii. any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal controls; and
6. The
registrant's other certifying officers and I have indicated in this annual
report whether or not there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.
Date: June 26, 2003
/s/ Tzvika Shukhman_
Tzvika Shukhman
Chief Executive Officer &
Chairman of the Board
CERTIFICATION PURSUANT TO
SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002
I, Ofer Lavie, certify that:
1. I have reviewed this annual report on Form 20-F of Metalink Ltd.;
2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;
3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;
4. The
registrant's other certifying officers and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-14 and 15d-14) for the registrant and have:
i. designed such
disclosure controls and procedures to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us
by others within those entities, particularly during the period in which this
annual report is being prepared;
ii. evaluated the effectiveness of the
registrant's disclosure controls and procedures as of a date within 90 days
prior to the filing date of this annual report (the "Evaluation Date"); and
iii.
presented in this annual report our conclusions about the effectiveness of the
disclosure controls and procedures based on our evaluation as of the Evaluation
Date;
5. The registrant's other certifying officers and I have disclosed, based
on our most recent evaluation, to the registrant's auditors and the audit
committee of registrant's board of directors (or persons performing the
equivalent function):
i. all significant deficiencies in the design or operation
of internal controls which could adversely affect the registrant's ability to
record, process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and
ii. any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal controls; and
6. The
registrant's other certifying officers and I have indicated in this annual
report whether or not there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.
Date: June 26, 2003
/s/ Ofer Lavie
Ofer Lavie
Chief Financial Officer
EXHIBIT 4.10
2003 Share Option Plan
Metalink Ltd.
2003 SHARE OPTION PLAN
A. NAME AND PURPOSE
1. Name: This plan, as amended from time to time, shall be known as the
"Metalink Ltd. 2003 Share Option Plan" (the "Plan").
2. Purpose: The purpose and intent of the Plan is to provide incentives
to employees, directors, consultants and contractors of Metalink Ltd., a company
organized under the laws of the State of Israel, or any subsidiary or affiliate
thereof (the "Company"), by providing them with opportunities to purchase
Ordinary Shares, nominal value of 0.10 New Israeli Shekel each (the "Shares") of
the Company, pursuant to a plan approved by the Board of Directors of the
Company (the "Board") which is designed to benefit from, and is made pursuant
to, the provisions of either Section 102 or Section 3(9) of the Israeli Income
Tax Ordinance [New Version] 1961 (the "Ordinance"), as applicable, and the rules
and regulations promulgated thereunder.
B. GENERAL TERMS AND CONDITIONS OF THE PLAN 3. Administration:
3.1 The Board may appoint a Share Incentive Committee, which
will consist of such number of Directors of the Company, as may be fixed from
time to time by the Board. The Board shall appoint the members of the committee,
may from time to time remove members from, or add members to, the Committee and
shall fill vacancies in the Committee however caused. The Plan will be
administered by the Share Incentive Committee, and until the Board delegates
administration to such committee or where not permitted according to Section 112
of the Companies Law, 1999 (the "Companies Law"), by the Board (collectively -
the "Committee").
3.2 The Committee shall select one of its members as its
Chairman and shall hold its meetings at such times and places, as it shall
determine. Actions taken by a majority of the members of the Committee, at a
meeting at which a majority of its members is present, or acts reduced to, or
approved in, writing by all members of the Committee, shall be the valid acts of
the Committee. The Committee may appoint a Secretary, who shall keep records of
its meetings and shall make such rules and regulations for the conduct of its
business, as it shall deem advisable.
3.3 Subject to the general terms and conditions of this Plan
and applicable law, the Committee shall have the full authority in its
discretion, from time to time and at any time to determine (i) the persons
("Grantees") to whom options to purchase Shares (the "Options") shall be
granted, (ii) the number of Shares subject to each Option, (iii) the time or
times at which the same shall be granted, (iv) the schedule and conditions on
which such Options may be exercised and on which such Shares shall be paid for,
and/or (v) any other matter which is necessary or desirable for, or incidental
to, the administration of the Plan. In determining the number of Shares subject
to the Options to be granted to each Grantee, the Committee may
consider, among other things, the Grantee's salary and the duration of the
Grantee's employment by the Company.
3.4 Subject to the general terms and conditions of the Plan
and the Ordinance, the Committee shall have the full authority in its
discretion, from time to time and at any time, to determine:
(a) with respect to the grant of 102 Options (as
defined in Section
5.1(a)(i) below) - whether the Company shall elect the "Ordinary Income Route"
under Section 102(b)(1) of the Ordinance (the "Ordinary Income Route") or the
"Capital Gains Route" under Section 102(b)(2) of the Ordinance (the "Capital
Gains Route") (each of the Ordinary Income Route or the Capital Gains Route - a
"Taxation Route") for the grant of 102 Options, and the identity of the trustee
who shall be granted such 102 Options in accordance with the provisions of this
Plan and the then prevailing Taxation Route.
In the event the Committee determines that the Company shall
elect one of the Taxation Routes for the grant of 102 Options, the Company shall
be entitled to change such election only following the lapse of one year from
the end of the tax year in which 102 Options are first granted under the then
prevailing Taxation Route; and
(b) with respect to the grant of 3(9) Options (as
defined in Section
5.1(a)(ii) below) - whether or not 3(9) Options shall be granted to a trustee in
accordance with the terms and conditions of this Plan, and the identity of the
trustee who shall be granted such 3(9) Options in accordance with the provisions
of this Plan.
3.5 Notwithstanding the aforesaid, the Committee may, from
time to time and at any time, grant 102 Options that will not subject to a
Taxation Route, as detailed in Section 102(c) of the Ordinance ("102(c)
Options").
3.6 The Committee may, from time to time, adopt such rules and
regulations for carrying out the Plan as it may deem necessary. No member of the
Board or of the Committee shall be liable for any act or determination made in
good faith with respect to the Plan or any Option granted thereunder.
3.7 The interpretation and construction by the Committee of
any provision of the Plan or of any Option thereunder shall be final and
conclusive and binding on all parties who have an interest in the Plan or any
Option or Share issuance thereunder unless otherwise determined by the Board.
4. Eligible Grantees:
4.1 The Committee, at its discretion, may grant Options to any
employee, director, consultant or contractor of the Company. Anything in this
Plan to the contrary notwithstanding, all grants of Options to office holders
(i.e., "Nosei Misra", as such term is defined in the Companies Law) shall be
authorized and implemented only in accordance with the provisions of the
Companies Law.
4.2 The grant of an Option to a Grantee hereunder, shall
neither entitle such Grantee to participate, nor disqualify him from
participating, in any other grant of options pursuant to this Plan or any other
share option plan of the Company.
5. Grant of Options, Issuance of Shares, Dividends and
Shareholder Rights: 5.1 Grant of Options and Issuance of
Shares.
(a) Subject to the provisions of the Ordinance
and applicable law, (i) all grants of
Options to employees, directors and office
holders of the Company, other than to a Controlling Shareholder of the Company
(i.e., "Baal Shlita", as such term is defined in the Ordinance), shall be made
only pursuant to the provisions of Section 102 of the Ordinance, the Income Tax
Rules (Tax Relief in Issuance of Shares to Employees), 2003 ("102 Rules") and
any other regulations, rulings, procedures or clarifications promulgated
thereunder ("102 Options"), or any other section of the Income Tax Ordinance
that will be relevant for such issuance in the future; and
(ii) all grants of Options under the Plan,
to consultants,
contractors or Controlling Shareholders of the Company shall be made only
pursuant to the provisions of Section 3(9) of the Ordinance and the rules and
regulations promulgated thereunder ("3(9) Options"), or any other section of the
Ordinance that will be relevant for such issuance in the future.
(b) Subject to Sections 7.1 and 7.2 hereof, the effective date of the
grant of an Option (the "Date of Grant") shall be the date the Committee
resolves to grant such Option, unless specified otherwise by the Committee in
its determination relating to the award of such Option. The Committee shall
promptly give the Grantee written notice (the "Notice of Grant") of the grant of
an Option.
(c) Trust. In the event Options are granted under the
Plan to a trustee
designated by the Committee in accordance with the provisions of Section 3.4
hereof and, with respect to 102 Options, approved by the Israeli Commissioner of
Income Tax (the "Trustee"), the Trustee shall hold each such Option and the
Shares issued upon exercise thereof in trust (the "Trust") for the benefit of
the Grantee in respect of whom such Option was granted (the "Beneficial
Grantee").
In accordance with Section 102, the tax
benefits afforded to 102
Options (and any Shares received upon exercise thereof) in accordance with the
Ordinary Income Route or Capital Gains Route, as applicable, shall be contingent
upon the Trustee holding such 102 Options for a period (the "Trust Period") of
at least (i) one year from the end of the tax year in which the 102 Options are
granted, if the Company elects the Ordinary Income Route, or (ii) two years from
the end of the tax year in which the 102 Options are granted, if the Company
elects the Capital Gains Route, or (iii) such other period as shall be approved
by the Israeli Commissioner of Income Tax.
With respect to 102 Options granted to the Trustee, the following
shall apply:
(i) A Grantee granted 102 Options shall not be entitled to sell the
Shares received upon exercise thereof (the "Exercised Shares") or to transfer
such Exercised Shares (or such 102 Options) from the Trust prior to the lapse of
the Trust Period; (ii) Any and all rights issued in respect of the Exercised
Shares, including bonus shares but excluding cash dividends ("Rights"(, shall be
issued to the Trustee and held thereby until the lapse of the Trust Period, and
such Rights shall be subject to the Taxation Route which is applicable to such
Exercised Shares.
Notwithstanding the aforesaid, Exercised Shares or Rights may be
sold or transferred, and the Trustee may release such Exercised Shares (or 102
Options) or Rights from Trust, prior to the lapse of the Trust Period, provided
however, that tax is paid or withheld in accordance with Section 102(b)(4) of
the Ordinance and Section 7 of the 102 Rules.
All certificates representing Shares issued to the Trustee under the
Plan shall be deposited with the Trustee, and shall be held by the Trustee until
such time that such Shares are released from the Trust as herein provided.
(d) Subject to the terms hereof, at any time after
the options have
vested, with respect to any Options or Shares the following shall apply:
(i) Upon the written request of any
Beneficial Grantee, the
Trustee shall release from the Trust the Options granted, and/or the Shares
issued, on behalf of such Beneficial Grantee, by executing and delivering to the
Company such instrument(s) as the Company may require, giving due notice of such
release to such Beneficial Grantee, provided, however, that the Trustee shall
not so release any such Options and/or Shares to such Beneficial Grantee unless
the latter, prior to, or concurrently with, such release, provides the Trustee
with evidence, satisfactory in form and substance to the Trustee, that all
taxes, if any, required to be paid upon such release have, in fact, been paid.
(ii) Alternatively, provided the Shares are
listed on a stock
exchange or admitted to trading on an electronic securities trading system (such
as the Nasdaq Stock Market), upon the written instructions of the Beneficial
Grantee to sell any Shares issued upon exercise of Options, the Trustee shall
use its reasonable efforts to effect such sale and shall transfer such Shares to
the purchaser thereof concurrently with the receipt, or after having made
suitable arrangements to secure the payment of the proceeds of the purchase
price in such transaction. The Trustee shall withhold from such proceeds any and
all taxes required to be paid in respect of such sale, shall remit the amount so
withheld to the appropriate tax authorities and shall pay the balance thereof
directly to the Beneficial Grantee, reporting to such Beneficial Grantee and to
the Company the amount so withheld and paid to said tax authorities.
5.2 102(c) Options Guarantee. In the event a 102(c) Option is
granted to a Grantee who is an employee at the time of such grant, if the
Grantee's employment is terminated, for any reason, such Grantee shall provide
the Company with a guarantee or collateral, to the Committee's full
satisfaction, securing the payment of all taxes required to be paid upon the
sale of the Exercised Shares received upon exercise of such 102(c) Option.
5.3 Dividend. All Shares issued upon the exercise of Options
granted under the Plan shall entitle the Grantee thereof to receive dividends
with respect thereto. For so long as Shares issued to the Trustee on behalf of a
Beneficial Grantee are held in the Trust, the dividends paid or distributed with
respect thereto shall be remitted to the Trustee for the benefit of such
Beneficial Grantee or distributed directly to such Beneficial Grantee, as shall
be solely determined by the Committee.
5.4 Shareholder Rights. The holder of an Option shall have no
shareholder rights with respect to the Shares subject to such Option until such
person shall have exercised the Option, paid the exercise price and become the
recordholder of the purchased Shares.
6. Reserved Shares: The Company has reserved authorized but unissued
Shares for purposes of the Plan subject to adjustments as provided in Section 11
hereof. Notwithstanding the aforesaid, the Committee shall have full authority
in its discretion to determine that the Company may issue, for the purposes of
this Plan, previously issued Shares that are held by the Company, from time to
time, as Dormant Shares (as such term is defined in the Companies Law). All
Shares under the Plan, in respect of which the right hereunder of a Grantee to
purchase the same shall, for any reason, terminate, expire or otherwise cease to
exist, shall again be available for grant through Options under the Plan.
7. Grant of Options:
7.1 The implementation of the Plan and the granting of any
Option under the Plan shall be subject to the Company's procurement of all
approvals and permits required by applicable law or regulatory authorities
having jurisdiction over the Plan, the Options granted under it and the Shares
issued pursuant to it.
7.2 The Notice of Grant shall state, inter alia, the number of
Shares subject to each Option, the vesting schedule, the dates when the Options
may be exercised, the exercise price, whether the Options granted thereby are
102 Options or 3(9) Options, and such other terms and conditions as the
Committee at its discretion may prescribe, provided that they are consistent
with this Plan. Each Notice of Grant evidencing a 102 Option shall, in addition,
be subject to the provisions of the provisions of the Ordinance applicable to
such options.
7.3 Vesting. Without derogating from the rights and powers of
the Committee under Section 7.3 hereof, unless otherwise specified by the
Committee, the Options shall be for a term of ten (10) years, and, unless
determined otherwise by the Committee, the Vesting Period pursuant to which such
Options shall vest, and the Grantee thereof shall be entitled to pay for and
acquire the Shares, shall be such that all Options shall be fully vested on the
first business day following the passing of 12 months from the Adoption Date
(the "Adoption Date" for the purpose of this Plan means the Date of Grant or any
other date determined by the Committee for a given grant of Options).
Notwithstanding anything to the contrary, with respect to 3(9) Options granted
to contractors or advisors of the Company, in the event that said Grantee
ceases, for any reason, to serve as an advisor or as a contractor, as
applicable, of the Company prior to the vesting of any of his Options pursuant
to the provisions of his Notice(s) of Grant, all Options theretofore granted to
such Grantee shall continue to vest according to the Plan, in the same manner as
the Options would vest if the Grantee continued to serve as an advisor or
independent contractor, unconditionally, under the Plan.
"Vesting Period" of an Option means, for the purpose of the Plan and its
related instruments, the period between the Adoption Date and the date on which
the holder of an Option may exercise the rights awarded pursuant to the terms of
the Option. 7.4 Acceleration of Vesting. Anything herein to the contrary in this
Plan notwithstanding, the Committee shall have full authority to determine any
provisions regarding the acceleration of the Vesting Period of any Option or the
cancellation of all or any portion of any outstanding restrictions with respect
to any Option or Share upon certain events or occurrences, and to include such
provisions in the Notice of Grant on such terms and conditions as the Committee
shall deem appropriate.
7.5 Unless otherwise determined by the Committee, in the event that a Grantee
ceases to be a full time employee of the Company and becomes a part time
employee of the Company (the "Decrease in Position"), the amount of Options
granted under the Plan to such Grantee, which are unvested on the date of
Decrease in Position shall be immediately reduced in a direct proportion to the
Decrease in Position.
8. Exercise Price: The exercise price per Share subject to each Option
shall be determined by the Committee in its sole and absolute discretion,
subject to applicable law.
9. Exercise of Options:
9.1 Options shall be exercisable pursuant to the terms under which they were
awarded and subject to the terms and conditions of the Plan.
9.2 The exercise of an Option shall be made by a written
notice of exercise (the "Notice of Exercise") delivered by the Grantee (or, with
respect to Options held in the Trust, by the Trustee upon receipt of written
instructions from the Beneficial Grantee) to the Company at its principal
executive office, specifying the number of Shares to be purchased and
accompanied by the payment therefor, and containing such other terms and
conditions as the Committee shall prescribe from time to time.
9.3 Anything herein to the contrary notwithstanding, but
without derogating from the provisions of Section 10 hereof, if any Option has
not been exercised and the Shares subject thereto not paid for within ten (10)
years after the Date of Grant (or any shorter period set forth in the Notice of
Grant), such Option and the right to acquire such Shares shall terminate, all
interests and rights of the Grantee in and to the same shall ipso facto expire,
and, in the event that in connection therewith any Options are still held in the
Trust as aforesaid, the Trust with respect thereto shall ipso facto expire, and
the Shares subject to such Options shall again be available for grant through
Options under the Plan, as provided for in Section 6 herein.
9.4 Each payment for Shares shall be in respect of a whole
number of Shares, and shall be effected in cash or by a bank's check payable to
the order of the Company, or such other method of payment acceptable to the
Company.
10. Termination of Employment:
10.1 Employees. In the event that a Grantee who was an
employee of the Company on the Date of Grant of any Options to him or her
ceases, for any reason, to be employed by the Company (the "Cessation of
Employment"), all Options theretofore granted to such Grantee when such Grantee
was an employee of the Company shall terminate as follows:
(a) The date of the Grantee's Cessation of Employment
shall be the
date on which the employee-employer relationship between the Grantee and the
Company ceases to exist (the "Date of the Cessation").
(b) All such Options which are not vested at the Date
of Cessation
shall terminate immediately.
(c) If the Grantee's Cessation of Employment is by
reason of such
Grantee's death or "Disability" (as hereinafter defined), such Options (to the
extent vested at the Date of Cessation) shall be exercisable by the Grantee or
the Grantee's guardian, legal representative, estate or other person to whom the
Grantee's rights are transferred by will or by laws of descent or distribution,
at any time until (i) with respect to 102 Options - 180 days from the Date of
Cessation, and (ii) with respect to 3(9) Options - the specified expiration of
the term of such Options, and shall thereafter terminate.
For purposes hereof, "Disability" shall mean
the inability to engage
in any substantial gainful occupation for which the Grantee is suited by
education, training or experience, by reason of any medically determinable
physical or mental impairment which is expected to result in such person's death
or to continue for a period of six (6) consecutive months or more.
(d) If the Grantee's Cessation of Employment is due
to any reason
other than those stated in Sections 10.1(c), 10.1(e) and 10.1(f) herein, such
Options (to the extent vested at the Date of Cessation) shall be exercisable at
any time until (i) with respect to 102 Options - 90 days after the Date of
Cessation, and (ii) with respect to 3(9) Options - the specified
expiration of the term of such Options, and shall thereafter terminate;
provided, however, that with respect to 102 Options if the Grantee dies within
such period, such Options (to the extent vested at the Date of Cessation) shall
be exercisable by the Grantee's legal representative, estate or other person to
whom the Grantee's rights are transferred by will or by laws of descent or
distribution at any time until 180 days from the Date of Cessation, and shall
thereafter terminate.
(e) Notwithstanding the aforesaid, if the Grantee's
Cessation of
Employment is due to (i) breach of the Grantee's duty of loyalty towards the
Company, or (ii) breach of the Grantee's duty of care towards the Company, or
(iii) the commission any flagrant criminal offense by the Grantee, or (iv) the
commission of any act of fraud, embezzlement or dishonesty towards the Company
by the Grantee, or (v) any unauthorized use or disclosure by the Grantee of
confidential information or trade secrets of the Company, or (vi) any other
intentional misconduct by the Grantee (by act or omission) adversely affecting
the business or affairs of the Company in a material manner, or (vii) any act or
omission by the Grantee which would allow for the termination of the Grantee's
employment without severance pay, according to the Severance Pay Law, 1963, all
the Options whether vested or not shall ipso facto expire immediately and be of
no legal effect.
(f) If a Grantee retires, he shall, subject to the
approval of the
Committee, continue to enjoy such rights, if any, under the Plan and on such
terms and conditions, with such limitations and subject to such requirements as
the Committee in its discretion may determine.
(g) Whether the Cessation of Employment of a
particular Grantee is by
reason of "Disability" for the purposes of paragraph 10.1(c) hereof or by virtue
of "retirement" for purposes of paragraph 10.1(f) hereof, or is a termination of
employment other than by reason of such Disability or retirement, or is for
reasons as set forth in paragraph 10.1(e) hereof, shall be finally and
conclusively determined by the Committee in its absolute discretion.
(h) Notwithstanding the aforesaid, under no circumstances
shall any Option be exercisable after the specified expiration of the term of
such Option.
10.2 Directors, Consultants and Contractors. In the event that a
Grantee, who is a director, consultant or contractor of the Company, ceases, for
any reason, to serve as such, the provisions of Sections 10.1(b), 10.1(c),
10.1(d), 10.1(e), 10.1(g) and 10.2(h) above shall apply, mutatis mutandis. For
the purposes of this Section 10.2, "Date of Cessation" shall mean:
(a) with respect to directors - the date on which a director
submits notice of resignation from the Board or the date on which the
shareholders of the Company remove such director from the Board; and
(b) with respect to consultants and contractors - the date on
which the consulting or contractor agreement between such consultant or
contractor, as applicable, and the Company expires or the date on which either
of the parties to such agreement sends the other notice of its intention to
terminate said agreement.
10.3 Notwithstanding the foregoing provisions of this Section
10, the Committee shall have the discretion, exercisable either at the time an
Option is granted or thereafter, to:
(a) extend the period of time for which the Option is
to remain
exercisable following the Date of Cessation to such greater period of time as
the Committee shall deem appropriate, but in no event beyond the specified
expiration of the term of the Option;
(b) permit the Option to be exercised, during the
applicable exercise
period following the Date of Cessation, not only with respect to the number of
Shares for which such Option is exercisable at the Date of Cessation but also
with respect to one or more additional installments in which the Grantee would
have vested under the Option had the Grantee continued in the employ or service
of the Company.
11. Adjustments, Liquidation and Corporate Transaction: 11.1
Definitions:
"Corporate Transaction" means the occurrence, in a single transaction or in
a series of related transactions, of any one or more of the following events:
(i) a sale or other disposition of all or substantially all, as determined by
the Board in its discretion, of the consolidated assets of the Company and its
subsidiaries; (ii) a sale or other disposition of at least eighty percent (80%)
of the outstanding securities of the Company; (iii) a merger, consolidation or
similar transaction following which the Company is not the surviving
corporation; or (iv) a merger, consolidation or similar transaction following
which the Company is the surviving corporation but the Ordinary Shares of the
Company outstanding immediately preceding the merger, consolidation or similar
transaction are converted or exchanged by virtue of the merger, consolidation or
similar transaction into other property, whether in the form of securities, cash
or otherwise.
11.2 Adjustments. Subject to any required action by the
shareholders of the Company, the number of Shares subject to each outstanding
Option, and the number of Shares which have been authorized for issuance under
the Plan but as to which no Options have yet been granted or which have been
returned to the Plan upon cancellation or expiration of an Option, as well as
the price per share of Shares subject to each such outstanding Option, shall be
proportionately adjusted for any increase or decrease in the number of issued
Shares resulting from a stock split, reverse stock split, stock dividend,
combination or reclassification of the Shares or the payment of a stock dividend
(bonus shares) with respect to the Shares or any other increase or decrease in
the number of issued Shares effected without receipt of consideration by the
Company; provided, however, that conversion of any convertible securities of the
Company shall not be deemed to have been "effected without receipt of
consideration." Such adjustment shall be made by the Committee, whose
determination in that respect shall be final, binding and conclusive. Except as
expressly provided herein, no issuance by the Company of shares of any class, or
securities convertible into shares of any class, shall affect, and no adjustment
by reason thereof shall be made with respect to, the number or price of Shares
subject to an Option.
11.3 Liquidation. Unless otherwise provided by the Board, in
the event of the proposed dissolution or liquidation of the Company, all
outstanding Options will terminate immediately prior to the consummation of such
proposed action. In such case, the Committee may declare that any Option shall
terminate as of a date fixed by the Committee and give each Grantee the right to
exercise his Option, including any Option which would not otherwise be
exercisable.
11.4 Corporate Transaction.
(a) In the event of a Corporate Transaction, unless
otherwise
determined by the Board, immediately prior to the effective date of such
Corporate Transaction, each Option may, at the sole and absolute discretion of
the Committee, either:
(i) be substituted for an option to purchase
securities of any
successor entity (the "Successor Entity Option") such that the Grantee may
exercise the Successor Entity Option for such number and class of securities of
the successor entity which would have been issuable to the Grantee in
consummation of such Corporate Transaction, had the Option been exercised
immediately prior to the effective date of such Corporate Transaction; or
(ii) be assumed by any successor entity such
that the Grantee
may exercise the Option for such number and class of securities of the successor
entity which would have been issuable to the Grantee in consummation of such
Corporate Transaction, had the Option been exercised immediately prior to the
effective date of such Corporate Transaction; or
(iii) automatically vest in full so that the
Option shall, ten (10)
days prior to the effective date of the Corporate Transaction, become fully
exercisable for all of the Shares at that time subject to the Option and may be
exercised for any or all of those Shares;
In the event of a clause (i) or clause (ii) action, appropriate adjustments
shall be made to the exercise price per Share to reflect such action.
Immediately following the consummation of the Corporate
Transaction, all outstanding Options shall terminate and cease to be
outstanding, except to the extent assumed by a successor entity.
(b) Notwithstanding the foregoing, the Committee
shall have full
authority and sole discretion to determine that any of the provisions of
Sections 11.4(a)(i), 11.4(a)(ii) or 11.4(a)(iii) above shall apply in the event
of a Corporate Transaction in which the consideration received by the
shareholders of the Company is not solely comprised of securities of a successor
entity, or in which such consideration is solely cash or assets other than
securities of a successor entity.
11.5 Sale. In the event that all or substantially all of the
issued and outstanding share capital of the Company is to be sold (the "Sale"),
each Grantee shall be obligated to participate in the Sale and sell his or her
Shares and/or Options in the Company, provided, however, that each such Share or
Option shall be sold at a price equal to that of any other Share sold under the
Sale (minus the applicable exercise price), while accounting for changes in such
price due to the respective terms of any such Option, and subject to the
absolute discretion of the Board.
11.6 The grant of Options under the Plan shall in no way
affect the right of the Company to adjust, reclassify, reorganize or otherwise
change its capital or business structure or to merge, consolidate, dissolve,
liquidate or sell or transfer all or any part of its business or assets.
12. Limitations on Transfer: No Option shall be assignable or
transferable by the Grantee to whom granted otherwise than by will or the laws
of descent and distribution, and an Option may be exercised during the lifetime
of the Grantee only by such Grantee or by such Grantee's guardian or legal
representative. The terms of such Option shall be binding upon the
beneficiaries, executors, administrators, heirs and successors of such Grantee.
13. Term and Amendment of the Plan:
13.1 The Plan was adopted by the Board on April 21, 2003. The
Plan shall terminate upon the earliest of (i) the expiration of the ten
(10)-year period measured from the date the Plan was adopted by the Board, or
(ii) the termination of all outstanding Options in connection with a Corporate
Transaction. All Options outstanding at the time of a clause (i) termination
event shall continue to have full force and effect in accordance with the
provisions of the Plan and the documents evidencing such Options.
13.2 Subject to applicable laws, the Board shall have complete
and exclusive power and authority to amend or modify the Plan in any or all
respects. However, no such amendment or modification shall adversely affect any
rights and obligations with respect to Options at the time outstanding under the
Plan, unless the Grantee consents to such amendment or modification.
13.3 Without derogating from the foregoing, the Board in its
discretion may, at any time and from time to time, without the approval of the
Shareholders of the Company, increase the amount of authorized but unissued
Shares reserved for purposes of the Plan.
14. Withholding and Tax Consequences: The Company's obligation to
deliver Shares upon the exercise of any Options granted under the Plan shall be
subject to the satisfaction of all applicable income tax and other compulsory
payments withholding requirements. All tax consequences and obligations
regarding any other compulsory payments arising from the grant or exercise of
any Option, from the payment for, or the subsequent disposition of, Shares
subject thereto or from any other event or act (of the Company, of the Trustee
or of the Grantee) hereunder, shall be borne solely by the Grantee, and the
Grantee shall indemnify the Company and/or the Trustee, as applicable, and hold
them harmless against and from any and all liability for any such tax or other
compulsory payment, or interest or penalty thereon, including without
limitation, liabilities relating to the necessity to withhold, or to have
withheld, any such tax or other compulsory payment from any payment made to the
Grantee.
15. Miscellaneous:
15.1 Continuance of Employment. Neither the Plan nor the grant
of an Option thereunder shall impose any obligation on the Company to continue
the employment or service of any Grantee. Nothing in the Plan or in any Option
granted thereunder shall confer upon any Grantee any right to continue in the
employ or service of the Company for any period of specific duration, or
interfere with or otherwise restrict in any way the right of the Company to
terminate such employment or service at any time, for any reason, with or
without cause.
15.2 Governing Law. The Plan and all instruments issued
thereunder or in connection therewith, shall be governed by, and interpreted in
accordance with, the laws of the State of Israel.
15.3 Use of Funds. Any proceeds received by the Company from
the sale of Shares pursuant to the exercise of Options granted under the Plan
shall be used for general corporate purposes of the Company.
15.4 Multiple Agreements. The terms of each Option may differ
from other Options granted under the Plan at the same time, or at any other
time. The Committee may also grant more than one Option to a given Grantee
during the term of the Plan, either in addition to, or in substitution for, one
or more Options previously granted to that Grantee. The grant of multiple
Options may be evidenced by a single Notice of Grant or multiple Notices of
Grant, as determined by the Committee.
15.5 Non-Exclusivity of the Plan. The adoption of the Plan by
the Board shall not be construed as amending, modifying or rescinding any
previously approved incentive arrangement or as creating any limitations on the
power of the Board to adopt such other incentive arrangements as it may deem
desirable, including, without limitation, the granting of stock options
otherwise than under the Plan, and such arrangements may be either applicable
generally or only in specific cases.
* * *
EXHIBIT 4.11
2003 International Employee Stock Option Plan
METALINK LTD.
2003 INTERNATIONAL EMPLOYEE STOCK OPTION PLAN
A. NAME AND PURPOSE
1. Name and Purpose: This Plan, as amended from time to time, shall be
known as the "2003 Metalink International Employee Stock Option Plan" (the
"Plan"). The purpose and intent of the Plan is to provide incentives to
officers, employees and consultants of any Subsidiary of Metalink Ltd (the
"Company"), other than Metalink Inc., the United States subsidiary of Metalink
Ltd. (the "Parent"), by providing them with opportunities to purchase Ordinary
Shares, nominal value 0.10 New Israeli Shekels each (the "Shares"), of the
Parent.
2. Definitions:
2.1 "Subsidiary" means a company whose more than 50% of its
voting rights and securities are held by Metalink Ltd.
B. GENERAL TERMS AND CONDITIONS OF THE PLAN
3. Administration:
3.1 The Plan will be administered by the Board of Directors of
the Parent (the "Board") or by a committee appointed by the Board (the
"Committee"), which, if appointed, will consist of such number of directors of
the Parent as may be fixed, from time to time, by the Board. If a Committee is
not appointed, the term Committee, whenever used herein, shall mean the Board.
The Board shall appoint the members of the Committee, may from time to time
remove members from, or add members to, the Committee and shall fill vacancies
in the Committee however caused.
3.2 The Committee shall select one of its members as its
Chairman and shall hold its meetings at such times and places, as it shall
determine. Actions taken by a majority of the members of the Committee, at a
meeting at which a majority of its members is present, or acts reduced to or
approved in writing by all members of the Committee, shall be the valid acts of
the Committee. The Committee may appoint a Secretary, who shall keep records of
its meetings and shall make such rules and regulations for the conduct of its
business, as it shall deem advisable.
3.3 Subject to the general terms and conditions of this Plan,
the Committee shall have the full authority in its sole and absolute discretion,
from time to time and at any time, (a) to determine (i) the persons ("Grantees")
to whom options to purchase Shares ("Option(s)") shall be granted, (ii) the
number of Shares to be covered by each Option, (iii) the time or times at which
the same shall be granted, (iv) the price, vesting schedule and conditions on
which such Options may be exercised and on which such Shares shall be paid for,
and (b) to interpret or construe the Plan or make determinations with respect to
any other matter which is necessary or desirable for, or incidental to, the
administration of the Plan. In determining the number of Shares covered by the
Option to be granted to each Grantee, the Committee may consider, among other
things, the Grantee's salary and the duration of the Grantee's employment by the
Parent or by the Company.
3.4 The Committee may, from time to time, adopt such rules and
regulations for carrying out the Plan as it may deem necessary. No member of the
Board or of the Committee shall be liable for any act or determination made in
good faith with respect to the Plan or any Option granted thereunder.
3.5 The interpretation and construction by the Committee of
any provision of the Plan or of any Option thereunder shall be final and
conclusive unless otherwise determined by the Board, in which event the Board's
determination shall be final and conclusive.
4. Eligible Grantees: The Committee, in its discretion, may grant
Options to any officer, director or consultant of the Company;. Anything in this
Plan to the contrary notwithstanding, all grants of Options to Directors and
Office Holders -- "Nosei Misra" -- as such term is defined in the Israeli
Companies Ordinance (New Version), 1983, as amended from time to time (the
"Companies Ordinance") -- shall be authorized and implemented only in accordance
with the provisions of the Companies Ordinance. The grant of an Option to a
Grantee hereunder, shall neither entitle such Grantee to participate, nor
disqualify him from participating, in any other grant of options pursuant to
this Plan or any other stock option plan of the Parent.
5. Grant of Options and Issuance of Shares: Subject to any applicable
law, the effective date of the grant of an Option (the "Date of Grant") shall be
the date specified by the Committee in its determination relating to the award
of such Option. The Committee shall
promptly give the Grantee written notice of the grant of an Option, and the
Grantee shall execute an agreement evidencing such grant and the rights and
obligations of the Grantee and the Company with respect to such Option Agreement
(the "Option Agreement").
6. Reserved Shares: The Parent will reserve such number of authorized
but unissued Shares for purposes of the Plan, as shall be determined from time
to time by the committee, subject to adjustments as provided in Section 11
hereof. All Shares under the Plan, in respect of which the right hereunder of a
Grantee to purchase the same shall, for any reason, terminate, expire or
otherwise cease to exist, shall again be available for grant through Options
under the Plan.
7. Grant of Options:
7.1 The Committee in its discretion may award to Grantees
Options to purchase Shares available under the Plan.
7.2 Each Option Agreement shall state, inter alia, the number
of Shares covered thereby, the dates when the Option may be exercised, the
exercise price, and such other terms and conditions as the Committee at its
discretion may prescribe, provided that they are consistent with this Plan.
7.3 Options granted hereunder shall be for such term as the Committee shall
determine,.
7.4 The schedule pursuant to which such Options shall vest and
pursuant to which the Grantee shall be entitled to pay for, and acquire, the
Shares, shall be determined by the Committee in its sole discretion. Vesting of
Options granted hereunder will continue only during periods when the
employer-employee or other service-provider relationship exists between the
Company and the Grantee. For the purposes of this paragraph 7.4, the
employer-employee or other service-provider relationship will not be deemed to
exist with regard to periods during which the Grantee is on an unpaid leave of
absence from the Company.
7.5 In the event the Grantee changes from a full time to a part time job his/her
number of unvested options will be reduced in accordance with the new time
definition of the job.
8. Exercise Price: The exercise price per Share covered by each Option
shall be determined by the Committee in its sole discretion; provided, however:
8.1 the per Share exercise price shall be no less than 100% of
the Fair Market Value per Share on the date of the grant.
8.2 In no event shall the exercise price of an Option be less
than the nominal value of the Shares into which such Option is exercisable.
8.3 For the purposes hereof, "Fair Market Value" means the
fair market value of the Shares as determined by the Committee; provided,
however, that Fair Market Value on any date shall be the last sale price
reported for the Shares in Nasdaq National Market on such date or on the last
day preceding such date on which a sale was reported.
9. Exercise of Options:
9.1 Options shall be exercisable pursuant to the terms under
which they were awarded and subject to the terms and conditions of this Plan and
the Option Agreement.
9.2 The exercise of an Option shall be made by a written
notice of exercise (the "Notice of Exercise") delivered by the Grantee to the
Parent at its principal executive office or as instructed by the Parent,
specifying the number of Shares to be purchased and accompanied by the payment
therefor, and containing such other terms and conditions as the Committee shall
prescribe from time to time. An Option may be exercised in whole or in part to
the extent exercisable under the Plan and Option Agreement.
9.3 Anything herein to the contrary notwithstanding, but
without derogating from the provisions of Sections 7 or 10 hereof, if any Option
has not been exercised and the Shares covered thereby have not paid for within
ten (10) years after the Date of Grant (or any shorter period set forth in the
Option Agreement), such Option and the right to acquire such Shares shall
terminate, and all interests and rights of the Grantee in and to the same shall
ipso facto expire.
9.4 Each payment for Shares shall be in respect of a whole
number of Shares, and shall be effected in cash or by a cashier's check payable
to the order of the Parent, or any other method of payment acceptable to the
Parent.
10. Termination of Employment:
10.1 In the event that a Grantee ceases, for any reason, to be
employed by the Company, all Options theretofore granted to such Grantee shall
terminate as follows:
(a) All Options which are not vested at the time of
the cessation of
employment shall terminate immediately.
(b) If the Grantee ceases to be employed by reason of
such Grantee's
death or "Disability" (as hereinafter defined), the Grantee's Options (to the
extent exercisable at the time of the Grantee's cessation of employment) shall
be exercisable by the Grantee's legal representative, estate or other person to
whom the Grantee's rights are transferred by will or by laws of descent or
distribution at any time until (i) one hundred and eighty (180) days from the
cessation of the Grantee's employment, but in no event after the expiration date
of such Option), and shall thereafter terminate. For purposes hereof,
"Disability" shall mean the inability, due to illness or injury, to engage in
any gainful occupation for which the individual is suited by
education, training or experience, which condition continues for at least
six (6) months.
(c) If the Grantee ceases to be employed for any
other reason, the
Grantee's Options (to the extent exercisable at the time of the Grantee's
cessation of employment) shall be exercisable at any time until (i) ninety (90)
days from the cessation of the Grantee's employment, but in no event after the
expiration date of such Option), and shall thereafter terminate; provided,
however, that, if the Grantee dies within such period, the Grantee's Options (to
the extent exercisable at the time of the Grantee's termination of employment)
shall be exercisable by the Grantee's legal representative, estate or other
person to whom the Grantee's rights are transferred by will or by laws of
descent or distribution at any time until the later of (i) the end of such
period or (ii) thirty (30) days after the date of the Grantee's death (but in no
event after the expiration date of such Option), and shall thereafter terminate.
(d) Notwithstanding the aforesaid in Section 10.1(c)
above, if the
Grantee's termination of employment is because (i) of a breach of the Grantee's
fiduciary duties towards the Company, (ii) of a breach of the Grantee's duty of
care towards the Company, (iii) the Grantee has committed any flagrant criminal
offense, (iv) the Grantee has committed a fraudulent act towards the Company, or
(v) the Grantee caused intentionally, by act or omission, any financial damage
to the Company, of the Grantee's Options (whether vested or not) shall ipso
facto expire immediately and be of no legal effect.
10.2 Whether the cessation of employment of a particular
Grantee is for reason of "Disability" for the purposes of paragraph 10.1(b)
hereof, or is a termination of employment other than by reason of such
Disability, or is for reasons as set forth in paragraph 10.1(d) hereof, shall be
finally and conclusively determined by the Committee in its absolute discretion.
10.3 Notwithstanding the foregoing provisions of Section 10.1,
the Committee may provide, either at the time an Option is granted or
thereafter, that such Option may be exercised after the periods provided for in
Section 10.1, but in no event beyond the term of the Option.
11. Adjustments, Liquidation and Corporate Transaction: 11.1
Definitions:
"Corporate Transaction" means the occurrence, in a single transaction or in
a series of related transactions, of any one or more of the following events:
(i) a sale or other disposition of all or substantially all, as determined by
the Board in its discretion, of the consolidated assets of the Parent and its
Subsidiaries; (ii) a sale or other disposition of at least eighty percent (80%)
of the outstanding securities of the Parent; (iii) a merger, consolidation or
similar transaction following which the Parent is not the surviving corporation;
or (iv) a merger, consolidation or similar transaction following which the
Parent is the surviving corporation but the Ordinary Shares of the Parent
outstanding immediately preceding the merger, consolidation or similar
transaction are converted or exchanged by virtue of the merger,
consolidation or similar transaction into other property, whether in the form of
securities, cash or otherwise.
11.2 Adjustments. Subject to any required action by the
shareholders of the Parent, the number of Shares subject to each outstanding
Option, and the number of Shares which have been authorized for issuance under
the Plan but as to which no Options have yet been granted or which have been
returned to the Plan upon cancellation or expiration of an Option, as well as
the price per share of Shares subject to each such outstanding Option, shall be
proportionately adjusted for any increase or decrease in the number of issued
Shares resulting from a stock split, reverse stock split, stock dividend,
combination or reclassification of the Shares or the payment of a stock dividend
(bonus shares) with respect to the Shares or any other increase or decrease in
the number of issued Shares effected without receipt of consideration by the
Parent; provided, however, that conversion of any convertible securities of the
Parent shall not be deemed to have been "effected without receipt of
consideration." Such adjustment shall be made by the Committee, whose
determination in that respect shall be final, binding and conclusive. Except as
expressly provided herein, no issuance by the Parent of shares of any class, or
securities convertible into shares of any class, shall affect, and no adjustment
by reason thereof shall be made with respect to, the number or price of Shares
subject to an Option.
11.3 Liquidation. Unless otherwise provided by the Board, in
the event of the proposed dissolution or liquidation of the Parent, all
outstanding Options will terminate immediately prior to the consummation of such
proposed action. In such case, the Committee may declare that any Option shall
terminate as of a date fixed by the Committee and give each Grantee the right to
exercise his Option, including any Option which would not otherwise be
exercisable.
11.4 Corporate Transaction.
(a) In the event of a Corporate Transaction, unless
otherwise
determined by the Board, immediately prior to the effective date of such
Corporate Transaction, each Option may, at the sole and absolute discretion of
the Committee, either:
(i) be substituted for an option to purchase
securities of any
successor entity (the "Successor Entity Option") such that the Grantee may
exercise the Successor Entity Option for such number and class of securities of
the successor entity which would have been issuable to the Grantee in
consummation of such Corporate Transaction, had the Option been exercised
immediately prior to the effective date of such Corporate Transaction; or
(ii) be assumed by any successor entity such
that the Grantee
may exercise the Option for such number and class of securities of the successor
entity which would have been issuable to the Grantee in consummation of such
Corporate Transaction, had the Option been exercised immediately prior to the
effective date of such Corporate Transaction; or
(iii) automatically vest in full so that the
Option shall, ten (10)
days prior to the effective date of the Corporate Transaction, become fully
exercisable for all of the Shares at that time subject to the Option and may be
exercised for any or all of those Shares;
In the event of a clause (i) or clause (ii) action, appropriate
adjustments shall be made to the exercise price per Share to reflect such
action.
Immediately following the consummation of the Corporate
Transaction, all outstanding Options shall terminate and cease to be
outstanding, except to the extent assumed by a successor entity.
(b) Notwithstanding the foregoing, the Committee
shall have full
authority and sole discretion to determine that any of the provisions of
Sections 11.4(a)(i), 11.4(a)(ii) or 11.4(a)(iii) above shall apply in the event
of a Corporate Transaction in which the consideration received by the
shareholders of the Parent is not solely comprised of securities of a successor
entity, or in which such consideration is solely cash or assets other than
securities of a successor entity.
11.5 Sale. In the event that all or substantially all of the
issued and outstanding share capital of the Parent is to be sold (the "Sale"),
each Grantee shall be obligated to participate in the Sale and sell his or her
Shares and/or Options in the Parent, provided, however, that each such Share or
Option shall be sold at a price equal to that of any other Share sold under the
Sale (minus the applicable exercise price), while accounting for changes in such
price due to the respective terms of any such Option, and subject to the
absolute discretion of the Board.
11.6 The grant of Options under the Plan shall in no way
affect the right of the Parent to adjust, reclassify, reorganize or otherwise
change its capital or business structure or to merge, consolidate, dissolve,
liquidate or sell or transfer all or any part of its business or assets.
12. Non-Transferability: No Option shall be assignable or transferable by the
Grantee to whom granted otherwise than by will or the laws of descent and
distribution, and an Option may be exercised during the lifetime of the Grantee
only by such Grantee or by such Grantee's guardian or legal representative. The
terms of such Option shall be binding upon the beneficiaries, executors,
administrators, heirs and successors of such Grantee.
13. Term and Amendment of the Plan:
13.1 The Plan was adopted by the Board on April 21, 2003. The
Plan shall terminate upon the earliest of (i) the expiration of the ten
(10)-year period measured from the date the Plan was adopted by the Board, or
(ii) the termination of all outstanding Options in connection with a Corporate
Transaction. All Options outstanding at the time of a clause (i) termination
event shall continue to have full force and effect in accordance with the
provisions of the Plan and the documents evidencing such Options.
13.2 Subject to applicable laws, the Board shall have complete
and exclusive power and authority to amend or modify the Plan in any or all
respects. However, no such amendment or modification shall adversely affect any
rights and obligations with respect to Options at the time outstanding under the
Plan, unless the Grantee consents to such amendment or modification.
13.3 Without derogating from the foregoing, the Board in its
discretion may, at any time and from time to time, without the approval of the
Shareholders of the Company, increase the amount of authorized but unissued
Shares reserved for purposes of the Plan.
14. Tax Consequences: All taxes payable by reason of the grant or
exercise of any Option, the payment for, or the subsequent disposition of,
Shares covered thereby or any other
event or act (of the Parent, the Company or the Grantee) hereunder, shall be
paid solely by the Grantee, and the Grantee shall indemnify the Company and the
Parent and hold them harmless against and from any and all liability for any
such tax or interest or penalty thereon, including without limitation,
liabilities relating to the necessity to withhold, or to have withheld, any such
tax from any payment made to the Grantee.
15. Restricted Stock: Unless heretofore registered under the Securities
Act of 1933 and the regulations promulgated hereunder (the "Act"), the Shares
issuable upon exercise of the Options granted herein will be "restricted
securities" and may not be resold absent registration under the Act or an
available exemption thereunder. In the event that an owner of restricted Shares
issued pursuant to this Plan effects a sale or transfer of such Shares under an
available exemption under the Act, such owner shall, before effecting such sale
or transfer, (i) notify the Parent in writing of the proposed disposition and
the name of the proposed transferees, (ii) furnish the Parent with an opinion of
counsel satisfactory in form and content to the Parent, and (iii) furnish the
Parent with an agreement in writing from the transferee pursuant to which such
transferee agrees to be bound by the provisions contained herein and in the
Option Agreement, or (iv) the Parent shall have waived, expressly and in
writing, its rights under clauses (i), (ii) and (iii) of this subsection.
16. Miscellaneous:
16.1 Continuance of Employment: Neither the Plan nor the grant
of an Option thereunder shall impose any obligation on the Company or the Parent
to continue the employment of any Grantee, and nothing in the Plan or in any
Option granted pursuant thereto shall confer upon any Grantee any right to
continue in the employ of the Company or the Parent, or restrict the right of
the Company or the Parent to terminate such employment at any time.
16.2 Governing Law; Regulations and Approvals:
16.2.1 The Plan and all instruments issued thereunder or in connection
therewith, shall be governed by, and interpreted in accordance with, the
laws of the State of Israel.
16.2.2 The obligation of the Parent to sell or deliver Shares with respect
to Options granted under the Plan shall be subject to all applicable laws, rules
and regulations and the obtaining of all such approvals by governmental agencies
as may be deemed necessary or appropriate by the Committee.
16.2.3 Subject to Section 9, the Board may make such changes as may be necessary
or appropriate to comply with the rules and regulations of any government
authority.
16.2.4 Each Option is subject to the requirement that, if at any time the
Committee determines, in its discretion, that the listing, registration or
qualification of Shares issuable pursuant to the Plan is required by any
securities exchange or under law, or the consent
or approval of any law, or the consent or approval of any governmental
regulatory body is necessary or desirable as a condition of, or in connection
with, the grant of an Option or the issuance of Shares, no Options shall be
granted or payment made or Shares issued, in whole or in part, unless listing,
registration, qualification, consent or approval has been effected or obtained
free of any conditions that are not acceptable to the Committee.
16.3 Application of Funds: The proceeds received by the Parent
from the sale of Shares pursuant to Options granted under the Plan will be used
for general corporate purposes of the Parent.
16.4 Multiple Agreements: The terms of each Option may differ
from other Options granted under the Plan at the same time, or at any other
time. The Committee may also grant more than one Option to a given Grantee
during the term of the Plan, either in addition to, or in substitution for, one
or more Options previously granted to that Grantee. The grant of multiple
Options may be evidenced by a single Option Agreement or multiple Option
Agreements, as determined by the Committee.
16.5 Non-Exclusivity of the Plan: The adoption of the Plan by
the Board shall not be construed as amending, modifying or rescinding any
previously approved incentive arrangement or as creating any limitations on the
power of the Board to adopt such other incentive arrangements as it may deem
desirable, including, without limitation, the granting of stock options
otherwise than under the Plan, and such arrangements may be either applicable
generally or only in specific cases.
16.6 Withholding of Taxes: In order to ensure compliance by a
Grantee with Section 14, the Parent and the Company shall have the right to
deduct from any payment of cash to any such Grantee an amount equal to the
income taxes and other amounts required by law to be withheld with respect to
any Option. Notwithstanding anything to the contrary contained herein, if a
Grantee is entitled to receive Shares upon exercise of an Option, the Parent and
the Company shall have the right to require such Grantee, prior to the delivery
of such Shares, to pay to the Parent and the Company the aggregate amount of any
income taxes and other amounts that the Parent and the Company are required by
law to withhold.
* * *
EXHIBIT 10.1
CONSENT OF INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statement (Form
S-8 No. 333-88172) pertaining to the Metalink Ltd. Employee Stock Purchase Plan
for the Employees of Metalink Ltd And Metalink Inc, of our report, dated January
27, 2003, with respect to the consolidated financial statements of Metalink Ltd.
included in its Annual Report (Form 20-F) for the year ended December 31, 2002.
/s/ Brightman Almagor & Co.
BRIGHTMAN ALMAGOR & CO
Certified Public Accountants
A member of Deloitte Touche Tohmatsu
Tel Aviv, Israel
June 27, 2003
EXHIBIT 99.1
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report on Form 20-F of Metalink Ltd. (the
"Company") for the period ending December 31, 2002 (the "Report"), I, Tzvika
Shukhman, Chief Executive Officer & Chairman of the Company, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
1. the Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and 2. the information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.
Date: June 26, 2003
/s/ Tzvika Shukhman
Tzvika Shukhman
Chief Executive Officer &
Chairman of the Board
A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to Metalink Ltd. and will be retained
by Metalink Ltd. and furnished to the Securities and Exchange Commission or its
staff upon request.
EXHIBIT 99.2
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report on Form 20-F of Metalink Ltd. (the
"Company") for the period ending December 31, 2002 (the "Report"), I, Ofer
Lavie, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:
1. the Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and 2. the information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.
Date: June 26, 2003
/s/_Ofer Lavie___
Ofer Lavie
Chief Financial Officer
A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to Metalink Ltd. and will be retained
by Metalink Ltd. and furnished to the Securities and Exchange Commission or its
staff upon request.